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ABSTRACT  
   
According to the World Health Organization, cancer is one of the leading causes 
of death around the world. Although early diagnostics using biomarkers and improved 
treatments with targeted therapy have reduced the rate of cancer related mortalities, there 
remain many unknowns regarding the contributions of the tumor microenvironment to 
cancer progression and therapeutic resistance. The tumor microenvironment plays a 
significant role by manipulating the progression of cancer cells through biochemical and 
biophysical signals from the surrounding stromal cells along with the extracellular 
matrix. As such, there is a critical need to understand how the tumor microenvironment 
influences the molecular mechanisms underlying cancer metastasis to facilitate the 
discovery of better therapies. This thesis described the development of microfluidic 
technologies to study the interplay of cancer cells with their surrounding 
microenvironment. The microfluidic model was used to assess how exposure to 
chemoattractant, epidermal growth factor (EGF), impacted 3D breast cancer cell invasion 
and enhanced cell motility speed was noted in the presence of EGF validating 
physiological cell behavior. Additionally, breast cancer and patient-derived cancer-
associated fibroblast (CAF) cells were co-cultured to study cell-cell crosstalk and how it 
affected cancer invasion. GPNMB was identified as a novel gene of interest and it was 
shown that CAFs enhanced breast cancer invasion by up-regulating the expression of 
GPNMB on breast cancer cells resulting in increased migration speed. Lastly, this thesis 
described the design, biological validation, and use of this microfluidic platform as a new 
in vitro 3D organotypic model to study mechanisms of glioma stem cell (GSC) invasion 
in the context of a vascular niche. It was confirmed that CXCL12-CXCR4 signaling is 
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involved in promoting GSC invasion in a 3D vascular microenvironment, while also 
demonstrating the effectiveness of the microfluidic as a drug screening assay. Taken 
together, the broader impacts of the microfluidic model developed in this dissertation 
include, a possible alternative platform to animal testing that is focused on mimicking 
human physiology, a potential ex vivo platform using patient-derived cells for studying 
the interplay of cancer cells with its surrounding microenvironment, and development of 
future therapeutic strategies tailored toward disrupting key molecular pathways involved 
in regulatory mechanisms of cancer invasion.   
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PREFACE 
This dissertation includes original research and review articles previously 
published by the primary author. Chapter 1 describes the introduction and background 
information of this thesis (N. Peela, Truong, et al., 2017). Chapter 2 describes the 
fabrication of a microfluidic with distinct tumor and stroma regions to study the influence 
of EGF on cancer invasion into the stroma (D. Truong et al., 2016).  Chapter 4 describes 
the use of a microfluidic model comprised of a tumor, stroma, and vascular region to 
study the interactions between glioma stem cells and the vasculature (Danh Truong et al., 
2018).
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CHAPTER 1 
INTRODUCTION 
1.1 Cancer 
Cancer is a world-wide public health issue being the second leading cause of 
death within the United States with approximately 1.7 million new cancer cases in each 
year (R. L. Siegel, Miller, & Jemal, 2018). Vast amounts of resources have been poured 
into stalling or eliminating cancer through discovery of novel drug candidates. However, 
development of many of these candidates have ended up costing over a billion dollar with 
an abysmal rate of 10% of these drugs eventually reaching the market (Cox, Reese, 
Bickford, & Verbridge, 2015). The high rate of failure has been attributed to use of 
oversimplified in vitro tumor models to simple two-dimensional (2D) cell cultures during 
preclinical screenings (Cox et al., 2015; N. Peela, Truong, et al., 2017). These models 
often did not reflect the complexities of the tumor microenvironment and therefore did 
not fully represent the intricacies of cancer. In fact, numerous investigations have pointed 
out that components of the tumor microenvironment, such as tissue dimensionality,  and 
tumor-stroma interactions, comprising of spatial organization of cells, cell-cell and cell-
ECM crosstalk, are prominent factors influencing tumor growth, progression, and 
resistance to therapy (Friedl & Alexander, 2011). Despite that, 2D testing remains as the 
standard for drug screening and testing during the early stages of drug development. 
Furthermore, even the simplest 3D models consisting of only cancer cells in a 3D matrix 
resemble the gene expression profiles of human cancers more closely than 2D models 
(Ridky, Chow, Wong, & Khavari, 2010). Therefore, it is necessary to design more 
complex and validated 3D in vitro models that appreciates the complexities of the tumor 
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microenvironment to improve understanding of cancer biology as well as predicting the 
efficacy of drug screening. 
1.2 The Tumor Microenvironment 
The importance of the tumor microenvironment (TME) has been increasingly 
accepted as the growing body of literature over the past decade have demonstrated that 
cancer cells do not act alone during tumor progression (Joyce & Pollard, 2009). However, 
the roles of the individual components within the TME during cancer invasion are still 
being elucidated (Dvorak, 2015; Kalluri, 2016). The TME could be divided into two 
major components, the malignant cells and the stroma. Although some aspects of the 
stroma have been appreciated, such as importance of the extracellular matrix (ECM) on 
cancer invasion, the contributions of the stromal cells residing near or within the tumor 
have not as nearly been focused on. Indeed, cancer cells do require assistance from the 
stromal cells as the tumor progresses toward metastasis (Mao, Keller, Garfield, Shen, & 
Wang, 2013). Interactions with stromal cells have also been implicated in promoting 
resistance to conventional cancer therapies (Castells, Thibault, Delord, & Couderc, 
2012). Unfortunately, dissecting the consequences of the interactions between tumor and 
stromal cells are further complicated by the evolution of stromal cell phenotypes during 
tumorigenesis, such as activation of fibroblasts or polarization of macrophages 
(Sugimoto, Mundel, Kieran, & Kalluri, 2006). This brings forth context dependent 
influence of stromal cells which can alter the TME by promoting or inhibiting cancer 
invasion (Mueller & Fusenig, 2004). Therefore, understanding the dynamic interactions 
between the tumor and the stromal cells will lead to significantly better cancer therapies. 
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Harold Dvorak in 1986 proposed that tumors were wounds that did not heal and 
that they required the presence of the surrounding stroma for the tumor to grow beyond 1 
to 2 mm (H. F. Dvorak, 1986). This hypothesis eventually laid the foundation for 
understanding how the tumor co-opted the surrounding stroma for nourishment and 
growth (Dvorak, 2015). As noted by many even before Dvorak, wound healing has many 
parallels to tumor growth and progression (Balkwill & Mantovani, 2001). Histology and 
gene expression profiling of both wounds and tumors have provided evidence in 
demonstrating similar biological processes occurring in both and that cancer cells did not 
create a new biological program but instead exploit an existing biological program – 
wound healing (Chang et al., 2004; H. F. Dvorak, 1986). Wound healing generally begins 
with a local tissue injury resulting in leakage of plasma proteins, platelets, and blood 
cells. Platelets aggregate and release growth factors, such as platelet-derived growth 
factor, transforming growth factor-β, and fibroblast growth factors, which act as 
chemoattractants and mitogens for stromal fibroblasts to infiltrate and proliferate. 
Fibroblasts are cells that reside in connective tissue whose roles includes synthesizing 
and depositing components of the ECM as well as promoting wound re-epithelialization 
and contraction (Florin, Maas-Szabowski, Werner, Szabowski, & Angel, 2005). 
Keratinocytes, the predominant cell in the epidermis, rearrange their actin cytoskeleton 
and reduce cell-cell contact to promote efficient migration and wound contraction during 
wound healing. Vascular factors from platelets induce vascular leakage promoting 
infiltration of inflammatory cells and plasma proteins. The inflammatory cells scavenge 
and remove tissue debris and foreign matter while also releasing vascular endothelial 
growth factor to promote angiogenesis or the process of new capillary formation. Overall, 
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this results in granulation tissue comprising of cells, edema, vessels, and connective 
tissue (Dvorak, 2015). Once the wound is healed, the granulation tissue is resorbed 
resulting in a scar. Likewise, tumor formation and progression follow a very similar 
biological process.  However, instead of a tissue injury, tumor cells promote vascular 
leakage through secretion of VEGF which is triggered due to hypoxic conditions in the 
tumor. In addition, tumor cells replace the role of platelets in recruiting fibroblasts and 
promoting ECM remodeling. Further, tumor cells also behave similarly to keratinocytes 
by adopting a mesenchymal phenotype to migrate and proliferate. In fact, similar gene 
profiles have been observed between keratinocytes during wound healing and cancer 
cells (Chang et al., 2004). Likewise, both wound re-epithelialization and 
migrating/growing tumor cells are affected by similar stromal-derived mitogens and 
chemoattractants, including stromal-derived factor 1 (SDF1), epidermal growth factor 
(EGF), and hepatocyte growth factor (HGF). Inflammatory cells, like macrophages, are 
also recruited into the tumor during cancer progression. Although, this may seem 
counterproductive to tumor development, there is much evidence pointing out that 
inflammatory cells promote cancer through stimulating angiogenesis, proliferation of 
cancer cells, and suppressing tumoricidal actions.  
Indeed, tumors are much more complex than wounds. For instance, unlike 
wounds, tumor cells exhibit genetic instability leading to loss of tumor suppression genes 
and promotion of oncogenes that drive tumor progression (Hanahan & Coussens, 2012; 
Hanahan & Weinberg, 2011). Further, enhanced expression of oncogenes could indeed 
engage the wound healing program further to generate a tumor-promoting 
microenvironment. This of course necessitates the need to understand the interaction 
  5 
between tumors and their microenvironment, specifically stromal cells, to abrogate the 
dynamic communication involved in promoting cancer growth and progression. Herein, 
we review some of the pro-tumorigenic stromal cells and how they contribute to cancer 
invasion.  
1.2.1 Contribution of Stromal Cells to Cancer Invasion 
Cancer invasion and metastasis is considered as one of the defining hallmarks of 
cancer (Hanahan & Weinberg, 2011). Indeed, stromal cells have been implicated as 
major contributors to promoting invasion and metastasis (Figure 1.1). A variety of 
stromal cells that are currently being studied could be classified generally as fibroblast, 
endothelial, and immune cells.  
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Figure 1.1 Schematic of the metastatic cascade.  
Tumor growth and development results in ECM remodeling (A) as well as differentiation 
of cancer stem cells and fibroblasts. Subsequently, angiogenesis, cancer cell invasion, 
and intravasation (B) occur. Finally, surviving cancer cells and cancer stem cells circulate 
through the body, attach to blood vessels, and extravasate (C) to form secondary 
metastases.  
1.2.2 Fibroblast Cells 
  7 
Cancer-associated fibroblasts (CAFs) among other non-cancer cells within the 
stroma stand out as the most prominent cell type within the TME (Kalluri, 2016; Ohlund, 
Elyada, & Tuveson, 2014). There ubiquitous nature within the TME allows them a 
unique position to significantly influence cancer invasion (Figure 1.1A). Ongoing studies 
have highlighted and demonstrated that the presence of CAFs promoted significant 
growth of different cancers, such as breast (Orimo et al., 2005), prostate (Olumi et al., 
1999), ovarian (Zhang et al., 2011), colon (Nakagawa et al., 2004), and non-small cell 
lung cancer (Bremnes et al., 2011). They have specifically implicated them as key 
components in cancer initiation, promotion, and therapeutic responses (Luo, Tu, Liu, & 
Liu, 2015; Ohlund et al., 2014; Paraiso & Smalley, 2013). Studies showed that the 
crosstalks between cancer and CAFs involve mediating factors such as growth factors, 
cytokines, and proteases that supports tumor growth and development (Allinen et al., 
2004; Jia et al., 2013; Olsen, Moreira, Lukanidin, & Ambartsumian, 2010; Orimo et al., 
2005; Soon et al., 2013; Sung et al., 2013). For instance, Orimo et al. demonstrated that 
CAFs present in the tumor promoted cancer growth through SDF1-a signaling as well as 
angiogenesis in part by the same cytokine (Orimo et al., 2005). Furthermore, CAFs have 
also been implicated in mediating tumor-enhancing inflammation. Erez et al. 
demonstrated that CAFs enhanced tumor growth by recruitment of macrophages into the 
TME. This process is highly dependent on NF-κB signaling (Erez, Truitt, Olson, Arron, 
& Hanahan, 2010). Furthermore, CAFs are a major source of proteases, including matrix 
metalloproteases (MMPs), during matrix remodeling. Giannoni et al. identified a 
reciprocal crosstalk between prostate cancer cells (PCCs) and fibroblasts that promoted 
MMP secretion and invasiveness. They showed that PCCs produced interleukin-6 (IL-6) 
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that activated fibroblasts which in turn led to increased secretion of MMP-2 and MMP-9. 
They suggested that this crosstalk was the basis for promoting cancer migration 
(Giannoni et al., 2010). Notably, other studies demonstrated that removal of CAFs from 
the in vivo TME within mice led to enhanced efficacy of chemotherapeutics as well as 
reduction in tumor volume and blood vessel density (Rakesh K. Jain, Duda, Clark, & 
Loeffler, 2006; Santos, Jung, Aziz, Kissil, & Pure, 2009). As such, understanding and 
targeting the crosstalks between cancer and CAFs within the TME is an appealing 
strategy for reducing cancer progression.   
1.2.3 Endothelial Cells 
The microvascular environment plays important physiological roles within the 
human body aside from supplying oxygen and nutrients to the surrounding tissues. For 
instance, the vascular endothelium wall functions as a selective barrier to control 
distribution of certain biomolecules. On the other hand, angiogenic signals from injured 
tissue cause the nearby endothelial cells (ECs) to migrate to the damaged area to form 
new capillary systems (Carmeliet & Jain, 2000). Inflammatory cells, such as 
macrophages and neutrophils, use the endothelium wall as an adhesion site for 
transendothelial migration to nearby tissues. However, in a TME, the tumor-associated 
vessels are often abnormally grown (Kerbel, 2008). Often these vessels are irregular, lack 
a basement membrane, and more leaky than normal endothelium (Carmeliet & Jain, 
2000).  
Tumor-associated angiogenesis and vascular growth is largely dependent on pro- 
and anti-angiogenic factors and the abundance of these factors depend on the 
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microenvironment (Figure 1.1B). Well-orchestrated gradients of angiogenic factors are 
required to properly produce new vessels, but unregulated release of angiogenic factors, 
like vascular endothelial growth factor (VEGF), from cancer cells can lead to misguided 
vessel formation (Hanahan & Weinberg, 2011). The resulting structure of tumor 
vasculature is heterogeneous, highly disorganized, and tortious with uneven diameters 
and gaps within the endothelium. Major consequences are regions of hypoxia that could 
select for more malignant cancer cells and lack of pericytes and smooth muscle cells that 
reduce the function of vessels (Kerbel, 2008). In addition, these defects lead to enhanced 
leakiness and permeability altering the TME and reducing the effectiveness of 
pharmacological drugs. Non-uniform surface markers are a result of tumor-associated 
angiogenesis as well. Lack or heterogeneic expression of these surface markers may 
explain why leukocyte–endothelial interaction is relatively low in tumors (R. K. Jain et 
al., 1996). This further creates challenges in targeting tumor vasculature due to 
differences or lack of targetable surface markers.  
The lymphatic system was historically thought to only play a passive role in 
cancer metastasis by providing tracks for cancer metastases (Christiansen & Detmar, 
2011). However, recent studies have indicated that there are dynamic interactions 
between the lymphatic system and cancer cells. For instance, secretion of VEGF-C and 
VEGF-D from cancer cells to lymphatic ECs (LECs) have been demonstrated to create 
highly permeable peritumoral lymphatics while also enlarging the existing collecting 
lymphatic to facilitate metastatic spread (Hirakawa et al., 2007). In fact, VEGF-C 
expression is well correlated with lymphatic metastasis while enhanced expression is 
raises the risk of distant metastasis and death (Akagi et al., 2000; Kurebayashi et al., 
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1999). In addition, the lymphatic vessels serve as a trafficking system for immune cells to 
travel from peripheral tissues to lymph nodes. This process is highly regulated by 
chemokines to coordinate the homing of immune cells. However, cancer cells have been 
demonstrated to exploit this process by expressing chemokine receptors therefore 
mediating their invasion toward distant tissues (Muller et al., 2001). For instance, LECs 
were shown to traffic dendritic cells (DCs) by secreting CC-chemokine ligand (CCL21) 
which is the ligand for receptor CCR7 located on the DCs (Vaahtomeri et al., 2017). 
Likewise, cancer cells have been shown to express CCR7 and experiments have 
demonstrated that this enabled migration toward CCL21 (Shields, Emmett, et al., 2007). 
Expression of CXCR4, a chemokine receptor for SDF-1 or CXCL12 mentioned earlier, 
has also been clinically associated with spread to lymphoid sites (M. Kim et al., 2010). 
Normally functioning lymphatics typically promote immune cell infiltration through 
regulated chemotactic gradients of CXCL12, but tumor-induced lymphatic vessels secrete 
CXCL12 in a de-regulated manner promoting cancer cell invasion (Hirakawa et al., 
2009). Surprisingly, CCR7, an overexpressed receptor on cancer cells mentioned earlier, 
has also been identified as a receptor for CXCL12 (Cabioglu et al., 2005). Taken 
together, the complex interactions between the lymphatic system and cancer cells 
highlight the dynamic contribution of the lymphatics to cancer invasion. 
1.2.4 Immune Cells 
Immune cells represent a class of cells that infiltrate the stroma and play an active 
role in tumorigenesis by promoting tumor growth, survival, and migration. For instance, 
tumor-associated macrophages (TAMs), which have a similar phenotype to activated M2 
  11 
macrophages, facilitate cancer cell migration through secretion of chemokines and 
mitogenic factors, by suppressing destructive immune functions and degradation of the 
surrounding matrix.  One such chemokine and mitogen, epidermal growth factor (EGF) 
had been implicated in a positive feedback loop enabling cancer invasion (J. Wyckoff et 
al., 2004; J. B. Wyckoff et al., 2007). Cancer cells release colony stimulating factor 1 
(CSF1) attracting TAMs which lead to further secretion of EGF from TAMs developing 
into a migration relay between the two cell types. Other well-known chemoattractants 
and mitogenic factors have included, chemokines like CXCL12, TGF-β, and interleukins. 
Infiltrating immune cells also suppress immune destruction and enable tumor cells to 
evade the immune surveillance (Quatromoni & Eruslanov, 2012). For instance, signaling 
through CCL22 have been shown to attract regulatory T (Treg) cells which suppresses 
autoreactive T cells, which normally target and destroy tumor cells (Curiel et al., 2004). 
In fact, recent studies showed high populations of Treg cells residing in tumors and lymph 
nodes (Beyer & Schultze, 2006; Curiel, 2007). In addition, like Treg cells, myeloid-
derived suppressor cells (MDSCs) serve as another avenue for evasion and suppression of 
the immune system (Bayne et al., 2012). These cells are immature myeloid cells known 
to regulate tissue homeostasis during times of injury. However, within a TME, this could 
lead to disruption of immune responses such as inhibition of dendritic or natural killer 
cells. Still, the role of other immune cells has not been well characterized in cancer.  
1.3 Tumor Microenvironment Research Models 
1.3.1 Conventional in vivo and in vitro models of the tumor microenvironment 
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To characterize the cellular and molecular basis of cancer invasion in response to 
stromal factors, a significant effort has been devoted to developing tumor models 
recapitulating tumor-stroma interactions. In vivo models play a crucially important role in 
studying the cellular and molecular basis of disease progression (Figure 1.2). For 
example, mouse models have utilized to study the role of signaling factors and 
chemokines, such as EGF (Provenzano et al., 2006; Provenzano et al., 2008; J. Wyckoff 
et al., 2004). Additionally, the role of stromal cells in cancer cell invasion such as CAFs 
and TAMs have also been studied using in vivo systems (Orimo et al., 2005). However, 
these models suffer from lack of high resolution observation and analysis of cell-cell 
interactions as well as precise control over critical parameters, like manipulating stromal 
cells, in the TME (Britta Weigelt, Ghajar, & Bissell, 2014). Importantly, this lack of 
precise control has created challenges to determining the cause and effect relationships 
within the heterotypic dialogues between cancer and stromal cells like CAFs (B. Weigelt, 
2014). Then there are crucial molecular and cellular differences between humans and 
mice limiting the scope for animal models to fully recapitulate human diseases (Mak, 
Evaniew, & Ghert, 2014).  
To overcome some of these problems, conventional in vitro platforms, including 
transwell assays and 3D spheroid-based models, have been used to study the role of 
microenvironmental factors on cancer invasion (Figure 1.2) (N. Peela, Truong, et al., 
2017; B. Weigelt, 2014). 2D assays have been extensively used to assess the role of 
chemoattractants on cancer cell migration (Saadi, Wang, Lin, & Jeon, 2006; S. J. Wang, 
Saadi, Lin, Minh-Canh Nguyen, & Li Jeon, 2004). Further, co-culture set-ups using 
fibroblasts or endothelial cells have teased out influences of ECM and soluble factors on 
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cancer cell invasion (Alexeyenko et al., 2015; Alkasalias et al., 2017; Alkasalias et al., 
2014; Kramer & Nicolson, 1979). Still, these models are often oversimplified and do not 
recapitulate proper organotypic arrangement of the tumor-stroma architecture due to 
random mixing of cells. This limits the available analyses to proliferation, morphology, 
and protein expression as opposed to precise spatial organization of cells which could 
enable assessment of migration metrics (i.e. distance, speed, persistence) (Orimo et al., 
2005; N. Peela, Truong, et al., 2017). Importantly, these models are often end-point 
assays that do not allow real-time observations of dynamic tumor-stroma interactions at 
cellular and molecular levels (Figure 1.2).  
 
Figure 1.2 Comparison of cancer research models.  
Reprinted from Microfluidic 3D models of cancer, 79-80, Sung, KE., Beebe, DJ., 68-78, 
Copyright (2014), with permission from Elsevier (Appendix F). 
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1.3.2 Microengineered models of the tumor microenvironment 
With the difficulties and challenges of conventional in vitro models of the TME 
(Figure 1.2), microengineering technologies has emerged to model different aspects of 
cancer unveil the cellular and molecular basis of cancer invasion in response to tumor-
stroma interactions (B. Weigelt, 2014). These technologies consist of 3D assays that 
enable tunable microenvironments to understand the complex interactions between tumor 
cells, stromal cells, biochemical and biophysical cues. As a result, large bodies of works 
have been devoted to developing these advanced 3D in vitro models of cancer to 
individually dissect important factors involved in cancer progression to reveal new 
biological insights (Figure 1.2). 
 Recent work by Boghaert et al., developed elastomeric stamps of PDMS to mold 
collagen microwells for 3D co-culture of mammary epithelial and tumor cells (Boghaert 
et al., 2012). The microwells were topped with a layer of polymerized collagen to create 
hollow ducts (Figure 1.3A) Following this, they studied the spatial positioning of tumor 
cells to observe their growth and invasive capacity and found that non-invasive tumor 
cells proliferated at a significantly higher rate at the edge of the ducts. Downstream 
computational (i.e. finite element) analysis revealed higher mechanical stresses at the 
edges, suggesting that biophysical parameters, such as tensional stress, contributed to 
cancer cell motility. This microengineering technique offered the ability to modulate the 
tissue geometry and mechanical stress, to assess their role on tumor growth and 
migration.   
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In addition to micromolding techniques, UV-based photopatterning has been 
widely used to develop in vitro 3D models for studying tumor growth and progression. 
For instance, Kaemmerer et al. utilized photocrosslinkable gelatin methacrylamide 
(GelMA) hydrogel to study the growth of ovarian cancer cell (Kaemmerer et al., 2014). 
GelMA hydrogel has previously been demonstrated to be advantageous for 3D culture of 
numerous cell types due to the high concentration of matrix metalloproteinase- (MMP) 
sensitive degradation sites (Navaei et al., 2016; Nichol et al., 2010; Nikkhah et al., 2012; 
Saini, Navaei, Van Putten, & Nikkhah, 2015). Additionally, the photocrosslinkable 
properties of GelMA provide distinct advantages over purely natural hydrogels by 
enabling the development of tissue constructs with well-defined microarchitectures (N. 
Peela et al., 2016). By modulating the concentration of GelMA hydrogel, the authors 
were able to regulate numerous biophysical attributes (i.e. stiffness, pore size, MMP-
cleavable sites) and subsequently assess the role of these factors on the morphology of 
the tumor. Encapsulated ovarian cancer cells uniformly assembled as loose aggregates at 
lower (2.5%) concentration of GelMA, while at higher hydrogel concentration (7%). 
spheroids were mostly non-uniform and displayed decreased metabolic activity. 
Additionally, within 5% GelMA, the spheroids exhibited tight intercellular junctions 
along with the highest metabolic activity and spheroid size. Furthermore, inhibition of 
MMP production decreased the spheroid size, confirming that the presence of MMP-
cleavable sites provide sufficient cues amenable for tumor formation (Kaemmerer et al., 
2014).  
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Figure 1.3 Example Microengineered Models of Cancer  
(A) Schematic (i) of fabrication of microengineered tissue surrogates, and representative 
immunofluorescent images (ii) of demonstrating invasion of tumor cells from the end of 
the cavities. Adapted with permission from the National Academy of Sciences: [PNAS], 
copyright (2012). (B) Schematic of microfluidic model (i) to study transition of 
MCF10A. DCIS to Invasive Ductal carcinoma in presence of Human mammary 
fibroblasts, and F-actin structure (ii) of co-cultured group MCF10A.DCIS cells as 
compared to mono-cultured MCF10A.DCIS cells. Adapted with permission from the 
Royal Society of Chemistry (RSC): [Integr. Biol.], copyright (2011). (C) Schematic (i) of 
seven channel microfluidic device, and immunostained images (ii) of Alpha SMA and F-
actin in mono-culture and co-culture conditions. Adapted with permission from PLOS: 
[PLOS ONE], open-access (2016). 
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Various groups have also utilized tumor spheroids embedded within ECM 
matrices to study mechanisms of cancer cell invasion (Carey, Starchenko, McGregor, & 
Reinhart-King, 2013; Jimenez Valencia et al., 2015; Kopanska, Alcheikh, Staneva, 
Vignjevic, & Betz, 2016). The Reinhart-King group developed tumor spheroids using 
cancer cell lines that were embedded in collagen to study the role of tumor heterogeneity 
in collective cell migration (Carey et al., 2013). They showed that collagen fiber 
alignment and proteolysis of the matrix modulated the invasion of different population of 
cancer cells. When spheroids were created using MCF10A cells, the collagen fibers were 
oriented parallel to spheroid boundary, but use of MDA-MB-231 cells led to 
perpendicular alignment of collagen fibers. Time lapse imaging of the multicellular tumor 
spheroids revealed that MDA-MB-231 cells degraded the surrounding matrix, and 
MCF10A cells followed the microtracks left by the MDA-MB-231 cells (Carey et al., 
2013). This study was crucial in elucidating the interactions between leader and follower 
cells within a 3D microenvironment indicating that this model could be used as a suitable 
invasion assay to study novel mechanisms of cancer cell migration.  
In a recent study, Kraning-Rush et al. created a tumor spheroid model 
encapsulated in collagen gel using PDMS stamps and micromolding (Kraning-Rush, 
Carey, Lampi, & Reinhart-King, 2013); a technique pioneered by Nelson et al. (Celeste 
M. Nelson, Inman, & Bissell, 2008; C. M. Nelson, VanDuijn, Inman, Fletcher, & Bissell, 
2006). Using photolithography techniques, silicon wafers were first fabricated with 
unique microarchitectures. Elastomeric stamps were next used to imprint collagen 
resulting in engineered microtracks. This technique allowed for rapid fabrication of a 
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high-density array of tumor constructs with desired geometry and spatial arrangement. 
The authors analyzed cellular microtracks created by invasive MDA-MB-231 cells in 
bulk collagen gel by using confocal reflectance microscopy. The authors further utilized 
micromolding techniques to recreate microtracks prior to cell seeding to evaluate 
migration within these patterned tracks. Their results demonstrated an increased single 
cell migration rate and distance in both non-invasive MCF10A and invasive MDA-MB-
231 cells in pre-formed microtracks compared to when encapsulated within nonpatterned 
collagen. To further investigate the effects of matrix architecture (i.e. microtracks) on cell 
migration, MT-MMP1 was knocked down preventing ECM degradation, which 
decreased the speed of invasive cancer cells on unpatterned collagen. However, cells 
within patterned collagen microtracks still maintained their initial speed despite MT-
MMP1 knockdown. These results suggest an alternate motility pathway that compensates 
for lack of MMPs by using microtracks within the ECM. Additionally, this result 
provided a basis for the potential cause of failure MMP inhibitors (Kraning-Rush et al., 
2013).  
1.4 Microfluidic Systems for Modeling the Tumor Microenvironment 
The prior mentioned microengineered models are some of the great and promising 
works that have been used to investigate cancer progression and provide biological 
insights. In particular, microfluidics are another type of microengineered technologies 
that have emerged allowing great control over cellular, biophysical and biochemical cues 
from the TME (Figure 1.2). As such, microfluidic models could also be used to bridge the 
gap between complex in vivo and simpler in vitro models to better recapitulate the tumor-
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stroma interactions (Sung & Beebe, 2014). One key advantage of microfluidics is the 
micro-scale nature which requires lower volumes of sample input providing an advantage 
in cases such as rare or difficult to obtain cells and materials (i.e. patient-derived cells, 
ECM, soluble cues) (I. K. Zervantonakis et al., 2012). In addition, their ease of design 
allows these devices to encompass multiple TME architectures to enable micro-
compartmentalization of different cells (i.e. fibroblast, immune and endothelial) and 
ECM (i.e. collagen, fibrin, laminin). This enables control over physiological scaling and 
architecture of complex cell-cell arrangement to better mimic the diseased tissue. 
Importantly, experiments using microfluidics could be designed using cells and ECM 
exclusively of human origin providing an advantage over animal models. Due to their 
flexible nature in design and low cost, microfluidic technologies have been pushing the 
boundary to replicate organ-level function (Huh, Hamilton, & Ingber, 2011). As such, 
microfluidics are a capable platform for modeling tumors of several kinds, like breast, 
brain, lung, etc., and at different steps of metastasis, such as growth, invasion, 
intra/extravasation (Jeon et al., 2014; H. Lee, Kim, Chung, Kim, & Jeon, 2014; Nagaraju, 
Truong, Mouneimne, & Nikkhah, 2018; N. Peela, Truong, et al., 2017; Ryu et al., 2015; 
D. Truong et al., 2016; I. K. Zervantonakis et al., 2012). Importantly, the transparent 
nature of the microfluidic enables observation of dynamic cell processes with high-
resolution without requirement of complex microscopy used in animal models. 
Additionally, with the type of control that microfluidics provide in modulating the TME, 
it can also visualize rare events such as cell-cell interactions during cancer invasion 
which is difficult to image in vivo. This of course enables microfluidics with relative ease 
to model the different steps of the metastatic cascade like tumor-stroma interactions 
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(Sung et al., 2011), invasion (Haessler, Kalinin, Swartz, & Wu, 2009; B. J. Kim et al., 
2013), angiogenesis (C. Kim, Kasuya, Jeon, Chung, & Kamm, 2015; J. Kim et al., 2015; 
H. Lee, Kim, et al., 2014), intravasation (I. K. Zervantonakis et al., 2012), and 
extravasation (Bersini et al., 2014; Jeon et al., 2015). 
Tumor-stroma interactions is comprised of the interplay between the cancer cells 
and the stromal cells residing in the surrounding TME. To model the interaction, different 
microfluidics have been fabricated. For instance, work by Sung et al. developed a 3D 
microfluidic model to spatially compartmentalize invasive MCF10DCIS.com breast 
cancer cells with mammary fibroblasts to mimick the tumor stroma interface (Sung et al., 
2011). They utilized a Y-shaped microfluidic platform so that two adjacent channels were 
loaded with cancer and stromal cells respectively to (Figure 1.3B). The aim of this study 
was to assess the transition of breast cancer from ductal carcinoma in situ (DCIS) to 
invasive ductal carcinoma (IDC) in the presence of mammary fibroblast cells. Their 
results demonstrated that MCF10A.DCIS cells transitioned from normal mammary or 
DCIS morphology (i.e. circular morphology) at the ECM interface between cancer and 
fibroblast cells to a more invasive phenotype when compared to the mono-culture 
condition (Figure 1.3B). Further downstream analysis correlated the changes in cellular 
morphology with remodeling of ECM, demonstrating downregulation of E-cadherin and 
degradation of ECM. Their work demonstrated that their microfluidic set up enabled 
crosstalk between the two cell types to observe the resulting transition of cancer cells 
toward an invasive phenotype while also demonstrating ECM remodeling due to 
fibroblasts in a single model. In separate study by Jeong et al., a seven-channel 
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microfluidic device was used to co-culture colorectal carcinoma tumor spheroids 
embedded in collagen hydrogel with normal colon fibroblasts (Figure 1.3C) (Jeong, Lee, 
Shin, Chung, & Kuh, 2016). The authors observed that co-culture with fibroblasts 
promoted significant increase tumor spheroid diameter compared to the mono-culture 
condition without fibroblasts. Further analysis revealed that the increase in diameter of 
the spheroids was not due to cancer cell proliferation, but instead due to the deposition of 
fibronectin within the spheroids. Consequently, during a drug study, paclitaxel diffused 
more slowly through the hydrogel in the co-culture condition due to the presence of 
fibronectin. They also demonstrated that the co-culture condition induced the transition of 
colon fibroblasts to a CAF phenotype, confirmed by increased expression of α-SMA and 
higher cell motility (Figure 1.3C). On the other hand, Kim et al. developed a microfluidic 
system to study the invasion of MDA-MB-231 cells through a 3D microenvironment in 
response to dual gradients of CXCL12 and EGF (B. J. Kim et al., 2013). This model 
highlighted the capability of controlling gradients of biochemical cues using the small 
channels in microfluidics. Notably, Zervantonakis et al. created an advanced microfluidic 
model consisting of a vascular endothelium, resident macrophages, and migrating tumor 
cells in a 3D microenvironment. Their work provided insight on the role of TNFα in 
tumor-macrophage-endothelial interactions.  (I. Zervantonakis et al., 2010; I. K. 
Zervantonakis et al., 2012). They observed that macrophages released TNFα which 
resulted in enhanced endothelium permeability leading to higher rates of intravasation (I. 
K. Zervantonakis et al., 2012). Gioiella et al. fabricated a microfluidic model and 
incorporated MCF7 cells in a tumor region and normal fibroblasts (NFs) in a stroma 
region to study the reciprocal effect of the two cell types on one another  (Gioiella, 
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Urciuolo, Imparato, Brancato, & Netti, 2016). Upon 48 hours, fibroblast cells within the 
stroma when in presence of MCF7 cells exhibited marked expression of αSMA as well as 
PDGF, suggesting activation of NFs to a CAF-like phenotype. Extracellular matrix 
proteins including collagen, hyaluronic acid and fibronectin were expressed higher in 
presence of the tumor cells. Using second harmonic imaging, ECM remodeling was 
observed in co-culture condition confirming the activation of NF when co-cultured with 
tumor micro-tissues. This study illustrated the ease of microfluidic platforms to study 
various aspects of cancer invasion including stroma activation, ECM remodeling, and cell 
migration.  
To that end, microfluidic platforms have shown significant promise to study 
different aspects of cancer through better recapitulation and direct control over distinct 
components (i.e. cells, ECM, soluble factors) within the TME (Sung & Beebe, 2014). 
These recent innovations have enabled the capture of different facets of metastasis such 
as biochemical signaling (I. Zervantonakis et al., 2010), tumor-stroma interactions (Sung 
et al., 2011), invasion (Haessler et al., 2009; B. J. Kim et al., 2013), intravasation (I. K. 
Zervantonakis et al., 2012), and extravasation (Bersini et al., 2014; Jeon et al., 2015). 
Despite significant progress, most of the previous findings have relied on models with 
simplified 3D models containing distinct tumor and stroma regions to precisely control 
spatial cell-cell and cell-ECM interaction. Notably, there have also been a lack of 
integrated molecular analyses, like proteomic or transcriptomic profiling, to probe for 
possible molecular mechanisms in tumor-stroma interactions during invasion. Further, 
current 3D microfluidic models of invasion have utilized established cell lines. While 
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these cells have provided a detailed understanding of the underlying biology mechanisms 
during invasion, cell lines often lose their in vivo-like phenotype. Incorporation of 
patient-derived cells within microengineered models will enable development of relevant 
understanding of invasion that also accounts for tumor heterogeneity, better design of 
therapeutic compounds, and fine-tuning of the models for applications geared toward 
personalized medicine. 
1.5 Thesis Aims and Overview 
The failures of current clinical studies have been attributed to lack of 
understanding cancer and stromal cell interactions from the TME. These interactions 
have been found to significantly affect many biological processes in cancer progression, 
such as tumor growth, cell survival and invasion. Therefore, the crosstalk between 
stromal and tumor cells still require further elucidation to effectively target as an anti-
cancer therapy.  
This thesis aims to develop a microfluidic model to study the interplay between 
tumor and stromal cells during cancer invasion. In this work, we have developed a 3D 
microengineered platform with configurable tumor-stroma architecture coupled with 
cellular and molecular assessments. This model contains distinct cell culture 
compartments to create 3D tumor and stroma regions. The proposed microfluidic is 
applicable across many types of cancer, due to flexibility in cell and ECM compositions. 
For proof of concept, we will first use breast cancer as our model system while also 
branching to glioblastoma. Following a bottom-up approach by additive addition of 
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stromal components and cells, we studied the influence of stromal factors on cancer 
invasion. We developed a breast tumor-stroma model by incorporating patient-derived 
fibroblasts of mammary origin in co-culture with breast cancer cells to study the 
influence of the fibroblasts on invasion. Then we utilized transcriptomic profiling to 
provide insight on the molecular mechanisms of enhanced invasion due to fibroblasts and 
we screened for a clinically relevant gene, GPNMB, and studied its role in cancer 
invasion using our model. Finally, building upon our prior works, we developed a glioma 
stem cell – vascular interaction model to study the influence of the vascular niche on 
glioma stem cell invasive behavior. 
We propose to complete this study through the following specific aims: 
1.5.1 Specific Aim 1 
Investigate the effect of biochemical stimuli (i.e. EGF) on invasion of cancer 
cells into a 3D stroma using microfluidics. Using our microfluidic tumor model and 
SUM-159 as our model invasive cancer cell line, we will investigate our hypothesis that 
EGF promotes further invasion of breast cancer cells into the stroma of our biomimetic 
TME.   
1.5.2 Specific Aim 2 
Study the influence of patient-derived CAFs on cancer cell invasion and gene 
expression profile and determine a possible mediator of invasion due to tumor-
stroma interactions. We will refine our microfluidic model developed in Aim 1 by 
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introducing patient-derived cancer-associated fibroblasts to reflect the native TME. Using 
this system, we will investigate the hypothesis that cancer-associated fibroblasts promote 
further migration of invasive cancer cells. We will also investigate a sub-aim of 
identifying possible mediator of invasion due to co-culture with cancer-associated 
fibroblasts.  
1.5.3 Specific Aim 3 
Use a microfluidic platform of the GSC vascular niche to study the influence 
of endothelial cells (ECs) on patient-derived GSC behavior and identify signaling 
cues that mediate their invasion and phenotype. We introduce a third region in the 
microfluidic model used in Aims 1 and 2 to incorporate tumor-associated vasculature. 
We will investigate the role of the TME on the phenotype and invasiveness of a sub-
population of glioblastoma cells, glioma stem cells. These studies will investigate our 
hypothesis that the vascular niche promotes migration of glioma stem cells while 
maintaining stem phenotype.  
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CHAPTER 2 
AIM 1: Investigate the effect of biochemical stimuli (i.e. EGF) on invasion of cancer 
cells into a 3D stroma using microfluidics. 
 
2 asdf 
2.1 Abstract 
In this study, to model 3D chemotactic tumor-stroma invasion in vitro, we 
developed an innovative microfluidic chip allowing side-by-side positioning of 3D hydrogel-based 
matrices. We were able to (1) create a dual matrix architecture that extended in a continuous manner, thus allowing 
invasion from one 3D matrix to another, and (2) establish distinct regions of tumor and stroma cell/ECM 
compositions, with a clearly demarcated tumor invasion front, thus allowing us to quantitatively analyze progression of 
cancer cells into the stroma at a tissue or single-cell level. We showed significantly enhanced cancer 
cell invasion in response to a transient gradient of epidermal growth factor (EGF). 3D 
tracking at the single-cell level displayed increased migration speed and persistence. 
Subsequently, we analyzed changes in expression of EGF receptors, cell aspect ratio, and 
protrusive activity. These findings show the unique ability of our model to quantitatively 
analyze 3D chemotactic invasion, both globally by tracking the progression of the 
invasion front, and at the single-cell level by examining changes in cellular behavior and 
morphology using high-resolution imaging. Taken together, we have shown a novel 
platform recapitulating 3D tumor-stroma interactions for studies of real-time cell invasion 
and morphological changes within a single platform. 
2.2 Introduction 
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 Breast cancer is the one of leading causes of cancer-related death among women 
in the United States (R. Siegel, Ma, Zou, & Jemal, 2014). This disease progresses in 
many steps ranging from tumor growth, stroma invasion, and spreading throughout the 
body (Gupta & Massague, 2006; Hanahan & Weinberg, 2011). Invasion into the 
surrounding stroma begins a process of interactions between tumor cells and the stroma 
by cellular crosstalk and paracrine signaling (i.e. fibroblasts, pericytes, immune cells, 
endothelial cells, etc.) and is influenced by biochemical/biophysical cues (i.e. drug and 
nutrient transport, ECM composition and stiffness, etc.) within the stroma (Conklin & 
Keely, 2012; Hanahan & Weinberg, 2011; Khamis, Sahab, & Sang, 2012; Mao et al., 
2013). Despite significant advances in therapeutic regimens, anti-cancer drugs often fail 
due to lack of comprehensive preclinical studies utilizing models incorporating the 
complexities of the native tumor-stroma microenvironment (dit Faute et al., 2002; J. M. 
Lee et al., 2013; McMillin, Negri, & Mitsiades, 2013; Paraiso & Smalley, 2013; Thoma, 
Zimmermann, Agarkova, Kelm, & Krek, 2014). In this regard, the interactions that 
specifically arise from a variety of biochemical and biophysical gradients, and cellular 
components should not be overlooked when developing in vitro tumor microenvironment 
models (Knowlton, Onal, Yu, Zhao, & Tasoglu, 2015; B. Weigelt, 2014).  
 Chemoattractants, such as epidermal growth factor (EGF), are aggressive drivers 
of cancer invasion by activating cell membrane receptors and intracellular pathways that 
provide guidance and motility cues to the cells(Gupta & Massague, 2006). For example, 
cancer cells have been shown to secrete colony stimulating factor-1 (CSF-1), which then 
causes macrophages to produce gradients of EGF (Goswami et al., 2005; Hagemann et 
al., 2004). This would often lead to enhanced proliferation, survival, and motility of 
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cancer cells (Dudu, Able, Rotari, Kong, & Vazquez, 2012; Meng, Xia, Fang, 
Rojanasakul, & Jiang, 2006; Price, Tiganis, Agarwal, Djakiew, & Thompson, 1999; J. 
Wyckoff et al., 2004). For example, micro-needles filled with Matrigel® and EGF 
inserted into the mouse fat pads attracted breast cancer cells to the site of injection. 
However, this model required expensive imaging, such as multiphoton laser-scanning and 
second harmonic generation (Provenzano et al., 2006; Provenzano et al., 2008), to 
observe the effect of EGF on cancer invasion in real-time (J. Wyckoff et al., 2004). 
Furthermore, animal models do not allow decoupled control of cell-cell and cell-ECM 
interactions creating significant difficulties in elucidating the role of each separate 
stromal component. For instance, migrating cells in vivo have been shown to migrate 
toward one specific areas of vascularization. However, it was unclear whether the cancer 
cell’s response was due to the sole role of biochemical (i.e. chemoattractants) or 
biophysical (i.e. interstitial flow or collagen stiffness) gradients (Shields, Fleury, et al., 
2007). Moreover, stromal cells, such as macrophages or fibroblasts, localized to specific 
regions within the tumor microenvironment can generate interfering signaling cues and 
chemoattractant gradients, which make it especially challenging, to elucidate the sources 
that trigger cancer cell invasion (Patsialou et al., 2009; Pinner & Sahai, 2008; J. B. 
Wyckoff et al., 2007).   
Conventional in vitro 2D assays have been extensively used to assess the role of 
chemoattractants on cancer cell migration (Saadi et al., 2006; S. J. Wang et al., 2004).  
Wang et al. utilized a 2D platform simplifying the tumor microenvironment to only a 
monolayer of cells. They demonstrated that breast adenocarcinoma cell line (MDA-MB-
231) migrated on 2D surfaces towards higher concentrations of EGF with varying speeds 
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(S. J. Wang et al., 2004). Although the findings were significant, the 2D model utilized in 
this study did not recapitulate the organization of tumor-stroma and ECM heterogeneity, 
normally found within the native tumor microenvironment. Most importantly, the lack of 
encapsulated cells within 3D ECM-based matrices, which are representative of cancer 
invasion within the stroma, could influence the biological findings (Yamada & 
Cukierman, 2007).  
 Traditional 3D systems currently used in invasion studies, such as Boyden 
chambers and Transwell migration assays, lack the ability to precisely control the spatial 
organization of cells in 3D matrices, cell-cell interactions, and cell-ECM interactions. To 
that end, microfluidic platforms have shown significant promise to study different aspects 
of cancer through better recapitulation and direct control over distinct components (i.e. 
cells, ECM, soluble factors) within the tumor microenvironment (Sung & Beebe, 2014). 
These recent innovations have enabled the capture of different facets of metastasis such 
as biochemical signaling (I. Zervantonakis et al., 2010), tumor-stroma interactions (Sung 
et al., 2011), invasion (Haessler et al., 2009; B. J. Kim et al., 2013), intravasation (I. K. 
Zervantonakis et al., 2012), and extravasation (Bersini et al., 2014; Jeon et al., 2015). 
Despite significant progress, most of the previous findings have relied on models with 
simplified or no compartmentalization of 3D interconnected tumor and stroma regions to 
precisely control spatial cell-cell and cell-ECM interactions. For example, some models 
that seeded cancer cells on 2D channels lacked the physiologically relevant influence of 
the 3D matrices (Chung et al., 2009; Jeon et al., 2015; I. K. Zervantonakis et al., 2012). 
There are also microfluidic devices that have demonstrated cell migration within 3D 
hydrogels (Haessler et al., 2009; B. J. Kim et al., 2013), but they were missing 
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incorporation of tumor-stroma entities, thus having only a single compartment for cancer 
cell encapsulation. These limitations reduced their ability to study cancer invasion 
through side-by-side heterogeneous ECM, organized co- or tri-culture of cells as well as 
transport of growth factors and nutrients through diffusive barriers (i.e. solid tumors). 
Apart from technological development, these models often have been limited by the lack 
of 3D real-time single cell migration analysis from the tumor toward the stroma region 
during active invasion. Alternatively, models that compartmentalized cells into separated 
3D stroma and tumor regions were not specifically intended to demonstrate real-time 3D 
invasion studies and enable modulation of microenvironmental cues (e.g. biophysical and 
biochemical signaling). Moreover, these platforms did not contain perfusable channels 
surrounding the tumor-stroma regions to assess the influence of chemotactic gradients on 
cancer cell invasion (Sung et al., 2013; Sung et al., 2011).  
 In this study, we have developed a new microfluidic cancer invasion platform 
capable of spatially organizing 3D cell-embedded hydrogel matrices while enabling real-
time capture of 3D cancer invasion within heterogeneous ECMs. The microengineered 
platform was designed to introduce 3D interconnected tumor and stroma regions with 
different ECM and cell compositions. This approach primarily provides an advantage 
over 2D platforms by enabling the study of 3D cellular migration within a native-like 
tumor microenvironment using hydrogel-based matrices. Moreover, our design allows the 
capture of an ECM-embedded high-density cell population (~ 15 million cells/mL) within 
a single compartment to mimic mechanical cues and diffusion of soluble factors within a 
3D solid tumor not possible in 2D platforms (B. Weigelt, 2014). On the other hand, when 
compared to previously established 3D platforms (B. J. Kim et al., 2013; Sung et al., 
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2011; I. K. Zervantonakis et al., 2012), our model contains a specific tumor region 
surrounded by a separate ECM-filled entity (stromal region) permitting a juxtaposition of 
different ECM or cell mixtures (e.g. cancer-associated fibroblasts (CAFs)) to recapitulate 
continuous cancer invasion throughout a heterogeneous tumor-stroma microenvironment.  
We utilized the proposed model to specifically assess how exposure to EGF impacts 3D 
cancer cell invasion through the stroma. In addition, the proposed design enabled 
generation of competing microenvironments, due to the presence of two separated 
channels, to specifically assess the effect of differential gradients of EGF on cancer cells 
invasion. We took advantage of our device to visualize and quantify 3D cell migration 
metrics and morphology, utilizing advanced microscopy technique, at both a global and 
single-cell level, within different time frames. As a result, we noted enhanced cell speed 
and persistence in the presence of EGF along with increased levels of cell proliferation 
and clustering of EGF receptors (EGFRs) indicative of cells responding to EGF. 
Furthermore, we correlated the enhanced invasiveness to cell morphology changes such 
as increased aspect ratio and number of protrusions. Overall, this work underscores a 
technical advance that was designed to recapitulate invasion of cancer cells in adjacent 
tumor and stroma regions of different ECM and cell compositions within a 
microengineered platform. This will allow future studies to assess the influence of 
various combinations of cell-cell and cell-ECM interactions on cancer invasion in a well-
controlled experimental condition.  
2.3 Methods 
2.3.1 Microfluidic design and fabrication 
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 The microfluidic platform was fabricated using photo- and soft-lithography 
techniques. First, the design was created utilizing cad software, and subsequently, a 
transparent mask was fabricated from this design to undergo SU-8 photolithography. 
SU8-2075 (MicroChem) was spun onto a silicon wafer with a height of 200 µm. Next, 
the wafer was placed underneath the transparent mask and exposed to UV to generate the 
mold for the microfluidic device. Polydimethylsiloxane (PDMS, Sylgard 184 Silicon 
Elastomer Kit, Dow Corning) was casted over the SU-8 wafer and baked for 1 h at 80 °C. 
Afterwards, the PDMS was peeled off and the devices were cut out with blades, and 
afterwards, the inlets and outlets were cored using biopsy punches. Next, these devices 
were treated with oxygen plasma (PDC-32G, Harrick Plasma) and were then bonded to 
glass with channel side facing down to create a sealed environment. The fabricated 
microfluidic chips were sterilized by wet autoclave followed by a dry autoclave. The 
chips were surface treated by injecting 1 mg/mL poly-d-lysine (PDL, Sigma-Aldrich) into 
the channels and chambers. The devices were incubated at 37 °C for 1 h and then washed 
with deionized (DI) water. Next, 0.1% (v/v) glutaraldehyde (GA, Sigma-Aldrich) 
solution was added into the channels and chambers and incubated at room temperature 
for 1.5 h. Finally, the devices were washed 4 times with DI water and placed in an 80 °C 
oven overnight to render the surfaces hydrophobic. 
2.3.2 Diffusion across the tumor-stroma 
COMSOL simulation of EGF diffusion was used to characterize and predict the 
time-dependent gradient within the platform. When performing the simulation, diffusion 
in x and y axis were the most important to investigate the diffusion of EGF due to the fact 
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there were no major influences on the diffusion in the z-axis as the EGF was uniformly 
distributed in the media. In addition, the diffusion coefficient of collagen remained 
relatively constant in all dimensions within the hydrogel so there would be no major 
change in diffusion influenced in the z direction of the hydrogel. Therefore, we utilized a 
two-dimensional model to simulate diffusion of EGF in the horizontal cross section or 
top-down view of the 3D device. In that regard, the geometry was created within 
AutoCAD and imported into the COMSOL software as a 2D-plane. Based on Stokes-
Einstein 𝐷" = 𝑘𝑇/6𝜋𝜂𝑅 relationship (Kothapalli & Honarmandi, 2014), where 𝑘 is the 
Boltzmann constant (1.38 × 10−23 J•K−1), 𝑇 = 298.15 K, 𝑅 is the Stokes radius (23 
angstroms), and 𝜂 is the dynamic viscosity of the media (0.78 × 10−3 N•s/m2) (C. Wang, 
Lu, & Schwartz, 2012), the diffusion coefficient for a 10 kDa molecule within media at 
37 °C was calculated to be 9.25 x 10-11 m2/s. The coefficient for the 3D collagen I gel 
(2.0 mg/mL) was determined to be 8.7 x 10-11 m2/s by multiplying the media coefficient 
by the diffusion hindrance coefficient 0.94 (i.e. diffusion through the gel compared to the 
solution). This value is predicted based on the area fraction of collagen related to the fiber 
diameter of isotropic fiber networks. The pores (> 0.75 µm for collagen area fraction of 
less than 1%) (Stylianopoulos, Diop-Frimpong, Munn, & Jain, 2010) within the collagen 
hydrogel being larger than the hydrodynamic radius of the dextrans (Stylianopoulos et al., 
2010; I. K. Zervantonakis et al., 2012) resulted in approximate diffusion hindrance to be 
0.94 based on work done by Stylianopoulos et al. Inlet was set to zero flow, the outlet 
was set to zero pressure, the concentration of the molecule within the channels was set 
equal to 10 µg/mL, and the inlet concentrations were set constant at 10 µg/mL. 
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 Fluorescent dextran (10 kDa FITC-Dextran (10 µg/mL)) was injected into the 
media inlets and the resulting fluorescent intensity across the platform was recorded over 
time for 2 h every 5 min. Relative intensity of the concentration gradient was quantified 
in ImageJ by using the profile tool. 
2.3.3 Cell Culture 
 SUM-159 breast cancer cells was chosen as a suitable cell type to invade through 
a 3D hydrogel(Sabeh, Shimizu-Hirota, & Weiss, 2009). The MCF-7, SUM-159 and 
mCherry-labeled SUM-159 breast cancer cells, provided by Mouneimne lab, were 
cultured in MCF-7 specific media (Dulbecco's Modified Eagle Medium supplemented 
with 5% heat inactivated fetal bovine serum (FBS), 1x penicillin-streptomyocin) and 
SUM specific media (Ham's F-12 with L-glutamine and supplemented with 5% heat 
inactivated fetal bovine serum (FBS), 1x penicillin-streptomyocin, 1 µg/ml 
hydrocortisone, and 5 µg/ml insulin) respectively. CAFs (passage > 55) were acquired 
from ATCC (ATCC® HTB 125™) and cultured in MCF-7 specific media. The cells 
were maintained within a humidified cell culture incubator at 37 °C and 5% CO2. 
2.3.4 Invasion assay 
 To load the cancer cells into the device for invasion experiments, cells were 
trypsinized and pelleted into 0.5 mL microcentrifuge tubes. Matrigel® (Corning), 
collagen I (2.0mg/mL, Corning® Collagen I, Rat Tail, 100mg, Product #354236, 
Corning) and a 1:1 mixture of Matrigel® to collagen type I (2.0 mg/mL) was added to the 
cells to create a mixed hydrogel cell solution (final concentration of collagen I at 1 
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mg/mL) with a density of 15 million cells/mL. The mixed hydrogel cell solution was 
injected into the tumor region of the microfluidic chip and polymerized by placing the 
devices into the humidified cell culture incubator at 37 °C. These chips were flipped 
every 1 min to create a homogenous distribution of cells within the mixed gel. After 8 
min within the incubator, the devices were taken out and subsequently a 2.0 mg/mL 
collagen type I solution was injected into the stromal region. For co-culture with CAFs, 
100,000 cells/mL were encapsulated in the collagen type I solution. The collagen was 
polymerized within the humidified incubator at 37 °C for 8 min. Next, SUM media was 
added into the channels of each device and the microfluidic chips were placed into the 
cell culture incubator overnight. On the next day, the media within EGF-stimulated 
devices ((+) EGF) was exchanged with SUM media supplemented with EGF (50 ng/mL). 
Unstimulated devices ((-) EGF) were based on the use of normal SUM media. Media was 
changed daily for the whole culture period.  
 Phase-contrast images of the cells were acquired once every day using 4 x 3 tiles 
with a 10x objective. Distribution of invading cells was quantified from these images by 
measuring the distance from the cells to the nearest micropost. If there was a cell in a 
cluster, only the furthest point on the furthest cell from that cluster was measured unless 
clear cell borders were distinguishable. Each measurement was taken from the most distal 
protrusion of the cell (not the cell body). To quantify the invading edge of the tumor (i.e. 
the invading tumor front), only the cells on the periphery were measured by considering 
the most distal points of the most distal cells. In this case, only the cells at the edge of the 
tumor (i.e. cells that have traveled the highest distance from the tumor region from each 
degree) were included in the quantification.  
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 To perform time-lapse imaging, mCherry-labeled SUM-159 cells were mixed 
together with normal SUM-159 at a ratio of 1:9 prior to the invasion assay. The devices 
were placed inside a custom miniature incubator (TC-MWP, Bioscience Tools) with a 4-
well insert, which enabled imaging of 4 devices at a time at 37 °C and 5% CO2. 
Fluorescent time-lapse imaging was performed using a fluorescent microscope (Zeiss 
Axio Observer Z1, Zeiss) equipped with the Apotome.2 and a 10x objective. The z-
resolution and the time interval were set to 3.45 µm and 45 min, respectively.  3D time-
lapse images were taken within 24 h of adding EGF and between days 3 and 4 of the 
invasion assay. Speed (defined as distance over time) and persistence (defined as 
euclidean distance over accumulated distance) were utilized to quantify cell migration 
metrics. To filter out the cells to obtain those that migrate toward the gradient, the 
average angles of each cell trajectory were compiled and reduced to those cells within ± 
30 ° of the y-axis (i.e. the direction of the gradient).  
2.3.5 Fluorescent staining  
 For immunofluorescent staining, the cells were fixed by adding warmed 4% 
paraformaldehyde into the channels of the microfluidic chip for 30 min. The devices were 
then washed twice with PBS-glycine (100 mM glycine in PBS) for 10 min at room 
temperature. This was followed by a single wash using PBS-Tween (0.05% (v/v) Tween-
20 in PBS). Next, immunofluorescent (IF) buffer (0.2% (v/v) Triton X-100 + 0.1% (v/v) 
BSA (radioimmunoassay grade) + 0.05% Tween 20, 7.7 mM NaN3 in PBS) + 10% (v/v) 
goat serum was added into the channels and the devices were incubated at room 
temperature for 1.5 h. Later, primary antibodies, monoclonal Anti-α-Tubulin (1:500, 
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T9026, Sigma-Aldrich), Ki-67 (1:100, (DSHB Hybridoma Product AFFN-KI67-3E6)), 
EGFR (1:1000, MA5-13319, Thermo Scientific), or pEGFR (1:100, 3777S, Cell 
Signaling Technology®) were diluted at in IF buffer and devices were parafilmed and 
kept at 4 °C overnight. Afterwards, the microfluidic channels were washed 3 times 
utilizing IF buffer for 20 min each. Then, the secondary antibody (Alexa Fluor® 488, 
555, or 647, Thermo Fisher Scientific) was diluted in IF buffer for 45 min at room 
temperature in the dark. The devices were washed once with IF buffer for 20 min and 
twice with PBS-Tween for 10 min each at room temperature. Afterwards, the nuclei and 
F-actin fibers were stained by using 4',6-diamidino-2-phenylindole (DAPI, Invitrogen) 
(1:1000) and Alexa Fluor® 488 Phalloidin (Invitrogen) (1:40) overnight at 4 °C. The 
dilutions were done using PBS-Tween. Finally, the devices were washed 5 times in PBS-
tween for 10 min each before imaging.  
2.3.6 Imaging and analysis 
 All imaging was performed using a Zeiss Axio Observer Z1 with the Zen Pro 
software suite. Phase-contrast images of the invasion assay were captured using a 10x 
objective lens. Immunofluorescent images were taken with 10x and 40x objective lenses 
together with the Apotome.2 (Zeiss). The Apotome.2 created optical sections of our 
devices, reducing scattered light, to generate clear fluorescent z-stacked images for 3D 
images.   
 To quantify cell proliferation, cells expressing mCherry were counted on days 1 
and 3 and compared. Moreover, Ki-67 proliferative marker was also quantified by 
comparing the cells expressing Ki-67 to total cell population. The index was developed 
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by dividing Ki-67 positive cells by all nuclei within a field of view (40x magnification, 
223 x 167 µm2).  
 To analyze EGFRs and pEGFRs on days 2 and 4, we thresholded images (40x 
magnification) of the receptors in ImageJ with actin for their respective coverage areas. 
EGFR and pEGFR areas were divided by the area of the cell body resulting in a 
normalized ratio. We also divided the pEGFR area by the EGFR area to analyze the 
phosphorylated receptors among the non-phosphorylated ones. Heat maps were created 
using the 3D surface plot plugin in ImageJ. 
To investigate the cytoskeletal organization of the cells, we looked at the actin 
area, cell shape, and protrusiveness. The actin fibers were thresholded in ImageJ 
producing an area value based on the number of pixels representing the F-actin fiber 
coverage area. Subsequently, this area was divided by the cell total count (nuclei) in the 
field of view (20x magnification, 0.45 x 0.34 mm2) on days 1 and 4 of culture. We used 
the particle analyzer plugin within the ImageJ suite to further quantify cell shape (i.e. 
aspect ratio, circularity, and roundness) based on the actin masks. Finally, the protrusions 
of the cells were manually counted in the actin cytoskeleton by quantifying the number of 
extensions (> 3 µm in length and 1 µm in width) from the cell body.  
2.3.7 Statistical Analysis 
All measurements were compiled from three or more independent devices for 
each experimental condition. The data were compared using unpaired student’s t-test, 
multiple comparisons test, and correlation analysis within the GraphPad Prism software 
(GraphPad Software). 
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2.4 Results 
2.4.1 Development of the 3D Spatially Organized Cancer Invasion Platform  
 
Figure 2.4 Spatial-organization of ECM and cells. 
(A) The tumor region is represented by the red color and the stroma is represented by the 
green. The depth of the channels is 200 µm. (B) Spatial-organization of cells and/or ECM 
is performed in a two-step process. Cancer cells were encapsulated in a tumor matrix and 
injected into the tumor filling port. The matrix was polymerized and then the stroma 
matrix was injected into the stromal filling port. This matrix was then polymerized and 
the final result is a tumor surrounded by a stroma. (C) Fluorescent image demonstrating 
ECM compartmentalization. A red hydrogel was injected into the tumor region while a 
green gel was injected into the stroma (scale bar: 200 µm). (D) Phase-contrast image of 
cells isolated within the tumor region while a cell-free stroma hydrogel surrounds it 
(scale bar: 200 µm). 
 
Motivated by the need to simulate the invasion of cancer cells from the primary 
‘tumor’ into the enclosing stroma, a microfluidic platform was designed to organize the 
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cancer cells into a central tumor region surrounded by a stroma entity (Bissell, Radisky, 
Rizki, Weaver, & Petersen, 2002; C. M. Nelson & Bissell, 2005). The microfluidic 
device specifically consisted of an inner chamber (tumor region) bordered by an outer 
chamber (stromal region) (Figure 2.1A) to produce a side-by-side arrangement of 3D 
matrices. The diameter and height of these concentric chambers were 3 mm and 200 µm, 
respectively. The distance between the edge of the inner chamber and outer chamber was 
1 mm. Both of these chambers were bounded by trapezoidal micro-posts spaced evenly at 
100 µm to create a concentric spatial organization with clear interfaces while allowing 
interaction between the different regions. The trapezoid shape was chosen to permit 
uniform gel formation between the posts due to the angle of the trapezoid being 
supplementary to the contact angle of the gel solution and PDMS (Farahat et al., 2012; C. 
P. Huang et al., 2009). Tumor cells were encapsulated within a hydrogel solution and 
loaded first into the device through the central cell filling port (Figure 2.1B and Appendix 
Figure A.1). The stromal region was then loaded with cell-free hydrogel to produce an 
interconnected platform. The platform had two inputs that can be filled with cell media 
containing a variety of molecules (e.g., EGF) to enhance or suppress cancer invasion. 
Additionally, the design of the platform enabled creating symmetric and asymmetric 
gradients of biomolecules. Compared to 2D models (Saadi et al., 2006; S. J. Wang et al., 
2004) and other conventional 3D models(B. J. Kim et al., 2013; B. Weigelt, 2014; I. K. 
Zervantonakis et al., 2012), this assay particularly allowed for control over 3D spatial 
compartmentalization of cells, ECM heterogeneity, and biomolecular gradients.  
 To demonstrate the formation of a clear-cut spatial arrangement of ECM, we first 
utilized fluorescent-labeled hydrogels. Rhodamine-6G hydrogel solution was loaded into 
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the tumor region followed by a fluorescein hydrogel solution loaded into the stromal 
region. After gelation, the formation of the hydrogels within specific regions of the 
platform was visualized under a fluorescent microscope (Figure 2.1C).  There were no 
gaps between the posts that could disrupt the interconnectivity of the two side-by-side 
regions, and the trapezoidal posts held the gels in place while also separating the inner 
and outer chambers. In that regard, the interconnectivity of the regions within the 
platform enabled signaling from the channels to the stroma to the tumor. Next, to 
demonstrate cell-ECM spatial organization, SUM-159 breast cancer cells were 
encapsulated within a collagen I matrix and loaded into the tumor region while cell-free 
collagen I was loaded into the stromal region. Following successful gelation of the 
hydrogels, carcinoma cells were present only within the tumor region while leaving the 
stroma pristine (Figure 2.1D). Additionally, no gaps or bubbles were present between the 
tumor and stroma and the cells were distributed in 3D (Appendix Figure A.2). The 
spatially organized tumor-stroma potentially allows for further studies utilizing different 
cell types and/or different ECM compositions, which will provide insight and 
understanding into how other cell types and environments influence cancer invasion 
(McMillin et al., 2013).  
2.4.2 Characterization of Diffusion Across the Platform 
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Figure 2.5 Diffusion of molecules through the two regions.  
(A, B) COMSOL simulation of 10 kDa molecule (10 µg/mL) through the device 
demonstrates the concentration gradient profile over time. (C) FITC-Dextran (10 kDa, 10 
µg/mL) was diffused from the stroma to the tumor region to demonstrate successful 
interconnectivity and concentration gradient between the two regions (scale bar: 100 
µm). (D) Quantified experimental results of diffusion of FITC-Dextran (10 kDa, 10 
µg/mL). 
 
COMSOL simulation of EGF diffusion was used to characterize the time-
dependent gradient during chemoinvasion within the platform. Diffusion of 10 kDa 
molecules was simulated within a 3D collagen I gel (2.0 mg/mL) at 37 °C. Figure 2.2A 
demonstrates the computed time-lapse of the concentration gradient across the tumor-
stroma microenvironment. In addition, Figure 2.2B shows the simulated concentration 
profile within the device. To experimentally demonstrate diffusion across the platform 
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and show that the regions within the device were well interconnected, 10 kDa FITC-
Dextran (10 µg/mL) was injected into the media inlets and the resulting fluorescent 
intensity across the platform was recorded over time. By 30 min (Figure 2.2C), the 
fluorescent dextran had continuously diffused across the stroma and into the tumor 
region, demonstrating that the interface between the two regions enabled diffusion of 
biomolecules from one region to the other while showing an established concentration 
gradient. Figure 2.2D provides the quantified experimental results for the concentration 
gradient profile showing similarities to the simulated gradient profile up to 2 h (Figure 
2.2B). Differences between the experiments and simulation likely arise from small 
convective flows generated during media changes. A gradient was established for up to 2 
h and leveled out afterwards.  This suggests that there is an optimum window to replenish 
the media at this time but other factors that can perturb the gradient profile are also in 
play such as cell-ECM interactions and cell-biochemical cue (i.e. the diffused cues) 
interactions.  
2.4.3 Cell Behavior within a Physiologically Relevant 3D Microenvironment  
To represent the invasive tumor microenvironment, SUM-159 breast carcinoma 
cells were initially encapsulated at a high density (15 x 106 cells/mL) within three distinct 
matrices namely, Matrigel®, (2 mg/mL) collagen I, and 1:1 mixture of Matrigel® and 
collagen I (final concentration of collagen I at 1 mg/mL) and were subsequently loaded 
into the tumor region. The stroma region was kept constant for all conditions by only 
loading the outer chamber with collagen I (2 mg/mL), which is the most abundant ECM 
protein outside the primary breast tumor area (Provenzano et al., 2006; Provenzano et al., 
2008). Initial studies revealed that the SUM-159 cells that were encapsulated within the 
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Matrigel® matrix demonstrated a mixture of round and elongated morphology after one 
day of culture (Figure 2.3A). As the cells migrated out from the tumor region and into the 
collagen matrix of the stroma, they began to adopt more elongated morphology 
representative of an invasive phenotype (Sung et al., 2011). On the other hand, breast 
carcinoma cells that were still within the tumor region (Matrigel®) maintained their 
roundness. SUM-159 that were encapsulated within collagen I (2mg/mL) matrix also 
exhibited a mixture of round cells and elongated cells after one day of culture (Figure 
2.3B). However, by the third day within the collagen-only tumor region, there were little 
to no round cells (Figure 2.3B), whereas the Matrigel®-only matrix still had round cells 
by day 3 (Figure 2.3A). Although the cells encapsulated in either collagen I or Matrigel® 
were able to successfully migrate out of the tumor region, there were significant matrix 
disruptions. The disruptions near the microposts created gaps within the matrix that 
would have prevented cells from traversing through the 3D microenvironment. To 
prevent the gap formation so that the cells may continuously invade from the tumor into 
the stroma while maintaining a physiologically relevant platform, Matrigel® and collagen 
I (2 mg/mL) were mixed at a ratio of 1:1 prior to cell encapsulation. As seen in Figure 
2.3C, cells demonstrated a mixture of round and elongated morphology within the mixed 
gel that was similar to the previous two matrices (Figure 2.3A and B) demonstrating the 
continuous invasion. By the third day, the cells invaded into the stroma without 
disruption of the matrix in contrast to the previous two conditions (Figure 2.3A and B). 
Additionally, unlike the collagen-only hydrogel, there were still round and elongated 
cells within the tumor region on day 3, which demonstrated similar morphology to the 
Matrigel®-only matrix. Thus the mixed gel was chosen for all subsequent experiments to 
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represent a more physiologically relevant primary tumor region (B. Weigelt, 2014), while 
still allowing cells to continuously invade throughout the platform with little matrix 
disruption. This potential to decouple and modulate the tumor and stroma characteristics 
could allow further studies to develop stiffness and ligand-density gradients to elucidate 
the effects of haptotactic and biophysical cues on invasion dynamics. 
 
Figure 2.6 Behavior of breast cancer cells within different ECMs. 
(A) SUM-159 breast cancer cells were initially encapsulated in Matrigel®. On the first 
day, the cells demonstrated round morphology and by the third day, the matrix was 
disrupted (scale bar: 100 µm). (B) Collagen I (2.0 mg/mL) was utilized to encapsulate 
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cells within the tumor region. The cells demonstrated similar morphology to Matrigel® 
on the first day. On day 3, cells migrated outside of the tumor region but also exhibited 
great disruption of the ECM, similarly to Matrigel® (scale bar: 100 µm).  (C) A mixed 
gel of Matrigel®:collagen I (1:1 ratio) was utilized to reduce matrix disruptions. By day 
3, the cells successfully migrated out but did not disrupt the tumor as heavily (scale bar: 
100 µm). (D) LIVE/DEAD was utilized to assess the viability of the cells on day 1 and 4 
within the mixed gel. The cells were highly viable and did not demonstrate any 
significant change between the two days (P < 0.05 calculated from student’s T test with 
more than three devices for each condition, scale bar: 100 µm).  
 
To investigate the survival of the breast cancer cells within the mixed gel 
(Matrigel®:collagen I) microenvironment, the encapsulated cells were stained with the 
LIVE/DEAD assay at days 1 and 3. The live cells, which fluoresced green, and the dead 
cells, which fluoresced red, were counted and compared between the two days (Figure 
2.3D). The viability was quantified to be 90.3 ± 3.44 % and 91.7 ± 0.88 % for days 1 and 
3 respectively and no statistical difference over the three days. These results suggested 
that the encapsulation of the cells within the mixed gel did not create a significant impact 
on cell survival.  
2.4.4 Tumor Growth and Dissemination of Invasive Breast Cancer Cells  
To understand the effects of EGF on the invasion of the SUM-159 within the 
spatially organized microenvironment, medium containing EGF (50 ng/mL) was added to 
the platform daily after an initial 24 h culturing period. The stimulated ((+) EGF) and 
unstimulated ((-) EGF) cells were tracked for a total of four days (96 h). During the first 
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24 h (Day 0), the cells adopted round morphologies and were contained within the tumor 
region (Figure 2.4A). After one day, the cells began to invade into the stroma with a 
mixture of round and elongated morphologies. Cells were distributed spatially similarly 
between the two EGF conditions (Figure 2.4B) By day 3 there was a significant 
difference in tumor dissemination when comparing the stimulated (715 ± 38.0 µm) and 
unstimulated conditions (556 ± 24.7 µm), demonstrated by a rightward distribution shift 
by (+) EGF cells along the x-axis (Figure 2.4B). We also calculated the progress of the 
tumor invasion front over the four day period for both conditions and found that by days 
3 and 4, the (+) EGF tumor invaded further than (-) EGF (Figure 2.4C). The invading 
distance of furthest distal cells from the microposts (Figure 2.4C) were compared daily 
demonstrating that by days 3 and 4, the (+) EGF tumor invaded further than (-) EGF. 
Moreover, whole device images taken of the actin cytoskeleton (Appendix Figure A.3) 
displayed the stark difference between the two conditions in terms of tumor growth and 
cell invasion. The stimulated cells migrated beyond the stroma and into channels by day 
4. In addition, we compared the invasion of SUM-159 breast cancer cells to non-invasive 
MCF-7 cells. MCF-7 cells developed into clusters of cells near the edge of the tumor 
region (Appendix Figure A.4A). EGF stimulation enhanced invasion of MCF-7 cells into 
the stroma (80 ± 8 µm) compared to the control condition without EGF (20 ± 2 µm) on 
day 2 (Appendix Figure A.4B). However, when comparing to SUM-159 cells, MCF-7 
invasion in presence of EGF was significantly lower by almost 10-fold within each day 
experiment (Appendix Figure A.4C). We also investigated the effect of EGF on 
proliferation of SUM-159 cells by quantifying the number of cells within the stromal 
region which revealed increased cell count in the presence of EGF stimulation from day 0 
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to day 3 (Figure 2.4D and Appendix Figure A.5A).  Moreover, expression of Ki-67 
proliferative marker was increased in the (+) EGF condition (Appendix Figure A.5B). 
These findings demonstrated that EGF enhances breast cancer cell invasion within the 
microengineered 3D platform, consistent with previous studies using 2D assays (S. J. 
Wang et al., 2004).  
 
Figure 2.7 Breast cancer 3D invasion assay.  
(A) Devices were split into two groups where one group (+ EGF) was introduced to EGF 
(50 ng/mL) and the other was not exposed to EGF (- EGF). Based on the representative 
images, (+) EGF showed more proliferation, as indicated by the higher density, and 
migration by reaching to the outer channels in 4 days. The (-) EGF group demonstrated 
migratory tendencies but did not have the same invasive profile as (+) EGF. (B) 
Distribution of cells was quantified for days 1 and 3. The profiles were similar between (-
) and (+) EGF for the first day. By the third day, there was a shift in cell distribution 
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toward the right indicating more cell count further away from the tumor region. 
Distribution for the fourth day was quantification was not possible due to the high density 
and overlapping cells (scale bar: 100 µm). (C) Invasion distance of the tumor front was 
calculated from the radial distances of the furthest cells from the tumor region. (+) EGF 
exhibited significantly higher invasion by days 3 and 4 (P < 0.05 calculated from 
student’s T test with more than three devices for each condition). (D) Number of cells of 
cells was quantified by counting the amount of cells on days 1 to 3. (+) EGF induced 
significantly higher cell count (P < 0.05 calculated from student’s T test with more than 
three devices for each condition). 
 In addition to global diffusion through the platform from both media channels, we 
introduced EGF (50 ng/mL) to a single media channel to localize the chemoattractants 
asymmetrically through half of the device (Figure 2.5A). The cells were consistently 
tracked for four days (96 h). We observed no differences in cell migration during the first 
24 h of culture. However, by day 2 (Figure 2.5B), there was a significant increase in 
invasion toward the channel in which we introduced EGF (Figure 2.5C). Such trend was 
consistent during days 3 and 4. In fact, by day 4, there were cells that had migrated out of 
the stroma and into the media channels on the EGF side, however, such behavior was not 
observed on the other side of the stroma (the media only side channel with no EGF 
(Figure 2.5A).  These observations clearly demonstrate the capability of our microfluidic 
platform to generate competing microenvironments (Figure 2.5C) through introduction of 
variable regimes of growth factors for invasion studies.    
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Figure 2.8 Breast cancer 3D invasion assay using asymmetric gradients.  
(A) EGF (50 ng/mL) to a single channel while the other contained no supplemented EGF 
media. We found increased cell gravitation toward the side with EGF (B) Invasion 
distance of the tumor front was calculated from the radial distances of the furthest cells 
from the tumor region. (+) EGF exhibited significantly higher invasion by days 2, 3, and 
4 (P < 0.05 calculated from student’s T test with more than three devices for each 
condition). (C) COMSOL simulation (24 h) of 10 kDa molecule (10 µg/mL) from a 
single channel through the device demonstrates the concentration gradient. 
2.4.5 High Resolution Real-time Imaging of Three-dimensional Cancer Invasion at a 
Single-cell Level 
In comparison to previous real-time migration studies (B. J. Kim et al., 2013; H. 
Ma, Liu, Qin, & Lin, 2010), our model and technique enabled us to observe the changing 
morphology of the invading cancer cells at a single-cell level within the 3D matrices, at a 
high-resolution, using light and fluorescent microscopy. In particular, cells migrated by 
utilizing thin protrusions probing in front of their cell body and moving their body toward 
the direction of the protrusions (Figure 2.6A, Appendix Movie D.1 and D.2). 
Furthermore, these cells appeared to drag their bodies along as the protrusive front moves 
forward. Using 3D time-lapse imaging (Appendix Movie D.3), we tracked individual 
cells, which was further analyzed in NIS Elements AR Microscope Imaging Software by 
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Nikon, to investigate the effects of EGF on 3D tumor cell migration within the initial 24 
h of adding EGF (Figure 2.6B). We found a significant increase in average individual cell 
speed (Figure 2.6C) (0.16 ± 0.006 µm/min) compared to the (-) EGF (0.14 ± 0.006 
µm/min) condition. Moreover, we did not see a significant difference in the persistence 
(Figure 2.6D) for (+) and (-) EGF at 0.32 ± 0.01 and 0.29 ± 0.01 respectively. However, 
when observing the cell trajectory plots (Figure 2.6B), we noticed migration differences 
between the cells along the gradient (Figure 2.2), where there were increased cell counts 
near the y-axis (Figure 2.6B, within the pie slice). To investigate this phenomenon, we 
filtered the cells to only those migrating within ± 30 ° of the gradient (y-axis) in order to 
isolate the sub-population of cells based on the diffusion gradient (Figure 2.6A) and 
subsequently compare the average speed and persistence. In doing so, we found that the 
average speed among filtered cells was still significantly higher for (+) EGF (0.23 ± 0.02 
µm/min) compared to (-) EGF (0.17 ± 0.02 µm/min). Furthermore, persistence within the 
filtered cells was found to be significantly higher for (+) EGF (0.52 ± 0.03) than (-) EGF 
(0.36 ± 0.03). We continued to culture the cells for two more days with daily media 
exchanges. The experiment was repeated again between 72 h and 96 h of culture (Figure 
2.7A). Consistently, we found a significant increase in average speed of individual cells 
(Figure 2.7B) for (+) EGF (0.14 ± 0.005 µm/min) compared to (-) EGF (0.11 ± 0.005 
µm/min) suggesting that EGF maintained high cell motility over prolonged exposure. 
Moreover, we noticed a significant difference in the persistence (Figure 2.7C) for (+) and 
(-) EGF at 0.40 ± 0.02 and 0.29 ± 0.02 respectively. When looking at the filtered cells 
(Figure 2.7D), we still found that the average speed was significantly higher for (+) EGF 
at 0.13 ± 0.009 µm/min whereas (-) EGF demonstrated 0.10 ± 0.006 µm/min. However, 
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the difference in persistence among the filtered cells (Figure 2.7E) was not found to be 
significant (0.60 ± 0.03 vs. 0.51 ± 0.05) suggesting cells behaving in more of a random 
walk fashion, at longer duration of culture, as compared to the initial 24 h of EGF 
stimulation. 
 
Figure 2.9 Time-lapse analysis of individually invading cells within 24 h of adding EGF.  
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(A) Dashed box indicates region of interest for time-lapse capture of cell invasion. 
Frames from a cell invasion movie where the cells are invading throughout the stroma 
toward the channels (scale bar: 100 µm). (B) The cell trajectories were plotted. (C) (+) 
EGF cells demonstrated a significant increase in average cell speed but (D) no significant 
difference for persistence (P < 0.05 calculated from student’s T test with n > 50 from 
more than three devices for each condition). (E and F) The cells were filtered out for cells 
following the gradient (y-axis). We found significant increases in cell speed and 
persistence for (+) EGF (P < 0.05 calculated from student’s T test with n > 25 from more 
than three devices for each condition). 
 
Figure 2.10 Time-lapse analysis of individually invading cells between 72 h and 96 h of 
EGF addition.  
(A) The cell trajectories were plotted. (B and C) (+) EGF cells demonstrated a significant 
increase in average cell speed and persistence (P < 0.05 calculated from student’s T test 
with n > 50 from more than three devices for each condition). (D and E) The cells were 
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filtered out for cells following the gradient (y-axis). We found significant increases in cell 
speed and but no significant difference in persistence for (+) EGF (P < 0.05 calculated 
from student’s T test with n > 9 from more than three devices for each condition). 
 
 
2.4.6 Analysis of EGF Receptors After Long-Term Stimulation 
We stained the cells for EGFRs and phosphorylated EGFRs (pEGFRs) after 1, 2, 
and 4 days of culture in order to visualize the patterning and activation of EGFR in 
response to EGF stimulation. Interestingly, when observing cells on the first day of 
culture on both a 2D surface and within the hydrogel matrices (no EGF), EGFRs 
localized near the cell membrane (Appendix Figure A.6A). After treatment with EGF for 
24 hours (Day 2 of culture, Appendix Figure A.6B), we noticed that EGFRs in the (+) 
EGF condition began to displace from the membrane toward the cell body and became 
more punctuated. In the (-) EGF condition (Day 2), the location of EGFRs remained 
similar to the receptors in Day 1 images (Appendix Figure A.6B). However, after 4 days, 
EGFRs no longer bordered the cell membrane unlike the first days of culture (Appendix 
Figure A.6B). Moreover, the receptors appeared in a punctate pattern throughout the cell 
body for both (±) EGF conditions (Figure 2.8A). We normalized the EGFR coverage area 
to the area of the cell body using actin as a marker for total cell area on Day 4. The EGFR 
to cell area ratio (Figure 2.8B) was significantly higher in the (-) EGF group. On the other 
hand, the pEGFR to cell area ratio (Figure 2.8C) was significantly higher in the (+) EGF 
group. Furthermore, for the (+) EGF group, we found a significantly higher pEGFR to 
EGFR area ratio suggesting more phosphorylated receptors among the available 
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receptors. We further examined the reason for why EGFR to cell area ratio was lower in 
the (+) EGF condition and found that these cells appeared to have clustered or localized 
EGFR. As can be seen in Figure 2.8E, heat maps of relative surface intensity also 
displayed high clustering of the EGFR near the nucleus in (+) EGF condition while 
EGFR was seen to be distributed through the cell body in (-) EGF condition. This 
illustrates that EGFRs are being trafficked within the cell after EGF exposure. Overall, 
our findings suggest that the migratory phenotype of breast cancer cells, is linked to the 
activation of EGFRs and further demonstrates successful delivery of EGF to the cells 
within the 3D microfluidic device. 
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Figure 2.11 Investigation of EGFR and pEGFR.  
(A) Cells were stained for EGFR (red), pEGFR (green), and nuclei (blue) (scale bar: 20 
µm). (B) (+) EGF demonstrated significantly lower EGFR to cell area ratio. (C and D) 
(+) EGF displayed significantly higher pEGFR to cell area ratio and pEGFR to EGFR 
area ratio (P < 0.05 calculated from student’s T test with n > 18 from more than three 
devices for each condition). (E) Representative images of EGFR clusters with 
corresponding heat maps of relative intensities.  
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2.4.7 Cytoskeleton Organization of Invasive Cells 
 We investigated the changes in the cytoskeleton due to EGF-induced invasion. 
Upon close inspection, we found that (-) EGF cells were not as spread as the cells within 
the EGF-stimulated devices. As seen in the Z-projection of the F-actin (Figure 2.9A), 
more round cells, indicated by the white arrows, were apparent in the (-) EGF group. The 
actin area, which delineates the area of the cell, (Figure 2.9B) was calculated by 
thresholding the fluorescent images and dividing the total actin area by the number of 
cells present in the field of view. This revealed that (+) EGF cells had almost twice the 
actin area than (-) EGF cells, which is representative of the higher spreading and 
elongation of cells seen in Figure 2.9B. As previously reported, these cytoskeletal 
arrangements and changes in morphology are indicative of a shift towards an invasive 
phenotype (Nikkhah, Strobl, De Vita, & Agah, 2010; Nikkhah, Strobl, Peddi, & Agah, 
2009; Nikkhah et al., 2011; Strobl, Nikkhah, & Agah, 2010). Furthermore, specific 
morphology descriptors (Figure 2.9C) including, aspect ratio (AR), circularity, and 
roundness, were calculated to divulge the effect of EGF on the cell shape. We limited the 
analysis to cells that were at the center of the z-stack to avoid the influence of attachment 
to the top and bottom of the chamber. The ARs of the cells, which indicated polarized 
length and extension, were significantly higher in (+) EGF (2.33 ± 0.14) than in (-) EGF 
(1.75 ± 0.08). The extended morphology suggested that EGF played a role in enhancing 
the migratory phenotype of the breast cancer cells(N. Peela et al., 2016; Sung et al., 
2011). Furthermore, the circularity of the cells within the EGF-stimulated devices was 
nearly half (0.25 ± 0.02) of the circularity for the (-) EGF cells (0.53 ± 0.02). These 
findings suggested that the protrusiveness or cell extensions were much lower in 
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unstimulated cells. Moreover, the roundness of the unstimulated cells was 0.66 ± 0.02 
compared to 0.53 ± 0.02, which reflected the significantly higher amount of round cells 
for (-) EGF demonstrated in Figure 2.9A. Interestingly, the distribution of elongated cells 
were opposite for the two conditions (Figure 2.9D). Specifically, the ARs of the cells 
were binned into three different groups, high (AR > 2), medium (2 > AR > 1.5), and low 
(1.5 > AR). As can be seen in Figure 2.9D, 55.8 ± 7.72 % of (+) EGF cells were regarded 
as high, whereas only 25.2 ± 4.73 % of (-) EGF had high ARs. In contrast, (-) EGF 
showed the enhanced low ARs and reduced high ARs. For the (-) EGF condition, 59.6 ± 
3.49 % of the cells had low ARs in comparison to the 27.2 ± 6.13 % of stimulated cells. 
There was no significant difference between the medium AR results. Furthermore, we 
examined the effect of (-) EGF and (+) EGF on protrusiveness (Figure 2.9E). On average, 
(+) EGF exhibited 3.94 ± 0.34 protrusions per cell whereas (-) EGF demonstrated 1.36 ± 
0.13 (Figure 2.9F). Furthermore, the protrusion count per cell was compared with the 
aspect ratio and the circularity to determine the relationship between cell protrusion and 
cell morphology under the context of EGF stimulation. These results suggested that ARs 
and cell protrusions slightly correlated (R-squared = 0.11, p < 0.001) prior to EGF 
stimulation, but upon introduction of EGF the correlation was negligible (R-squared = 
0.00, p < 0.61). Furthermore, protrusions were correlated with circularity (Appendix 
Figure A.7) indicating that under (-) EGF condition, the circularity sharply decreased 
when cell protrusions increased. With EGF stimulation, circularity moderately declined 
(R-squared = 0.16, p < 0.001) with increasing cell extensions where the correlation was 
weaker than (-) EGF condition (R-squared = 0.45, p < 0.0001).  This result suggested that 
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EGF stimulation reduced the correlation between circularity and cell protrusions similarly 
when looking at ARs and protrusions.  
 
Figure 2.12 Analysis of cell morphology.  
(A) Cells were stained for F-actin (green) and nuclei (blue). (-) EGF exhibited more cells 
with round morphology (white arrows), which was correlated to a less invasive 
phenotype. (+) EGF appeared to be more protrusive (scale bar: 20 µm). (B) Actin area 
calculated from thresholded images indicated higher quantities for (+) EGF after 4 days 
of culture. There was no significant difference between days 1 and 4 for (-) EGF (P < 
0.05 calculated from multiple comparisons test with more than three devices for each 
condition). (C) Cell shape descriptors of the actin-cytoskeleton were quantified using 
ImageJ software suite (particle analyzer plugin). (+) EGF had significantly higher aspect 
ratio (AR) and lower circularity and roundness; all of which correlate to a higher invasive 
phenotype (P < 0.05 calculated from student’s T test with n > 70 from more than three 
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devices for each condition). (D) AR was reorganized into three categories, low: 1 < AR < 
1.5, medium: 1.5 < AR < 2.0, and high 2.0 < AR. Interestingly, (+) EGF contained 
significantly higher amounts of cells with high ARs whereas (-) EGF contained 
significantly higher amounts of cells with low ARs. Both groups had no significant 
difference for the medium category (P < 0.05 calculated from student’s T test with n > 70 
from more than three devices for each condition). (E) Protrusions (white star) were 
counted for each cell for the two conditions. (F) (+) EGF cells had significantly more 
protrusions than (-) EGF (P < 0.05 calculated from student’s T test with n > 70 from 
more than three devices for each condition).  
 
 Further immunostaining, clearly demonstrated microtubule networks in both 
conditions (Figure 2.10A). We also observed morphology changes between 3D stroma 
and 2D glass surface. In Figure 2.10B, the red arrow indicates a cell migrating across the 
2D plane while the yellow arrow indicates cells exiting the stroma. The morphology of 
the cells on 2D plane (Figure 2.10B, red arrow) was distinctly different from that of the 
cells encapsulated within the 3D stroma (Figure 2.10A, Appendix Movie D.4 and D.5) 
showing that the device can recapitulate 2D and 3D morphologies (Even-Ram & 
Yamada, 2005; Smalley, Lioni, & Herlyn, 2006). The actin stress fibers (Figure 2.10B, 
red arrow) spread across the relatively flat cell body with partial local alignment toward 
the direction of movement. Furthermore, the microtubules exhibited higher amount of 
fibers and polarization in the same direction. When observing the cells in the 3D stroma 
(Figure 2.10A, Appendix Movie D.4 and D.5), the cells were less spread, more spherical, 
and either with or without protrusions. The cells within the stroma presented long 
  61 
protrusions reaching into the matrix whereas cells on the 2D surface had short and flat 
protrusions (Appendix Figure A.8, white and yellow arrow indicates protrusion and 
collagen stroma respectively, Appendix Movie D.6). Additionally, in Figure 2.10B, the 
cells transitioning out of the matrix demonstrated a spherical cell body, similar to cells 
embedded within the 3D stroma. The flat short protrusions that were reaching out onto 
the 2D surface were characteristics of cells on glass substrate.  
 
Figure 2.13 3D Analysis of F-actin and microtubules.  
(A) Fluorescent staining revealed cell morphology within the 3D matrix. Cells appeared 
to be round with slight protrusions. Microtubule fluorescence was intense in all directions 
for (-) EGF, but had a slight affinity toward a single direction (white arrows) in the (+) 
EGF group. (B) Cell on 2D substrate appeared to be flat comprised of wide lamellipodia 
(red arrow). Cells moving toward the glass substrate had round cell body but large and 
wide protrusions (yellow arrow). 
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2.4.8 CAFs Enhance Breast Cancer Cell Invasion 
To incorporate further complexities in the proposed tumor microenvironment, we 
investigated the invasive response of SUM-159 cells in the presence of CAFs (Figure 
2.11A). Specifically, we incorporated the tumor region with only the SUM-159 cells 
while loading the stroma with only CAFs. In doing so, a 3D tumor-stroma arrangement of 
breast cancer cells and fibroblasts was successfully generated within the microfluidic 
device. We observed that over the course of 3 days, SUM-159 cells expressing mCherry 
were migrating through the surrounding stroma (Figure 2.11B), where the presence of 
CAFs influenced invasive profile of cancer cells (Figure 2.11C). Specifically, CAFs 
induced more invasion distance in SUM-159 cells (720 ± 15 µm) as compared to the 
control condition (564 ± 12 µm) containing no fibroblasts. 
 
Figure 2.14 Co-culture invasion assay. 
(A) Schematic of breast cancer cell and fibroblast interactions. (B) Invading SUM-159 
breast cancer cells expressing mCherry (red) into the stroma with or without CAFs, scale 
bar: 100 µm. (C) Comparison of migration between SUM-159 only and SUM-159 + 
CAFs groups on day 3. (P < 0.05 calculated from student’s T test with n > 6 from more 
than three devices for each condition). 
2.5 Discussion 
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Despite significant progress, the majority of microfluidic models lack cell and 
ECM spatial organization that allows for separate manipulation of side-by-side tumor and 
stromal regions to assess the roles of microenvironmental factors on 3D cancer invasion, 
in a real-time fashion (Mosadegh, Saadi, Wang, & Jeon, 2008; Saadi et al., 2006; Sung & 
Beebe, 2014; S. J. Wang et al., 2004). For instance, work done by Sung et al. provided 
3D microenvironment models to spatially compartmentalize different cell types, however 
the overall objective of the work was not to assess real-time cancer cell invasion in 3D 
matrix (Sung et al., 2013; Sung et al., 2011). Additionally, these models did not 
incorporate perfusable channels surrounding the tumor-stroma regions to allow for 
diffusion of biomolecule gradients of chemotactic factors to the cells. Instead, their model 
was used to show differences in cell phenotype, which we also demonstrated in our 
platform. Furthermore, Kim et al., studied invasion in a 3D hydrogel but the model did 
not offer the ability to separately compartmentalize cancer cells and stromal ECM (B. J. 
Kim et al., 2013). Moreover, work by Zervantonakis et al., provided insight on the role of 
tumor-macrophage-endothelial interactions in invasion within a microfluidic tumor 
model, but was not designed to examine side-by-side arrangement of different 3D ECM 
components, which is crucial in understanding the invasion process (Farahat et al., 2012; 
I. Zervantonakis et al., 2010; I. K. Zervantonakis et al., 2012). Our model enabled 
compartmentalization of tumor and stroma entities, which would allow for fine-tuning 
and control of heterogeneous ECM and cell components, as well as diffusive barriers (i.e. 
solid tumors) for nutrient and growth factor transport. Another contribution of our work 
was real-time high-resolution 3D invasion (in all x, y, z dimensions) and morphology 
studies at the single cell level.  
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 Cancer cells were compartmentalized within our platform to represent a tumor 
surrounded by a stromal matrix (Figure 2.1) where biochemical cues (i.e. EGF) diffused 
from outside of the stoma toward the center of the tumor region (Figure 2.2) (Provenzano 
et al., 2006). We primarily investigated the cell morphology and tensional homeostatic 
effect of encapsulating SUM-159 cells within three different matrices namely Matrigel®, 
collagen I, and 1:1 mixture of Matrigel® and collagen I (Figure 2.3). Our analysis 
revealed that as the cells migrated and proliferated, they disrupted in the matrix either by 
proteolytic or tensional effect(Paszek et al., 2005) showing that either collagen I or 
Matrigel® matrix alone was unable to maintain high fidelity of the tumor-stroma 
architecture.  Furthermore, by mixing collagen I and Matrigel® (1:1 ratio), the combined 
matrix was able to support continuous migration (from tumor to stroma) and proliferation 
of the cancer cells with similar morphology compared to Matrigel®-only matrix. 
Collagen I was chosen for the surrounding stroma matrix where we demonstrated that the 
two matrices (i.e. Matrigel®:collagen I at 1:1 and collagen I) were not mixed but 
spatially organized as a stromal (collagen I) component surrounding the tumor region 
(Matrigel®:collagen I, Figure 2.1). Such capability will enable addition of other cell 
types (i.e. CAFs) within the stroma region, which have been known to reduce 
chemoresistance (Sung et al., 2013) as well as enhance tumor growth and invasion 
(Khamis et al., 2012).  
 We modulated the invasiveness of breast cancer cells by the introduction of a 3D 
EGF gradient within the tumor-stroma platform. The encapsulated breast cancer cells 
migrated (Appendix Movie C.1) in a radial direction outward from the 3D tumor region. 
EGF was found to heavily influence cell proliferation and invasion distance to which by 
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day 4, there were stark differences in tumor area coverage between the two studied 
conditions. The (+) EGF devices exhibited further invasion and increased transitioning 
from the 3D stroma to the surrounding media channels (Figure 2.4). Moreover, we 
showed that EGF was also capable of inducing invasiveness in the non-invasive MCF-7 
cells (Appendix Figure A.4), however when compared to SUM-159 cells, the level of 
invasiveness of MCF-7 cells into the collagen stroma was almost 10-fold lower. Our 
platform also enabled creating competing microenvironments, specifically through 
introducing EGF in only one of the two segregated channels. SUM-159 cells were 
attracted to and demonstrated higher invasion to the EGF side (Figure 2.5). Our findings 
were consistent with those from in vivo studies (Patsialou et al., 2009; J. Wyckoff et al., 
2004) that demonstrated EGF enhanced invasion within mouse models.  However, real-
time high-resolution tracking of individual cells and visualization of 3D cell morphology 
were not possible using in vivo models (B. Weigelt, 2014; J. Wyckoff et al., 2004). 
Moreover, in previous microfluidic models (B. J. Kim et al., 2013; I. K. Zervantonakis et 
al., 2012) that utilized EGF as a chemoattractant, cell invasion characteristics were not 
fully captured within a 3D matrix in all x, y and z dimensions. 
 Our analysis of the real-time imaging (Appendix Movie D.2 and D.3) revealed 
that the cells increased their individual motility in response to EGF, which confirms that 
the invasion of the stroma region was not limited to cell proliferation (Figure 2.4D) but 
also included chemokinesis (Figure 2.6 and 2.7). We found that during the initial 24 h, 
the whole cell population responded to EGF with increased motility but the overall 
persistence was not significant. However, when looking only at the filtered cells 
migrating along the gradient (y-axis) (Figure 2.6D and E), we found significant increases 
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for individual cell motility and persistence in (+) EGF condition. As expected, there was 
no difference in persistence for (-) EGF for the whole population of cells as well as the 
filtered cells (Appendix Figure A.9). This suggests that the population of cells may be 
heterogeneous in that sub-populations respond to EGF differently (Campbell & Polyak, 
2007). Therefore, by analyzing chemotactic responses based on population averages, the 
end results may fail to account for the aggressive sub-population that can contribute the 
most to invasion(Hughes-Alford & Lauffenburger, 2012).  For longer times (after 72 h), 
there was no significant difference in persistence toward the gradient (Figure 2.7E) which 
overall appeared to be more of a random walk. This suggests that over saturation of EGF 
(72 h) may prolong the overall persistence regardless of the direction (Figure 2.7C). 
Consistently, several studies have indicated that prolonged exposure to EGF will 
internalize or localize clusters of EGFRs thus reducing the amount of surface EGFRs 
(Schulte et al., 2012; Q. Wang, Villeneuve, & Wang, 2005), which we also observed in 
our results (Figure 2.8). However, none of the previous studies showed prolonged loss of 
chemotactic responses (i.e. persistence toward the gradient), despite ongoing 
chemokinesis (i.e. cell speed) in the later stages of invasion, which may be due to 
saturation of EGFRs (B. J. Kim et al., 2013; Saadi et al., 2006; S. J. Wang et al., 2004). 
Other studies have also discussed that the effect of EGFR clustering will modify the 
strength of downstream kinase activity, such as AKT, which may subsequently influence 
cellular chemotaxis (Mutch, Howden, Jenner, Poulter, & Rappoport, 2014; Schaupp et 
al., 2014). Moreover, activation of integrins in the presence of EGF has shown to enhance 
EGFR clustering, which results in Rho responsible for cell contraction during migration 
(Raftopoulou & Hall, 2004). This could be a potential area of study to investigate the 
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prolonged spatiotemporal signaling of EGF, in relation to chemokinetic and chemotactic 
responses, in cancer cells.  
 Cell morphology analysis, indicated that cells migrating on the glass appeared to 
have flat and wide protrusions resembling lamellipodia. These cells (Appendix Movie 
D.7) appeared to follow the characteristic migration steps, which are the exploration and 
then attachment of the leading edge followed by the detachment and pulling of the rear 
cell body (Friedl & Wolf, 2003). On the other hand, within 3D matrix, the cells did not 
clearly exhibit the classical stages of migration (Even-Ram & Yamada, 2005) but instead 
appeared to entangle inside the matrix with the thin-like protrusions (Appendix Movie 
D.2), which induced a slow moving crawl. Similarly, F-actin staining of the encapsulated 
cells (Appendix Figure A.3) revealed thin protrusions surrounding the cell body 
correlating to what was observed in the migrating cells (Appendix Movie D.2). 
Consistently, Lämmermann et al. demonstrated elongation and dragging of the cell body, 
hypothesized that this phenomenon happened in areas of increased spacing between 
collagen fibers (Lammermann et al., 2008). Similarly to the results found with our 
device, Fraley et al. showed several protrusions extending from migrating cells in 3D 
matrices but did not show wide lamellipodia in 3D. Furthermore, they suggested that the 
cells utilized these protrusions to probe the surrounding matrix which led to correlating 
the extent and amount of protrusions to cell motility in 3D (Fraley et al., 2010). We 
further observed noticeable deformation of the collagen matrix overtime in the device, 
which was the driving factor to producing a suitable matrix composition for the 
encapsulation of the invasive cancer cells. When closely observing the migrating cells, 
there were some cells that tended to follow in the tracks of another cell. This observation 
  68 
was in line with previous work by Gaggioli et al. who studied invasion inducing-
microtracks (Gaggioli et al., 2007). This behavior would require further analysis to 
elucidate the mechanisms of this migratory phenotype.  
 Stromal cells, such as fibroblasts, endothelial cells, and immune cells, have been 
demonstrated to heavily influence cancer invasion and therapy (Kalluri & Zeisberg, 2006; 
B. Weigelt, 2014). In particular, CAFs enhances cancer survival and invasion through 
cell-cell signaling (Kalluri & Zeisberg, 2006). In our model, we showed that in the 
presence of CAFs, SUM-159 cells responded by increasing their migration distance 
compared to control condition (no CAFs) (Figure 2.11C). Based on previous literature 
and our own experiments, we believe that CAFs are potentially secreting 
chemoattractants (Orimo et al., 2005) such as stromal cell-derived factor 1α (SDF-1α or 
CXCL12) that promote breast cancer invasion. This phenomenon creates a unique 
opportunity for future studies to mechanistically assess the influence of paracrine 
signaling and the resulting effects within a heterogeneous population of cells on cancer 
invasion using our proposed platform.  
Taken together, our microfluidic platform demonstrated the capability of studying 
tumor growth and cancer cell migration at a single cell level with the advantage of direct 
control over spatial cell-ECM, cell-cell and cell-ligand interactions. In our future studies, 
we aim to incorporate stromal cells (i.e. cancer associated fibroblasts) surrounding the 
tumor region for more physiologically relevant invasion studies.  
2.6 Conclusions 
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In this work, a new 3D microfluidic platform, designed with separate tumor-stroma 
entities, was developed to recapitulate 3D cancer cell invasion. Our platform enabled, 
precise control over cell-ECM and cell-growth factor interactions.  We specifically 
investigated the invasion enhancing effects of EGF and validated the platform as a real-
time functional assay for fundamental biological processes (i.e. cell invasion, cellular 
signaling). Our unique approach allowed for visualization and quantification of invasion 
and morphology changes, at a single cell level, which was not possible in conventional 
Transwell assays, 3D macroscale hydrogels, and animal models. We spatially organized a 
high density of SUM-159 breast cancer cells within a confined 3D tumor region 
composed of Matrigel® and collagen type I. A stromal matrix of collagen type I 
surrounded the tumor region, which allowed diffusion of EGF through the stroma into the 
primary tumor. On a global level, we observed enhanced invasiveness of the breast 
cancer tumor front when stimulated with EGF. At a single-cell level, we performed real-
time 3D migration, which confirmed the increased motility and persistence of cells due to 
EGF stimulation. Moreover, we showed changes in persistence and migration at different 
time frames, where we observed that initially a subset of cells migrated preferentially 
toward the gradient. However, after prolonged exposure to EGF, we found no difference 
in persistence between the EGF condition and the control despite still increasing cell 
motility due to EGF. Subsequently, we found higher EGFR clustering within the cell 
after 4 days of EGF exposure suggesting possible receptor saturation(Schulte et al., 2012; 
Q. Wang et al., 2005), which could explain the lowered chemotactic responses at later 
time points We observed cytoskeletal and morphological changes in the EGF-stimulated 
devices, where the cells demonstrated a more invasive phenotype (i.e. increased aspect 
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ratio and reduced circularity) with higher protrusion counts. Lastly, we investigated the 
co-culture of SUM-159 cells and CAFs within the tumor and stroma region respectively 
resulting in enhanced SUM-159 invasion. Together, this demonstrates the ability of our 
device to visually observe a combination of cell migration, morphology, survival, and 
proliferation changes, which provides a valuable tool that recapitulates 3D tumor-stroma 
interaction and invasion in a single platform. 
Our future studies will be focused on adding complexities to this process by 
studying heterotypic cell interactions such as the understanding the diverse roles of CAFs 
within the stroma region. We further plan to take advantage of our device to investigate 
and image real-time changes in cell morphology and migration under different 
therapeutics regimens such as suberoylanilide hydroxamic acid (Strobl et al., 2010), 
nocodazole (Nikkhah et al., 2010), paclitaxel (Loessner et al., 2010), etc. Moreover, we 
aim to manipulate the cell-cell interactions to study how the heterotypic dialogue affects 
drug resistance.  
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CHAPTER 3 
AIM 2: Study the influence of patient-derived CAFs on cancer cell invasion and 
gene expression profile and determine a possible mediator of invasion due to tumor-
stroma interactions. 
3 sadf 
3.1 Abstract 
Tumor-stroma interactions significantly influence cancer cell metastasis and 
disease progression. These interactions are partly comprised of crosstalk between tumor 
and fibroblasts, but key molecular mechanisms within the crosstalk governing cancer 
invasion are still unclear. Here we develop a 3D in vitro organotypic microfluidic to 
model tumor-stroma interaction by directly juxtaposing tumor and stroma regions to 
mimic the spatial organization of the tumor microenvironment. We co-culture breast 
cancer and patient-derived fibroblast cells in the tumor and stroma regions respectively 
and combine functional assessment of cancer invasion, like migration and proliferation, 
with transcriptome profiling to unveil the molecular influence of tumor-stroma 
interactions on cancer invasion. Through this work, we uncovered a novel gene of 
interest, GPNMB, and unveiled that CAFs enhanced breast cancer invasion by up-
regulating the expression of GPNMB on breast cancer cells resulting in increased 
migration speed. Overall, these results demonstrate the ability of our model to 
recapitulate patient specific tumor microenvironment to investigate cellular and 
molecular consequences of tumor-stroma interactions. 
3.2 Introduction 
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Tumor-stroma interactions significantly influence cancer cell metastasis and 
disease progression (Kalluri, 2016). These interactions in part comprise of heterotypic 
crosstalk between tumor and stromal cells, however, the mechanism and functional 
consequences of the interactions on cancer invasion are still unclear (Kalluri, 2016). 
Cancer-associated fibroblasts (CAFs) stand out as the most abundant non-cancer cell type 
due to their ubiquitous nature within the tumor-stroma microenvironment, which allows 
them a unique position to significantly influence cancer invasion (Kalluri, 2016; Ohlund 
et al., 2014; Tchou & Conejo-Garcia, 2012). Ongoing studies have demonstrated that the 
presence of CAFs have promoted invasion of many different cancers, such as breast, 
prostate, ovarian, colon, and non-small cell lung cancer (Kalluri, 2016). Particularly, 
breast cancer has been known to harbor many CAFs within their tumor 
microenvironment (Kalluri, 2016; Orimo et al., 2005). Further, triple negative breast 
cancers (TNBCs), which do not express estrogen, progesterone, and Her2-neu receptors, 
lack effective targeted therapies. However, there is ample evidence that interactions 
between TNBC and the tumor microenvironment do play crucial role in breast cancer 
progression (Orimo et al., 2005; Tchou & Conejo-Garcia, 2012). As such, understanding 
and targeting the crosstalks between cancer and CAFs within the tumor 
microenvironment is a novel treatment strategy for breast cancer, shifting away from the 
neoplastic cell-centric to a tumor-stroma paradigm. 
To unveil the cellular and molecular basis of cancer invasion in response to CAFs, 
a significant effort has been devoted to developing tumor models allowing complex 
tumor-stroma interactions. Although, in vivo models play a crucially important role in 
studying the cellular and molecular basis of disease progression, they suffer from lack of 
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high resolution observation and analysis of cell-cell interactions as well as precise control 
over critical parameters, like manipulating stromal cells, in the tumor microenvironment 
(B. Weigelt, 2014). Importantly, this lack of precise control creates challenges to 
determining the cause and effect relationships within the heterotypic dialogues between 
cancer and stromal cells like CAFs (B. Weigelt, 2014). Furthermore, there are crucial 
molecular and cellular differences between humans and mice limiting the scope for 
animal models to recapitulate human diseases (Mak et al., 2014). To overcome some of 
these problems, conventional co-culture in vitro platforms, including transwell migration 
assays as well as 3D spheroid-based models, have been widely utilized to perform 
biological studies for cancer invasion (Gaggioli et al., 2007; Glentis et al., 2017; Tyan et 
al., 2011). Still, these models are often oversimplified and do not replicate proper 
organotypic arrangement of the tumor-stroma architecture due to random mixing of cells. 
This limits the available analyses to proliferation, morphology, and protein expression as 
opposed to precise spatial organization of cells which could enable assessment of 
migration metrics (i.e. distance, speed, persistence) (dit Faute et al., 2002; S. A. Kim, 
Lee, & Kuh, 2015; Orimo et al., 2005; Yang et al., 2015). Importantly, these models are 
often end-point assays that do not allow real-time observations of dynamic tumor-stroma 
interactions at cellular and molecular levels.  
Recently, there have been a significant thrust to use microfluidics to develop 
complex 3D tumor models, with precise control over cell-cell, cell-matrix and cell-
soluble factor interactions (D. Truong et al., 2016). Various microfluidics integrated with 
hydrogel-based 3D matrices allow the study of different steps of the metastatic cascade 
such as invasion, intravasation, and extravasation within a well-controlled tumor 
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microenvironment (Nagaraju et al., 2018; N. Peela, Barrientos, Truong, Mouneimne, & 
Nikkhah, 2017; N. Peela, Truong, et al., 2017; D. Truong et al., 2016). Since tumor 
progression is a complex and dynamic process, our group developed a tumor invasion 
model of breast cancer on the premise of utilizing and understanding chemoattractants 
and paracrine signaling (Nagaraju et al., 2018; N. Peela, Barrientos, et al., 2017; D. 
Truong et al., 2016). We studied the effects of EGF on breast cancer cell invasion, 
providing quantitative data on real-time invasion at a single-cell level in 3D, cancer cell 
phenotype, and EGF receptor activation (D. Truong et al., 2016). However, the analyses 
were limited to cell-based functional assessments, such as migration or proliferation, and 
did not integrate transcriptome profiling to better inform the influence of stromal factors 
on cancer invasion. In that work, stromal cells were also represented by simple 
biomolecule cues, such as EGF, or immortalized cell lines. In regards to other works, the 
impact of their studies using complex in vitro models in the context of breast cancer were 
also limited due to lack of CAF co-culture or the use of non-mammary cells, such as 3T3 
or dermal fibroblasts, rather than using patient-specific CAFs (Nikkhah et al., 2011; 
Strobl et al., 2010). Thus, there is a crucial need to develop a patient-specific and 
physiologically relevant tumor-stroma model to understand the extent of the molecular 
and cellular influence of stromal CAFs on cancer invasion. 
In this present study, we incorporated breast cancer patient-derived CAFs and 
NFs into our in vitro organotypic microfluidic model of breast tumor-stroma interactions 
to investigate the interplay between fibroblasts and breast cancer cells (Figure 1.1A and 
Appendix Figure B.1). Using this 3D co-culture model, we found that the interaction 
between invasive SUM-159 breast cancer cells and mammary fibroblasts had distinct 
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consequences on cancer migratory behavior depending on the fibroblast phenotype (i.e. 
CAFs or NFs). From there, we paired our functional assessments with transcriptional 
profiling to evaluate the molecular changes during cancer invasion. Here, we uncovered a 
novel gene of interest, glycoprotein non-metastatic B (GPNMB), and unveiled that CAFs 
enhanced breast cancer invasion through up-regulation of GPNMB on breast cancer cells. 
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Figure 3.15 3D organotypic co-culture invasion assay.  
(A) Fibroblasts were derived from patient biopsies. SUM-159 breast cancer cells were 
cultured in the tumor (red) region while fibroblasts (NFs or CAFs) were cultured in the 
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stroma (green). (B) Microfluidic device shown next to a penny depicting the size of the 
platform. The tumor region of the platform demonstrates a dense amount of cancer cells. 
The tumor-stroma interface within the device shows migrating cancer cells. Fibroblasts 
are shown within the stroma region. (C) Magnified images of cancer migration in the 
presence of fibroblasts alongside images of the tumor-stroma regions. (D) + CAF1 and + 
CAF3 migration was significantly higher than Ctrl while + NF was lower than all groups. 
(E) + CAF1 and + CAF3 had increased expression of BrdU compared to Ctrl. + NF was 
significantly lower than CAF co-cultures. * denotes significant difference and $ denotes a 
significantly different group for p < 0.05.  
3.3 Materials and Methods 
3.3.1 Microfluidic design and fabrication 
 The microfluidic platform design and fabrication was established in our previous 
studies (D. Truong et al., 2016). Briefly, SU8-2075 (MicroChem) was spun onto a silicon 
wafer for a final height of approximately 200 µm. A patterned wafer was created by 
placing the silicon wafer underneath the mask containing the microfluidic design and 
exposing them to UV followed by developing the wafer. Polydimethylsiloxane (PDMS, 
Sylgard 184 Silicon Elastomer Kit, Dow Corning) was then poured on to the pattern SU-
8 wafer and baked for 1 h at 80 °C. Afterwards, the PDMS containing the patterns of the 
device was peeled from the silicon wafer. Next, the PDMS was processed by cutting out 
individual microfluidic device and punching the inlets and outlets with biopsy punches. 
Next, these devices were treated with oxygen plasma (PDC-32G, Harrick Plasma) and 
were then bonded to glass with channel side facing down to create a sealed cell culture 
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environment and sterilized using an autoclave. To enhance attachment of collagen to the 
microfluidic devices, 1 mg/mL poly-d-lysine (PDL, Sigma-Aldrich) was injected into the 
cell culture regions and incubated at 37 °C for 1 h and then washed with deionized (DI) 
water. Next, 0.1% (v/v) glutaraldehyde (GA, Sigma-Aldrich) solution was introduced 
incubated at room temperature for 1.5 h. Finally, the devices were washed 4 times with 
DI water and placed in an 80 °C oven overnight to render the surfaces hydrophobic. 
3.3.2 Fibroblast Isolation 
CAFs were selected from regions adjacent to the tumor mass. Collagenase I (1 
mg/mL, Worthington) and hyaluronidase (125 U/ml, Sigma-Aldrich) were used to digest 
the tissues at 37 ºC in DMEM) and 10% fetal bovine serum (FBS). Following this, a cell 
strainer was used to isolate cells from the dissociated tissues and re-suspended in 
complete DMEM. Fibroblasts were grown in complete DMEM and passaged three times 
before use.  
3.3.3 Cell culture 
 In order to model 3D migration, SUM-159 breast cancer cells was chosen as a 
suitable cell type due to their readiness to invade 3D hydrogels(Sabeh et al., 2009). The 
mCherry-labeled SUM-159 breast cancer cells, provided by Mouneimne lab, were 
cultured in SUM specific media (Ham's F-12 with L-glutamine and supplemented with 
5% heat inactivated fetal bovine serum (FBS), 1% penicillin-streptomyocin, 1 µg/ml 
hydrocortisone, and 5 µg/ml insulin). NFs were obtained from ZenBio. CAFs were 
isolated from breast tissue. mCherry-labeled MDA-MB-231 and MCF7 were provided by 
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the Mounmeine Lab. The cells were maintained in complete Dulbecco’s Modified Eagle 
Media (DMEM supplemented with 10% heat inactivated fetal bovine serum (FBS), 1% 
L-glutamine, and 1% penicillin-streptomyocin).  
3.3.4 Fibroblast Characterizations  
Scratch assay was performed by seeding fibroblasts into a 24-well plate and 
allowing cells to become confluent. Afterwards, a pipette tip was used to scratch the 
monolayer in straight line down the center. The wells were washed 3 times with PBS 
prior to imaging. Images were taken at 0 and 24 h. NIH ImageJ was used to quantify the 
gap closure. 
 alamarBlue® was performed according the manufacturer’s instructions. Briefly, 
4000 cells were seeded per well within a 96-well plate. alamarBlue® reagent was added 
on days 0, 1, 3, and 5 at a ratio of 1:10 to cell culture media. The fluorescence intensity 
was read using a plate reader at 560 nm excitation and 590 nm emission. Values were 
calculated as a relative intensity based on the day 0 samples.  
 To characterize fibroblasts in 3D microenvironment, we used our microfluidic 
model based on our previous publications(D. Truong et al., 2016). Briefly, a 1:1 mixture 
of Matrigel® to collagen type I (2.0 mg/mL) was injected into the tumor region of the 
microfluidic chip and polymerized by placing the devices into the humidified cell culture 
incubator at 37 °C. After 2 min within the incubator, the devices were taken out and 
subsequently a 2.0 mg/mL collagen type I solution containing 50,000 cells/ml was 
injected into the stroma region. The collagen was polymerized within the humidified 
incubator at 37 °C for 8 min and flipped every min. Next, SUM media was added into the 
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channels of each device and the microfluidic chips were placed into the cell culture 
incubator. Media was exchanged daily. Fibroblasts were imaged daily and migration was 
measured based on final and initial location of the fibroblasts.  
3.3.5 3D Co-culture Microfluidic Invasion assay 
 The invasion assay was based on our previous publications(D. Truong et al., 
2016). Briefly, a 1:1 mixture of Matrigel® to Collagen I (2.0 mg/mL) was added to the 
cells to create a mixed hydrogel cell solution (final concentration of Collagen I at 1 
mg/mL) with a density of 15 million cells/mL. The mixed hydrogel cell solution was 
injected into the tumor region of the microfluidic chip and polymerized within the cell 
culture incubator at 37 °C. These devices were flipped every minute to create a 
homogenous distribution of cells 3D hydrogel. After 2 min within the incubator, the 
devices were taken out and subsequently a 2.0 mg/mL collagen type I solution was 
injected into the stroma region. For co-culture with CAFs, 50,000 cells/mL were 
encapsulated in the collagen type I solution. The collagen was polymerized within the 
humidified incubator at 37 °C for 8 min and flipped every min when fibroblasts were 
encapsulated. SUM-159 cell media was added into the channels and the devices were put 
in the cell culture incubator. Media was exchanged daily.  
3.3.6 Proliferation assay 
Click-iT™ EdU Alexa Fluor™ 488 Imaging Kit (ThermoFisher) was used to 
assess proliferation by following manufacturer’s protocol. 10 µM of EdU was added to 
the cell culture media in the microfluidic on day 2 of culture. Cells were incubated 
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overnight for 16 h before fixation. Next, cells were permeabilized and blocked prior to 
EdU activation. Then EdU was tagged using Click-iT™ reaction cocktail before imaging. 
EdU to nuclei ratio was defined as the proliferative metric. 
3.3.7 Time-lapse imaging 
 To perform time-lapse imaging, mCherry-labeled SUM-159 cells were mixed 
together with normal SUM-159 at a ratio of 1:9 prior to the invasion assay. The devices 
were placed inside a custom miniature incubator (TC-MWP, Bioscience Tools) at 37 °C 
and 5% CO2. Fluorescent time-lapse imaging was performed using a fluorescent 
microscope (Zeiss Axio Observer Z1, Zeiss) equipped with the Apotome.2 and a 10x 
objective. The Apotome.2 utilized structural illumination technique to create optical 
sections of our devices to reduce scattered light and to generate high-resolution Z-stacked 
fluorescent 3D images.  The time interval was set to 45 min. Time-lapse images were 
taken on day 2 of the invasion assay for 12 h overnight followed by migration metric 
quantifications. 
3.3.8 Immunofluorescent staining  
 For immunofluorescent staining, the cells were fixed by adding warmed 4% 
paraformaldehyde into the channels of the microfluidic chip for 30 min. The devices were 
then washed twice with PBS-glycine (100 mM glycine in PBS) for 10 min at room 
temperature. This was followed by a single wash using PBS-Tween (0.05% (v/v) Tween-
20 in PBS). Next, immunofluorescent (IF) buffer (0.2% (v/v) Triton X-100, 0.1% (v/v) 
BSA (radioimmunoassay grade), 0.05% Tween 20, 7.7 mM NaN3 in PBS), 10% (v/v) 
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goat serum was added into the channels and incubated at room temperature for 1.5 h. 
Primary antibodies, vimentin (ab92547, abcam), αSMA (ab7817, abcam), pan-
cytokeratin (MA5-13203, ThermoFisher), and anti-BrdU (G3G4 (anti-BrdU) was 
deposited to the DSHB by Kaufman, S.J.) was diluted at in IF buffer and kept at 4 °C 
overnight. Afterwards, the microfluidic channels were washed with IF buffer. Then, the 
secondary antibody (Alexa Fluor, Thermo Fisher Scientific) diluted in IF buffer was 
added for 45 min at room temperature in the dark. The devices were washed once with IF 
buffer and twice with PBS-Tween at room temperature. Afterwards, the nuclei and F-
actin fibers were stained by using 4',6-diamidino-2-phenylindole (DAPI, Invitrogen) 
(1:1000) and Alexa Fluor® 488 Phalloidin (Invitrogen) (1:40) overnight at 4 °C. The 
devices were washed before imaging.  
3.3.9 Western blotting 
Western blotting was performed as described. Briefly, cells were scraped, lysed using 
NP-40 buffer and protease inhibitors, and boiled prior to running. SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) was used to separate protein by molecular weight. 
Proteins were transferred to PVDF membrane and subjected to antibodies for analysis.  
Primary antibodies include anti-αSMA (ab7817, abcam), anti-GPNMB (ab125898, 
abcam), anti-Vinculin (ab18058, abcam), and anti-GAPDH (sc-365062, Santa Cruz). 
Blots were imaged using Odyssey® CLX imaging system (Li-Cor) and analyzed in 
Image Studio™ Software (Li-Cor). 
3.3.10 Gene expression profiling 
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mCherry-labeled SUM-159 breast cancer cells interacted with fibroblasts within 
the microfluidic device for 3 days. Collagenase (2 mg/mL) was injected into the media 
channel and allowed to incubate for 30 minutes. Physical agitation was used to release 
cells from the ECM. Cell mixtures were centrifuged and collagenase was replaced with 
cell culture media. BD FACSAria II (BD Biosciences) at the Barrow Neurological 
Institute was used to separate SUM-159 cells from fibroblasts. Cells were sorted directly 
into RNA lysis buffer and then RNA was extracted using the Quick-RNA™ Microprep 
kit (Zymo Research). RNA-Seq library prep was performed using Kapa RNA kit. Next 
generation sequencing was done using a hiSeq 3000, from which we obtained > 30 
million 1x50 bp reads to measure gene expression level. The reads were aligned by 
STAR(Dobin & Gingeras, 2015) and the TPM (transcripts per million reads) were 
compared in the edgeR package (Robinson, McCarthy, & Smyth, 2010).  
3.3.11 Breast Cancer Dataset Analysis 
cBio (www.cbioportal.org) was used to query The Cancer Genome Atlas Breast Invasive 
Carcinmoa (TCGA-BRCA) for alteration and expression of GPNMB. Breast cancer 
patient gene expression datasets were obtained from GEO (www.ncbi.nlm.nih.gov/geo). 
mRNA expression of GPNMB from tissues were obtained from accession nos. 
GSE3744(Richardson et al., 2006), GSE14548(X. J. Ma, Dahiya, Richardson, Erlander, 
& Sgroi, 2009), and GSE9014(Finak et al., 2008). Survival data was queried from 
Geneanalytics tool (http://geneanalytics.duhs.duke.edu). Low and high expression of 
GPNMB were distinguished using lower and upper quartiles respectively. Correlation 
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analysis of GPNMB expression and tumor staging was obtained through Oncomine 
(www.oncomine.org) (Rhodes et al., 2004).  
3.3.12 Vectors and Gene Transduction 
shRNA clone set against Human GPNMB (NM_001005340.1, GeneCopoeia™, 
HSH000547-LVRU6MP) were used to produce GPNMB knockdown lines. A scrambled 
shRNA was used to produce the shCtrl (GeneCopoeia™, CSHCTR001-LVRU6MP). 
Lenti-Pac HIV Expression Packaging Kit (LT001, GeneCopoeia™) was used to 
transduce the SUM-159 breast cancer cells based on manufacturer’s protocol.  
3.3.13 Imaging analysis 
Phase-contrast images of the invasion assay were acquired once every day using 4 
x 3 tiles with a 10x objective. To quantify the invading edge of the tumor (i.e. the 
invading tumor front), the cells on the periphery were measured by considering the most 
distal points of the most distal cells. In this case, only the cells at the edge of the tumor 
(i.e. cells that have traveled the highest distance from the tumor region from each degree) 
were included in the quantification.  
Real-time analysis was conducted using CellTracker software(Piccinini, Kiss, & 
Horvath, 2015). Speed (defined as distance over time) and persistence (defined as 
euclidean distance over accumulated distance) were utilized to quantify cell migration 
metrics.   
Shape descriptors (area, circularity, aspect ratio, and protrusiveness) were used to 
describe the cell shape for cancer cells and fibroblasts based on the actin cytoskeleton. 
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We used the particle analyzer plugin within the NIH ImageJ suite to quantify cell shape 
based on the actin images. 
Protein signals were quantified in NIH Image J consistent to previous 
literature(Acerbi et al., 2015). Staining protocol and image capture settings were kept 
consistent for all samples/ Image fluorescent intensity integrated density per cell was 
used to quantify the protein signal. 
3.3.14 Statistical analysis   
 All measurements were compiled from three or more independent devices or 
replicates for each experimental condition and repeated at least three times. Reported 
measurements are shown as average ± standard error of mean. The data were compared 
using unpaired t-test, paired t-test, multiple comparisons test with corrections, and 
correlation analysis as appropriate within the GraphPad Prism software (GraphPad 
Software). Volcano plots and heatmaps were generated using R (Kolde, 2015; R 
Development Core Team, 2010). 
3.4 Results 
3.4.1 Isolation and characterization of patient-derived CAFs  
We isolated CAFs from breast tumor tissue samples of three different patients 
varying in hormone and Her2 receptor status from the Mayo Clinic (Phoenix, AZ) 
(Appendix Table E.1). We obtained NFs from reduction mammoplasty. Next, CAFs are 
routinely identified through expression of alpha smooth muscle actin (αSMA), contractile 
stress fibers, and vimentin(Ohlund et al., 2014). Immunofluorescent (IF) images of both 
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NFs and CAFs showed positive staining for vimentin and negative expression of 
cytokeratin demonstrating the overall purity of the fibroblast populations (Appendix 
Figure B.1A). CAFs expressed significantly higher αSMA levels (Appendix Figure 
B.1B). We further corroborated the IF results with western blotting (Appendix Figure 
A.1C and D), demonstrating that the quantified levels of αSMA were indeed higher in 
CAFs than NFs. 
 Differences between CAFs and NFs also extended to morphology(Kalluri, 2016). 
Generally, NFs were smaller and more spindle shaped, while CAFs were larger and 
polygonal with actin stress fibers (Appendix Figure B.2A) (Evans, Tian, Steadman, & 
Phillips, 2003). Based on morphometric analyses, all three CAFs demonstrated larger cell 
spreading area and aspect ratio compared to NFs, where the differences for CAF2 and 
CAF3 but not CAF1 were statistically significant (Appendix Figure B.2B and C). Next, 
we analyzed the 2D migration of the fibroblasts using a scratch wound healing assay 
(Appendix Figure B.2D), and found that NFs and CAFs migrated similarly (Appendix 
Figure B.2E). Overall, these results indicated that CAFs shared general characteristics 
with NF in 2D culture, but were heterogeneous in their morphology and αSMA 
expression. 
3.4.2 Stromal CAF and NF behavior within a 3D matrix 
To examine the cell morphology and behavior of NF and CAFs in 3D culture, the 
fibroblasts were cultured in the stroma region of the 3D microfluidic platform. All 
fibroblast populations showed elongated morphology (Appendix Figure B.3A and B). 
Time-lapse image analysis demonstrated that fibroblasts were mostly stationary for 3 
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days, and no statistical difference was observed between the migratory activities of NF 
and CAF similar to the 2D wound healing assay (Appendix Figure B.3C). Both NF and 
CAF1 exhibited significantly lower cell area than CAF2, while CAF3 was not 
statistically different to any other fibroblasts (Appendix Figure B.3B and D). 
Interestingly, no difference was found for cell aspect ratio in 3D suggesting less 
morphological heterogeneity in 3D culture (Appendix Figure B.3E).  
3.4.3 Fibroblasts differentially influence breast cancer cell invasion 
 To investigate the influence of patient-derived CAFs on migration and 
proliferation of invasive breast cancer cells, we utilized 3D tumor-stroma microfluidic as 
a co-culture system (Figure 3.1B) (D. Truong et al., 2016). SUM-159 breast cancer cells, 
which were derived from invasive ductal carcinoma of a TNBC patient, were chosen for 
their propensity to migrate within a 3D hydrogel(L. Ma, Teruya-Feldstein, & Weinberg, 
2007; N. Peela, Barrientos, et al., 2017; D. Truong et al., 2016). SUM-159 cells in the 
tumor region were observed over 3 days invading into the stroma region of the 
microfluidic either with or without fibroblasts (Figure 3.1C, Appendix Figure B.4). We 
found a significant increase in migration distance for CAF1 (+ CAF1) and CAF3 (+ 
CAF3) but not with CAF2 (+ CAF2) when compared to the mono-culture condition (Ctrl) 
(Figure 3.1D). Notably, the NF co-culture (+ NF) had significantly lower migration 
compared to all CAF co-cultures and the Ctrl (Figure 3.1D).  In parallel, we investigated 
cancer cell proliferation influenced by fibroblasts. The + NF condition had a lower 
fraction of BrdU-positive SUM-159 cells compared to the three CAF co-cultures 
indicating less proliferation in NF co-culture (Figure 3.1E). On the other hand, we 
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observed a significant increase in BrdU expression for + CAF1 and + CAF3 versus the 
Ctrl, and for + CAF2 to a lesser extent. In summary, NFs demonstrated a suppressive 
effect on cancer cell invasion and proliferation, while CAF1 and 3 exhibited an invasion- 
and proliferation-promoting activities. Taken together, this suggests that fibroblasts of 
different microenvironmental origin (i.e. patients) and phenotype, although all were 
mammary derived, could exert distinct effects on invasion and proliferation of cancer 
cells in 3D culture conditions.  
 We also investigated MDA-MB-231, another TNBC cell line, but derived from 
pleural effusion, and MCF7 cells, which are also pleural effusion-derived but less 
invasive(L. Ma et al., 2007). We asked if CAFs had a similar influence on migration for 
these breast cancer cell lines. The CAF3 population was utilized as it demonstrated the 
highest increase in SUM-159 cell migration (Figure 3.1D). We observed that both MCF7 
and MDA-MB-231 cells showed propensity to migrate into the 3D stroma but MCF7 had 
far less migration capacity. Importantly, adding CAFs into the stroma influenced both 
MCF7 and MDA-MB-231 cells by significantly enhancing their 3D invasive capacity 
into the stroma similar to SUM-159 cells (Appendix Figure B.5A and B). Consistent with 
the literature, MDA-MB-231 had less invasive capacity as compared to SUM-159 
cells(C. Bao et al., 2016). Taken together, this suggests that patient-derived CAFs 
promoted invasion of broad types of breast cancer cell lines.  
3.4.4 Real-time analysis of cell migration reveals bi-directional cancer-fibroblast 
crosstalk 
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Figure 3.16 Real-time analysis of cell migration.  
(A) SUM-159 migration tracked over 12 h in presence of absence of CAFs. (B) Overlay 
of all migration tracks showed SUM-159 cells migrated further in presence of CAFs. (C, 
D) CAFs significantly enhanced migration speed of SUM-159 cells but not for 
persistence. * denotes significant difference for p < 0.05. (E) CAF migration tracked over 
12 h in presence of absence of SUM-159 cells. (F) Overlay of all migration tracks 
showed CAFs migrated further in presence of SUM-159 cells. Presence of SUM-159 
cells significantly enhanced both (G) migration speed and (H) persistence of CAFs. * 
denotes significant difference for p < 0.05. 
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To investigate the migration of cancer cells in real-time, at a single cell level, 
within our co-culture system, we measured the influence of CAFs on SUM-159 migration 
speed using CAF3. We traced cell migration tracks and quantified the migration speed 
observing that the presence of CAFs significantly enhanced migration speed of SUM-159 
cells (Figure 3.2A-C, Appendix Movie D.8 and D.9). However, there was no statistical 
difference for persistence of migration (Figure 3.2D). Surprisingly, CAFs, which were 
largely stationary in the absence of cancer cells (Appendix Figure B.3A), showed 
enhanced migration behavior when co-cultured with migrating cancer cells (Figure 3.2E 
and F, Appendix Movie D.10 and D.11). Quantification indeed showed that presence of 
SUM-159 cells significantly promoted both migration speed and persistence of CAFs 
(Figure 3.2G and H). Taken together, these analyses demonstrated the presence of a bi-
directional crosstalk between cancer and fibroblast cells mutually influencing their 
migratory behaviors of both SUM-159 cells and CAFs. 
3.4.5 Morphometric analysis of SUM-159 cells co-cultured with fibroblasts 
 As morphology is closely linked to cell migratory behavior, we utilized shape 
descriptors to analyze the morphology of cancer cells by assessing the cell area, 
circularity, aspect ratio, and protrusiveness of SUM-159 cells that have migrated into the 
stroma (Figure 3.3A and B) (Yu, Lim, Xiong, Tan, & Shim, 2013). Only CAF3 but no 
other fibroblast population significantly increased cell area and decreased circularity of 
the SUM-159 cells (Figure 3.3C and D). We found significant lowered aspect ratio 
between + NF vs. + CAF1 and + NF vs. + CAF2 (Figure 3.3E). Protrusiveness was 
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measured using the inverse of solidity and we found that SUM-159 cells showed 
significantly higher levels of protrusion in CAF co-cultures than the Ctrl and + NF 
(Figure 3.3F). To summarize the phenotypic influence (i.e. changes in morphology, 
proliferation, and migration) of the heterogeneous fibroblast population and SUM-159 
cells, we performed a hierarchical clustering on the morphological and behavioral 
measurements (Figure 3.3G). The analysis showed that CAF co-culture conditions 
clustered together and that + CAF3 was separated from + CAF1 and + CAF2, agreeing 
with the data showing that + CAF3 exerted the largest influence in cell migration 
compared to the other two CAF isolates.  
 
Figure 3.17 Morphometric analysis of SUM-159 cells after co-culture.  
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(A) Depiction of cancer cell shape during co-culture with fibroblasts. (B) Morphometric 
key for the analysis circularity, protrusiveness, and aspect ratio. (C-F) Graph comparing 
different cell shape descriptors. * denotes significant difference for p < 0.05. $ denotes 
significantly different groups for p < 0.05. (G) Unsupervised clustering revealed Ctrl and 
NF co-culture as more similar than the CAF co-cultures.  
3.4.6 Gene expression profiles of SUM-159 cells upon tumor-stroma interaction 
 To couple our functional assessments (i.e. migration, proliferation, morphology) 
with molecular changes, we performed RNA-seq on sorted populations of SUM-159 cells 
extracted from the microfluidic device after co-culture with fibroblasts. Multi-
dimensional scaling (MDS) analysis on total expression profiles showed that SUM-159 
cells in NF and CAF co-cultured conditions separated away from the mono-cultured cells 
(Ctrl, Figure 3.4A).  Furthermore, + CAF1, 2, and 3 clustered together indicating that 
SUM-159 cells in CAF co-cultures share a similar transcriptional profile distinct from the 
+ NF condition, concordant with our functional assessments (Figure 3.3G). By an 
ANOVA-like test, we identified 280 differentially expressed genes (DEGs, fold change ≥ 
1.5 and FDR < 0.05 in any pairwise comparison) across all conditions. Hierarchical 
clustering on the expression profiles (Figure 3.4B) resulted in an identical grouping 
pattern as the MDS analysis (Figure 3.4A). We then compared Ctrl vs. all fibroblast co-
culture conditions, and identified 149 DEGs (92 up and 57 down, fold change ≥ 1.5 and 
FDR < 0.05). These genes represented a common set of transcriptional changes elicited 
by any fibroblasts, and were associated with Pathways in Cancer, Focal Adhesion, and 
PI3K-Akt signaling pathway. We next compared the expression profiles of Ctrl vs. NF as 
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well as Ctrl vs. CAF co-cultures to identify DEGs uniquely regulated by either NFs or 
CAFs, and found 108 DEGs in the NF co-culture (70 up and 38 down, fold change ≥ 1.5 
and FDR < 0.05, Figure 3.4C) and 175 DEGs in CAF co-cultures compared to mono-
culture (118 up and 57 down, fold change ≥ 1.5 and FDR < 0.05, Figure 3.4C). KEGG 
pathway analysis revealed enrichment for cell adhesion, collagen fibril organization, and 
extracellular matrix organization-related terms for Ctrl vs. CAFs, while inflammatory 
response, response to liposaccharide, and leukocyte migration-related terms were 
enriched in Ctrl vs. NFs (Figure 3.4D). Finally, we identified 22 unique DEGs between 
NF and CAF co-cultures that could potentially play a role in cancer invasion (FDR < 
0.05, Appendix Table E.2), including VAMP1, GPNMB, BGN, and CEND1, which were 
up-regulated in the CAF co-cultures, and RGS16, SOCS3, CXCL8, SAA2, and IL6, which 
were expressed higher in NF co-culture.  
 
Figure 3.18 Gene expression profiling of SUM-159 breast cancer cells after interacting 
with fibroblasts.  
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(A) Multi-dimensional scaling of gene expression profile revealed that cancer cells in 
CAF co-cultures shared a similar transcriptional profile distinct from the + NF condition 
(B) Heatmap of 280 differentially expressed genes (DEGs, fold change ≥ 1.5 and FDR < 
0.05 in any pairwise comparison) across all conditions. (C and D) Volcano plots and 
Venn diagrams show Ctrl vs + CAF (118 up and 57 down, fold change ≥ 1.5 and FDR < 
0.05) and Ctrl vs + NF (70 up and 38 down, fold change ≥ 1.5 and FDR < 0.05). (E) Top 
5 GO terms from Ctrl vs CAF or NF co-cultures.  
3.4.7 Clinical relevance of glycoprotein non-metastatic B in cancer 
 
Figure 3.19 Clinical relevance for GPNMB.  
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(A) Heat map of top 10 DEGs when comparing NF and CAF co-cultures. (B) Incidence 
of GPNMB alterations in two different cohorts from public datasets(Cancer Genome 
Atlas, 2012; Cerami et al., 2012; Curtis et al., 2012; Gao et al., 2013; Pereira et al., 2016). 
(C) GPNMB expression from TCGA-BRCA in breast cancer compared to normal. * 
denotes significant difference for p < 0.05; unpaired t-test(Finak et al., 2008; X. J. Ma et 
al., 2009; Richardson et al., 2006; Zhou et al., 2012). (D) GPNMB expression positively 
correlated with tumor stage (Cancer Genome Atlas, 2012; Curtis et al., 2012). (E) 
Kaplan–Meier analysis of overall survival from TCGA-BRCA data sets. HR, 2.04; P = 
1e-2. High expression of GPNMB was correlated to poorer patient prognosis using 
TCGA data (Cancer Genome Atlas, 2012). 
 
As we found striking differences in CAF co-cultures compared to Ctrl (mono-
culture of SUM-159 cells), we asked which of the up-regulated genes could play a role 
for the enhanced migration in SUM-159 cells in co-culture with CAFs (Figure 3.5A, 
Table S8). We investigated GPNMB as one of the possible mediator of promoting 
invasion.  GPNMB encodes for a cell surface transmembrane glycoprotein that is highly 
expressed among many cancers, including breast cancer. It has also been implicated in 
tumor invasion, angiogenesis, cell adhesion, and immune suppression(April AN Rose et 
al., 2010). To determine whether GPNMB may play a tumor-promoting role in breast 
cancer, we evaluated two large publically available datasets (METABRIC and TCGA) 
for mutations, copy-number variations and changes in expression(Cancer Genome Atlas, 
2012; Cerami et al., 2012; Gao et al., 2013; Pereira et al., 2016). We found that 
alterations occurred in 10 and 16% of breast cancer patients, respectively, in two data sets 
  96 
(Figure 3.5B). mRNA overexpression in breast carcinoma was significantly increased in 
TCGA and other data sets, when compared to the normal tissue controls (Figure 3.5C). 
Additionally, the TNBC-related subtypes (i.e. basal-like and claudin-low) expressed 
higher levels of GPNMB than other subtypes (Appendix Figure B.6A). Next, expression 
of GPNMB also positively correlated with tumor stage (Figure 3.5D). To determine the 
impact of GPNMB overexpression, we next investigated the effect on patient survival. 
Analysis of the public breast cancer data sets from TCGA-BRCA and web-based 
GeneAnalytics revealed that high expression of GPNMB correlated with poorer 
metastasis-free and overall survival (Figure 3.5E and Appendix Figure B.6B and C). 
Taken together, these data provided important evidence for the potential clinical 
relevance of GPNMB in breast cancer. 
3.4.8 Role of GPNMB in tumor-stroma interaction and SUM-159 cancer cell migration 
  97 
 
Figure 3.20 Functional study of GPNMB in tumor-stroma interactions.  
(A) Migration distance was lowered in GPNMB knockdown lines compared to the 
control. CAF co-culture increased migration of control knockdown, but did not increase 
migration of GPNMB knockdowns. * denotes significant difference for p < 0.05. (B) 
CAF co-culture increased IF expression of GPNMB in shCtrl cells, but did not increase 
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IF expression of GPNMB in shG knockdown lines. * denotes significant difference for p 
< 0.05. (C) No difference was found in proliferation using EdU assay. (D, E) GPNMB 
knockdown significantly reduced migration speed and persistence of SUM-159 cells. * 
denotes significant difference for p < 0.05. 
 
We first validated for expression of GPNMB in our cell lines. Western blotting 
demonstrated that GPNMB was indeed expressed highly in SUM-159 and MDA-MB-231 
cells and lowly in MCF7 and MCF10A cells corroborating prior studies (Appendix 
Figure B.7A) (Smuczek et al., 2017). Next, to study the role of GPNMB in the context of 
tumor microenvironment, we assessed the expression of GPNMB in SUM-159 cells in 
mono- or co-culture with CAFs (CAF3). IF imaging revealed punctate expression 
throughout the cell body of SUM-159 cells while quantification of the IF signal 
demonstrated a significant increase GPNMB expression in SUM-159 cells of the CAF 
co-culture agreeing with the RNA-seq data (Appendix Figure B.7B). Next, we knocked 
down GPNMB using two independent short hairpin RNAs (shRNA) on SUM-159 breast 
cancer cells and characterized the resulting invasive phenotype of GPNMB knockdown 
lines (shG). Successful knockdown was confirmed by a western blot (Appendix Figure 
B.8A) and IF images of 2D culture demonstrated qualitatively less punctuates compared 
to shG cells (Appendix Figure B.8B). Proliferation of shG lines were significantly 
attenuated as compared to the shControl (shCtrl) line in 2D cultures (Appendix Figure 
B.8C). We also observed reduced cell spreading area and higher circularity on a 2D 
substrate, which was correlated to reduced invasive capacity (Appendix Figure B.8D and 
E), but no difference among the knockdown lines was found in adhesion to collagen 
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substrate (Appendix Figure B.8F). Then, we asked whether GPNMB is crucial for breast 
cancer cell migration in a 3D hydrogel-based stroma using our microfluidic model. It was 
observed that GPNMB knockdown significantly decreased 3D migration of SUM-159 
breast cancer cells (Figure 3.6A).  When we co-cultured with CAFs (CAF3), we found a 
significant increase in migration into the stroma for only the shCtrl line but not for the 
shG knockdown lines (Figure 3.6A). Next, we examined expression change of the 
GPNMB protein in SUM-159 cells by IF when in presence of CAFs and found an 
increase in expression for the shCtrl line but found no significant difference for the shG 
lines (Figure 3.6B). Then we asked if the slower migration of shG cells was due to either 
reduced cell proliferation, cell migration speed, or both. EdU assay was used to measure 
cell proliferation, and we found no significant difference between the shCtrl and shG 
lines (Figure 3.6C). On the other hand, time-lapse imaging of cell migration in 3D 
revealed that GPNMB knockdown significantly attenuated migration speed by nearly half 
and migration persistence to a lesser extent when compared to the control knockdown 
(Figure 3.6D and E, Appendix Movie D.12 and D.13). This suggested that the decreased 
migration distance into the 3D stroma for the GPNMB knockdown lines was likely due to 
attenuated cell migration speed.  Taken together, these data demonstrated that GPNMB 
plays a key role in enhancing cancer invasion in 3D by affecting cell migration speed and 
that co-cultured CAFs induced GPNMB expression in cancer cells.  
Despite the significance of tumor-stroma interactions in early steps of cancer 
metastasis, not many models have studied and paired the functional assessments to 
molecular changes in cancer cell invasion in a suitable and relevant tumor 
microenvironment (Kalluri, 2016; B. Weigelt, 2014). In this work, we aimed to take a 
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significant step forward by developing an innovative organotypic tumor 
microenvironment model with configurable tumor and stroma regions coupled with 
integrated molecular and cellular studies on the influences of patient-derived fibroblasts 
on breast cancer invasion. The 3D microfluidic co-culture system contained side-by-side 
tumor and stroma regions to resemble the architecture of the early tumor 
microenvironment. This spatial organization enabled bi-directional crosstalk between the 
cancer cells and stromal cells, while still allowing imaging-based quantifications such as 
migration and proliferation. Most importantly, our model also addressed the limitations 
of previous systems, which only used functional assessments (i.e. cell migration and 
proliferation), by incorporating RNA-seq to profile the transcriptome of the cancer cells 
in co-culture with patient-derived fibroblasts to better dissect the molecular mechanisms 
and provide insights in tumor-stroma crosstalk during invasion.  
3.5 Discussion 
 We demonstrated that interaction between invasive breast cancer and mammary 
fibroblasts led to distinct consequences on cancer cell migration behavior depending on 
the fibroblast phenotype. NFs with lower expression of αSMA showed a tumor 
suppressive behavior compared to CAFs with higher levels of αSMA.  Despite that 
patient-derived CAFs showed no difference in αSMA expression among themselves in 
2D, only CAF1 and CAF3 significantly promoted migration and proliferation and CAF2 
to a lesser extent suggesting further CAF heterogeneity beyond αSMA levels (Kalluri, 
2016). Owing to the complexity in fibroblast heterogeneity, previous studies have 
proposed that fibroblasts could be subdivided into categories based on their functional 
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heterogeneity, like tumor-straining or tumor-promoting (Kalluri, 2016; Ohlund et al., 
2014). The NFs that we examined showed tumor-restraining properties which indeed 
corroborated with prior studies (Sadlonova et al., 2007). On the other hand, we 
demonstrated that two of three patient-derived CAFs, including CAFs from a TNBC 
patient, exhibited tumor-promoting behavior. Therefore, we envision that the changes in 
SUM-159 behavior when in co-culture with fibroblasts were due to the differences in 
fibroblast phenotype and their microenvironmental origin.  
One interesting consequence of tumor-stroma interactions that was revealed 
through our model was the possibility of a bi-directional crosstalk between SUM-159 
cells and fibroblasts influencing migration of both cell types. Specifically, real-time 
analysis of CAF migration demonstrated increased cell motility and persistence in 
presence of SUM-159. In reverse, SUM-159 cells also expressed enhanced migration 
speed in presence of CAFs. Previous studies have used cancer-conditioned media by 
adding to fibroblasts also showed enhanced elongation and migration of these cells in 
scratch assays (Henriksson et al., 2011; Karagiannis et al., 2014). Building upon these 
studies, our work incorporated both cancer cells and fibroblasts in a 3D matrix to reveal 
this reciprocal effect on cell motility instead of utilizing conditioned media to simulate 
cell-cell signaling.   
Many studies have indicated that the shape of the cell carries information 
determining the cell behavior, such as invasiveness(Yu et al., 2013). Here we showed that 
SUM-159 cells alone or when in co-culture with NFs demonstrated higher circularity as 
well as lower protrusiveness, area, and aspect ratio compared to when co-cultured with 
CAF populations. We connected the shape changes of the cancer cells to invasive 
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behavior by demonstrating that the increase in migration and proliferation of SUM-159 
cells correlated with increases in aspect ratio and protrusiveness. These results build upon 
the growing body of literature that have previously reported the relationship between 
protrusive activity and invasion (Mouneimne et al., 2012). Taken together, this suggested 
that the CAF isolates within our system promoted invasive morphology and migratory 
behavior of breast cancer cells (Kalluri, 2016; Yu et al., 2013).  
To screen for molecular influences on cancer migration due to the stromal 
fibroblasts (i.e. both CAFs and NFs), we profiled the transcriptome of the cancer cells 
and performed bioinformatics analyses. Within the NF co-culture, we found higher 
expression of genes related to inflammatory responses, such as CXCL8, ILR2, and IL6. A 
recent paper by Camp et al. co-cultured basal-like cancer cells (i.e. SUM-159) with 
immortalized fibroblasts obtained from reduction mammoplasty similar to NFs in our 
study (Camp et al., 2011). Consistently, they showed up-regulated immune responses, 
such as IL6, CXCL8, STAT1, CXCL1, and ILR2, corroborating our results. In addition, we 
found over-expression of Regulator of G protein signaling 16 (RGS16) within NF co-
culture. RGS16 is a possible tumor suppressor gene down-regulating cancer migration 
and proliferation (Carper et al., 2013). On the other hand, CAF co-culture over-expressed 
genes related to cell adhesion, like BGN, GPNMB, and IFITM10. The gene BGN encodes 
for biglycan, a small leucine-rich repeat proteoglycan found within the ECM, which has 
been demonstrated to be up-regulated within the breast tumor stroma (Casey et al., 2009). 
GPNMB has been associated with poor prognosis within basal/triple-negative subtype of 
breast cancers (April AN Rose et al., 2010). Prior research has implicated GPNMB in 
tumor invasion, angiogenesis, cell adhesion, and immune suppression for melanoma, 
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breast, prostate, pancreatic, and lung cancers (Fiorentini et al., 2014; Oyewumi et al., 
2016; A. A. Rose et al., 2007). Therefore, of the genes we screened for, we chose 
GPNMB as a possible mediator of cancer invasion in our model. Previous studies have 
mainly utilized transwell and colony forming assays to assess the influence of GPNMB in 
tumor invasion (A. A. Rose et al., 2007). We intended to clarify the role of GPNMB in 
3D cancer migration and tumor fibroblast interactions. Using our 3D model, we 
confirmed that GPNMB knockdown reduced breast cancer cell invasion within a 3D 
hydrogel-based stroma, suggesting its requirement for efficient migration in a 3D 
microenvironment. We showed through time-lapse imaging that the decrease in migration 
distance was due to attenuated cell migration speed in the 3D matrix. Our work is the first 
time that it was shown that GPNMB contributed to breast cancer cell migration speed in 
3D culture. In prior works, GPNMB has been demonstrated to engage integrins and 
MMPs which are crucial for 3D migration (Even-Ram & Yamada, 2005; Fiorentini et al., 
2014; Maric et al., 2015; A. A. Rose et al., 2007). We did indeed observe similar 
association between GPNMB and integrins and MMPs in our RNA-seq data (Table S9). 
GPNMB interaction with integrin was also shown to activate SRC and FAK signaling, 
which regulate cell migration (Maric et al., 2015; Smuczek et al., 2017). Our results taken 
together with the current findings suggested that GPNMB plays a crucial role in cancer 
invasion in 3D microenvironment.  
The influences of GPNMB on invasion has mainly been studied using a 
neoplastic-cell centric approach. To identify the involvement of the tumor 
microenvironment, we specifically asked whether CAFs promoted invasion of cancer 
cells through a GPNMB-dependent manner. Using the CAF co-culture model, we showed 
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through IF that patient-derived CAFs residing in the biomimetic stroma enhanced protein 
expression of GPNMB on breast cancer cells validating the RNA-seq data. Furthermore, 
knockdown of GPNMB of SUM-159 cells in the co-culture model blunted the effect of 
CAFs on promoting invasion. To the best of our knowledge, tumor-stroma interaction 
through GPNMB has not been explored before. In a similar study to ours, Le bras et al. 
established a 3D organotypic co-culture model using a collagen matrix, human 
esophageal epithelial cells, and human skin fibroblasts and demonstrated enhanced tumor 
proliferation and growth (Le Bras et al., 2015). Concordant with our work, gene 
expression analysis revealed more than a 1.5 fold-increase in GPNMB compared to non-
invasive cultures. However, studying the role of GPNMB was not the focus of that study. 
To that end, our work adds to the growing body of literature implicating GPNMB in 
promoting tumor invasion and progression, while supporting that GPNMB expression is 
enhanced through tumor-stroma interactions between breast cancer and CAFs (Even-Ram 
& Yamada, 2005; Fiorentini et al., 2014; Maric et al., 2015; A. A. Rose et al., 2007). 
There are some potential mechanisms by which CAFs could induce GPNMB expression 
in cancer cells. Smuczek et al. showed that C16, a laminin-111 subunit, could enhance 
GPNMB expression and promote MDA-MB-231 cell migration (Smuczek et al., 2017). It 
was suggested that C16 was produced through cell-induced proteolysis of the ECM 
through MMP9 and MMP9 has been shown to be secreted by CAFs (Siqueira et al., 
2016; Stuelten et al., 2005). In a separate study, GPNMB was upregulated in 
hepatocellular carcinoma by colony-stimulating factor 1, which is a known factor 
secreted from fibroblasts (Teng et al., 2016; Tian et al., 2013). Taking these prior 
findings with our results indicate that either directly through paracrine signaling or 
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indirectly by enzymatic release of bound peptides from ECM, GPNMB could be induced 
through tumor-stroma interactions.  
3.6 Conclusions 
In conclusion, we engineered a 3D organotypic microfluidic co-culture system to 
represent the breast tumor microenvironment by juxtaposing 3D tumor and stroma 
regions in order to study the molecular and cellular influence of patient-derived 
fibroblasts on breast cancer invasion. We found clear evidence that interactions between 
invasive SUM-159 breast cancer cells and mammary fibroblasts displayed distinct 
consequences on cancer migratory behavior depending on the fibroblast phenotype. 
Particularly, NFs expressed a tumor-suppressive behavior shown by reduction in 
migration, proliferation, and cell aspect ratio. On the other hand, two of the three CAFs 
studied demonstrated tumor-promoting behavior while the other to a lesser extent. 
Through transcriptome profiling of the SUM-159 cells, we found that NF co-cultures 
were enriched for inflammatory pathways while CAF co-cultures were enriched cell 
adhesion and ECM. This led to the observation that CAFs enhanced breast cancer 
invasion within a 3D microenvironment by inducing the expression of a novel gene of 
interest, GPNMB, in breast cancer cells resulting in increased invasion speed. 
Importantly, knockdown of GPNMB led to blunting the effect of CAFs on promoting 
cancer invasion. Overall, we propose that this organotypic microfluidic model has 
potential to tease out and understand key molecular pathways in tumor-stroma 
interactions for discovering druggable targets for inhibiting cancer invasion. In future 
studies, we intend to correlate the changes in gene expression to the molecular 
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differences in fibroblasts to predict how distinct patient-specific tumor 
microenvironments could influence cancer progression.  
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CHAPTER 4 
AIM 3: Use a microfluidic platform of the GSC vascular niche to study the influence 
of endothelial cells (ECs) on patient-derived GSC behavior and identify signaling 
cues that mediate their invasion and phenotype. 
4 Nothing 
4.1 Abstract 
Glioblastoma (GBM) is one of the deadliest forms of cancer. Despite many treatment 
options, prognosis of GBM remains dismal with a 5-year survival rate of 4.7%. Even 
then, tumors often recur after treatment. Tumor recurrence is hypothesized to be driven 
by glioma stem cell (GSC) populations which are highly tumorigenic, invasive, and 
resistant to several forms of therapy. GSCs are often concentrated around the tumor 
vasculature, referred to as the vascular niche, which are known to provide 
microenvironmental cues to maintain GSC stemness, promote invasion, and resistance to 
therapies. In this work, we developed a 3D organotypic microfluidic platform, integrated 
with hydrogel-based biomaterials, to mimic the GSC vascular niche and study the 
influence of endothelial cells (ECs) on patient-derived GSC behavior and identify 
signaling cues that mediate their invasion and phenotype. The established microvascular 
network enhanced GSC migration within a 3D hydrogel, promoted invasive morphology 
as well as maintained GSC proliferation rates and phenotype (Nestin, SOX2, CD44). 
Notably, we compared migration behavior to in vivo mice model and found similar 
invasive morphology suggesting that our microfluidic system could represent a 
physiologically relevant in vivo microenvironment. Moreover, we confirmed that 
CXCL12-CXCR4 signaling is involved in promoting GSC invasion in a 3D vascular 
microenvironment by utilizing a CXCR4 antagonist (AMD3100), while also 
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demonstrating the effectiveness of the microfluidic as a drug screening assay. Our model 
presents a potential ex vivo platform for studying the interplay of GSCs with its 
surrounding microenvironment as well as development of future therapeutic strategies 
tailored toward disrupting key molecular pathways involved in GSC regulatory 
mechanisms. 
4.2 Introduction 
Glioblastoma (GBM) is one of the most common and deadliest forms of brain cancer in 
adults. Despite aggressive treatment, including surgery, radiation and chemotherapy, 
prognosis for GBM patients remains dismal with a 5-year survival rate of 4.7% (Omuro 
& DeAngelis, 2013). These tumors almost always recur within a few months after 
treatment. Tumor recurrence is hypothesized to be driven in part by glioma stem cell 
(GSC) populations within the primary brain tumor (S. Bao et al., 2006; Lathia et al., 
2011). GSCs have similar properties to neural stem cells  ̶  they can self-renew and 
differentiate into several neuro-glial lineages leading to intratumoral heterogeneity 
(Lathia, Mack, Mulkearns-Hubert, Valentim, & Rich, 2015). Importantly, GSCs are also 
highly tumorigenic, invasive, and resistant to several forms of therapy (Sundar, Hsieh, 
Manjila, Lathia, & Sloan, 2014). As such, GSCs evade conventional therapies that target 
bulk populations of cancer cells allowing these cells to survive and regenerate the tumor 
(Venere, Fine, Dirks, & Rich, 2011). 
 GSCs are often concentrated near specific niches around pre-existing blood 
vessels, referred to as the perivascular niche and around necrotic areas known as the peri-
necrotic or hypoxic niches (Calabrese et al., 2007; Li et al., 2009; Sharma & Shiras, 
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2016). These specialized niches shelter, maintain, and regulate GSC stem phenotypes, 
invasion, and therapeutic resistance (Hambardzumyan & Bergers, 2015). Previous studies 
have shown that cell-cell interactions within the perivascular niches, which involve 
soluble factors released by endothelial cells (ECs) of the nearby blood vessels, lead to 
self-renewal of GSCs and propagation of the brain tumor in vivo (Calabrese et al., 2007). 
Different signaling pathways have been implicated in GSC-EC interactions, such as 
Notch, TGFβ, nitric oxide, and sonic hedgehog (SHH) (Sharma & Shiras, 2016). 
Targeting some of these signaling pathways have resulted in reduced tumor growth 
(Charles et al., 2010; Zhu et al., 2011).  Therefore, disruption of vascular niches could 
serve as a potential therapeutic strategy for GBM. In that regard, it is important to 
identify specific signaling pathways within the niches that support GSC self-renewal and 
propagation. 
The CXCL12-CXCR4 signaling axis regulates cell migration and proliferation 
during normal development in several tissues including the brain (Wurth, Bajetto, 
Harrison, Barbieri, & Florio, 2014). However, high levels of the chemokine receptor 
CXCR4 is overexpressed in gliomas and its expression level is correlated with tumor 
grade and poor prognosis (Bian et al., 2007). Expression of CXCL12 was also found to 
be highly expressed in the endothelium surrounding GBM whereas normal brain tissue 
lacked CXCL12 expression (Rao et al., 2012). As such, CXCL12-CXCR4 signaling axis 
has been described to play a central role in tumorigenesis of GBM along with several 
other human cancers, such as breast, colon, pancreatic, ovarian, and prostate (Ehtesham, 
Mapara, Stevenson, & Thompson, 2009; Orimo et al., 2005; Scotton et al., 2002; 
Taichman et al., 2002; Z. Wang et al., 2008; Zeelenberg, Ruuls-Van Stalle, & Roos, 
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2003). Importantly, inhibition of the CXCL12-CXCR4 signaling using AMD3100 has 
resulted with some success in tumor regression in vivo (Redjal, Chan, Segal, & Kung, 
2006). However, it is still unclear if GSC-EC interaction enhances GSC migration within 
the vascular niche and if this effect is mediated by CXCL12-CXCR4 interaction. 
 To better understand the role of the vascular niche and cell-cell signaling, such as 
CXCL12-CXCR4, that govern GBM tumorigenesis, an appropriate model with well-
controlled architecture is needed to recapitulate the components of the in vivo tumor 
microenvironment. Conventional in vitro platforms, such as transwell assays and 
spheroid models, have been widely utilized to perform biological studies and drug 
screening (Britta Weigelt et al., 2014). However, transwell systems are end-point assays 
that do not allow real-time observations of dynamic cellular interactions (S. A. Kim, Lee, 
& Kuh, 2015; Yang et al., 2015). In addition, these conventional assays often require a 
large population of cells, which may be problematic for patient-derived cells. Most 
importantly, these models do not fully recapitulate the complex in vivo tumor 
microenvironment leading to non-physiologically relevant cell behavior (Hutmacher et 
al., 2010). Therefore, there have been significant innovations in the use of microscale 
tissue-engineered technologies to develop complex 3D tumor models across different 
types of cancer, with precise control over cell-cell, cell-matrix and cell-soluble factor 
interaction (Chonan, Taki, Sampetrean, Saya, & Sudo, 2017; Jeon et al., 2015; Ngo & 
Harley, 2017; N. Peela, Barrientos, et al., 2017; N. Peela et al., 2016; N Peela, Truong, 
Barrientos, Mouneimne, & Nikkhah, 2016; N. Peela, Truong, et al., 2017; D. Truong et 
al., 2016; Britta Weigelt et al., 2014). While these 3D models have had great success in 
interrogating tumor responses to the microenvironment, few have studied GBM and even 
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less in the context of the vascular niches (i.e. tumor-vascular interactions) within a 3D 
platform (Ayuso et al., 2016; S. Kim, Lee, Chung, & Jeon, 2013). While these 3D models 
have had great success in interrogating tumor responses to the microenvironment, few 
have studied GBM and even less in the context of the vascular niches (i.e. tumor-vascular 
interactions) within a 3D platform (Ayuso et al., 2016; S. Kim et al., 2013). For instance, 
a 3D in vitro model of the perivascular niche was developed by Infanger et al. to study 
GSC behavior using 3D hydrogels. However, in this model, GSCs and ECs were not co-
cultured together simultaneously and EC-conditioned medium was used to simulate 
paracrine signaling (Infanger et al., 2013).  On the other hand, a 3D microfluidic device 
was used to study glioma invasion influenced by ECs. The GSCs and ECs were seeded as 
2D monolayers separated by a 3D collagen layer in between, which did not truly 
represent the 3D GBM microenvironment (Chonan et al., 2017). With recent attempts in 
modeling vasculature in 3D, there have also been notable advances in developing 
vascular networks with increasing physiological relevance within 3D hydrogels (Jeon et 
al., 2015; S. Kim et al., 2013; H. Lee, Park, Ryu, & Jeon, 2014; Nagaraju et al., 2018). 
However, much of the focus have not been on GBM or patient-derived GSCs. 
Additionally, those studying GBM were specifically investigating the influence of GBM 
on tumor-associated angiogenesis, such as the work from Cui et al, which highlighted the 
importance of macrophage-associated immunosuppression during GBM angiogenesis, 
and not the changes in GSC invasion and stem phenotype within the context of a vascular 
niche, which is the focus of our study (Cui et al., 2018; H. Lee, Park, et al., 2014). 
 We previously developed microfluidic technologies comprising of 3D hydrogel-
based layers for multi-culturing of tumor and stromal cells side-by-side to mimic the 
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architecture of the native tumor microenvironment (N. Peela, Barrientos, et al., 2017; D. 
Truong et al., 2016). We have investigated breast cancer cell invasion in response to 
signaling cues and stromal cells, such as cancer-associated fibroblasts and ECs (N. Peela, 
Barrientos, et al., 2017; D. Truong et al., 2016). In this study, we describe the design, 
biological validation, and use of our microfluidic platform as a new in vitro 3D 
organotypic model for GSC invasion in the context of a vascular niche (Figure 4.1A). We 
formed a spontaneously assembled 3D vasculature within our platform, and then 
incorporated patient-derived GSCs within the core of the tumor region. The novelties of 
our model enabled the interaction of patient-derived GSCs and a 3D microvascular 
network which has not been described in previous studies. We specifically investigated 
the effect of GSC-EC interactions within our microfluidic on GSC proliferation, invasion, 
and stem phenotype. Importantly, in parallel to our in vitro experiments, we utilized a 
patient-derived xenograft (PDX) in vivo model to evaluate the physiological relevance of 
our microfluidic platform.  Indeed, we observed similar GSC invasive behaviors between 
the two systems in terms of GSC migration, morphology, and proximity to the 
vasculature. Lastly, to determine the influence of CXCL12-CXCR4 signaling on EC-
mediated GSC invasion, we tested the effect of AMD3100, a CXCR4 antagonist, within 
our in vitro microfluidic model. As such, our study presents a physiological relevant 3D 
organotypic model of GSC invasion for investigating the interaction between GSC and 
the surrounding microenvironment. 
 
4.3 Materials and Methods 
4.3.1 Microfluidic device fabrication 
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The microfluidic platform was designed using CAD software, and transferred 
onto a transparent mask. The design consisted of three concentric semicircles comprising 
of tri-layer tumor, stroma, and vasculature regions with diameters of 1, 2, and 3 mm with 
heights of 200 µm. The intraregional distance between the concentric semicircles was 
1 mm. Trapezoidal microposts were spaced evenly at 100 µm bound each region. The 
microposts were configured to separate the regions, while also enabling interactions 
between the regions by allowing exchange of media, biomolecules, and cells throughout 
the platform. To create a master mold of the devices, SU8-2075 (MicroChem) was spun 
to height of 200 µm onto a silicon wafer after which, the wafer was exposed to UV 
through the mask placed on the wafer forming the primary mold. The surfaces of the 
silicon wafer were made hydrophilic by treatment with methyltrichlorosilane (MTCS, 
Sigma-Aldrich). Next, polydimethylsiloxane (PDMS, Sylgard 184 Silicon Elastomer Kit, 
Dow Corning) was poured over the wafer and cured for 1.5–2 h at 80 °C. The PDMS cast 
was then peeled from the micro-patterned mold. Individual devices were then cut from 
the cast using a razor, and inlet and outlet holes were hollowed out using biopsy punch. 
PDMS device casts were then bonded to 18 mm2 glass slides to form the channels of the 
microfluidic. Before bonding, devices and glass slides were cleaned with ethanol and 
pressurized nitrogen gas and subjected to oxygen plasma (PDC-32G, Harrick Plasma) to 
produce hydrophilic surfaces on both the devices and the glass. PDMS device casts were 
then joined to glass slides with the channel side facing down and placed in oven at 80 °C 
overnight to secure bonding. Next, device sterilization was performed by one treatment in 
the liquid autoclave and a subsequent treatment by dry autoclave. Finally, devices were 
placed in the oven at 80 °C overnight to dry completely. 
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To enhance attachment of the hydrogels (i.e. Matrigel and Fibrin) to the 3D cell 
culture regions, poly-d-lysine (1 mg mL−1) (PDL, Sigma-Aldrich) was injected into the 
cell culture region and incubated at 37 °C for 1 h, then washed with deionized (DI) water. 
Glutaraldehyde (1% (v/v)) (GA, Sigma-Aldrich) was then added to the culture region and 
incubated for 1.5–2 h at room temperature, then washed 4–5 times with DI water to 
remove excess GA. The devices were then placed in the oven at 80 °C overnight to 
restore the hydrophobicity of the channels. Hydrophobicity enabled microposts to contain 
a hydrogel within the culture regions before it can polymerize and attach to the inner 
surface (C. P. Huang et al., 2009).  
4.3.2 Cell culture 
Patient samples used for this research were provided by the Biobank Core Facility 
at St. Joseph’s Hospital and Medical Center and Barrow Neurological Institute (BNI), 
Phoenix, Arizona. The samples were de-identified and conformed to the Biobank 
Institutional Review Board (IRB) protocol. Patient-derived cell line GB3 was established 
from resected primary GBM tumor tissue at BNI. Briefly, tumor tissue was processed 
using the Gentle MACS Dissociator and Tumor Tissue Dissociation kit (Miltenyi Biotec 
Inc.). Cells were expanded as neurospheres in tissue culture dishes coated with poly-(2-
hydroxyethyl methacrylate) (Sigma-Aldrich) or grown adherent on laminin (Fisher 
Science), in neural stem cell (NSC) medium consisting of DMEM and F12-Glutamax 
supplemented with B27 and N2 (Fisher Science), in the presence of 20 ng ml-1 EGF and 
20 ng ml-1 FGF2 (EMD Millipore). To generate GB3-RFP cell line, GB3 cells were 
transduced with pre-made lentiviral particles (Amsbio) expressing RFP-Luc (GB3-RFP) 
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and were selected using blasticidin (2 µg ml-1). Human umbilical vein endothelial cells 
(HUVECs) were obtained from Lonza and cultured in EGM-2 (Endothelial Growth 
Medium, Lonza) and passaged at 70-80%.  
4.3.3 Vasculogenesis in the microfluidic device 
To model vasculogenesis within our microfluidic platform, HUVECs were 
dislodged from culture flasks using trypsin-EDTA and centrifuged. Next, 5 mg mL−1 
bovine fibrinogen (Sigma-Aldrich) dissolved in Dulbecco's phosphate buffered saline 
(DPBS, Gibco) was used to make the fibrinogen solution. Bovine thrombin (Sigma-
Aldrich) was dissolved in DPBS to create 4 U ml-1 thrombin solution. Fibrinogen and 
thrombin solutions were then filter sterilized (Denville scientific). HUVECs were added 
to the fibrin solution (5 mg ml-1 fibrinogen plus 4U ml-1 thrombin) to form a hydrogel 
with the final cell density of 20 million cells ml-1. The mixture was then immediately 
injected into the vascular region (third layer, Figure 4.1B) of the device and the devices 
were incubated at room temperature for 10 min to promote fibrin polymerization. After 
hydrogel polymerization, EGM-2 (endothelial growth medium supplemented with 
additional 50 ng ml-1 VEGF) was added to each device and the platforms were kept in the 
incubator (humidified, 37 °C, 5% CO2). Cell culture medium was exchanged every 24 h 
throughout vasculogenesis (3 d). 
4.3.4 Co-culture invasion assay 
To study GSC-EC interactions, GB3-RFP cells, referred to as GB3 hereafter, were 
added to the devices after vasculogenesis. GB3 cells were dissociated, centrifuged, and 
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then the cells were directly suspended in pure Matrigel® with a final cell density of 15 
million cells ml-1. The cell–hydrogel solution was mixed and injected into the tumor 
region of the device (Figure 4.1B). The devices were then incubated (humidified, 37 °C, 
5% CO2) for 3 min. Subsequently, Matrigel® was injected into the stroma region 
followed by 5 min of incubation allowing hydrogel polymerization. Cell culture medium 
was added afterwards and exchanged daily. Invasion distance was measured by drawing 
lines from the microposts to the edge of leading cells and then averaging at least 10 lines. 
Extensions from the cell body were measured by drawing a line from the front edge of 
nucleus to the end of the extension. Click-iT EdU Alexa Fluor 488 Imaging Kit (Thermo 
Fisher) was used to assess proliferation in invasion assay.  
4.3.5 In vivo animal Experiments 
Animal husbandry was performed according to the guidelines of St. Joseph 
Hospital and Medical Center and Barrow Neurological Institute under the Institutional 
Animal Care and Use Committee–approved protocol. Five- to six-week-old IcrTac:ICR-
Prkdcscid mice were used for in vivo orthotopic transplant of fluorescently-tagged GB3 
cells. For orthotopic transplants, 2 µL of dissociated cells at a density of 50,000 cells µL-1 
were injected in the right hemisphere (stereotactic coordinates AP 0, ML -2, DV -2.5), as 
described previously (Ligon et al., 2007; S. Mehta et al., 2011). 8 weeks after injection, 
tumor-bearing mice were euthanized with a lethal intraperitoneal injection of 2.5% 
Avertin (2,2,2-Tribromoethanol, Sigma-Aldrich; T48402; tert-Amyl alcohol, Sigma-
Aldrich, A1685). Tissues were fixed through intracardial perfusion with Ringer’s solution 
(Electron Microscopy Sciences; 11763-10) supplemented with 40 mM NaNO2, 2 mM 
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NaCHO3, and 50 IU mL-1 heparin, followed by ice-cold 4% paraformaldehyde (PFA) in 
0.1 M phosphate buffer (PB). Brains were subsequently cryoprotected with incubation in 
a solution of 30% sucrose in PB for 48 hours before being frozen and cut into 40 µm 
coronal sections using a cryostat (Microm HM550, Thermo Scientific). 
4.3.6 Immunostaining within the microfluidic device 
Cells within microfluidics were fixed in 4% PFA following 3 days after co-culture 
by removing cell culture medium and exchanging for 4% PFA before applying a gentle 
negative pressure to other well to create flow. Devices were then incubated for 30 min at 
room temperature (RT). After incubation, the samples were rinsed twice with PBS-
glycine (100 mM glycine in PBS) incubating for 10 min at RT and washed with PBS-
Tween (0.05% (v/v) Tween-20 in PBS) for another 10 min at room temperature to 
permeabilize the cells. Following permeabilization, the samples were blocked with 
immunofluorescence buffer and 10% goat serum (GS) (IF buffer: (0.2% (v/v) Triton X-
100, 0.1% (v/v) BSA (radioimmunoassay grade), 0.05% Tween 20, 7.7 mM NaN3 in 
PBS) for 2 h to inhibit nonspecific binding of antibodies. Primary antibody was diluted in 
PBS-tween and then added to the blocked samples and kept at 4 °C overnight. Devices 
were kept in petri dishes and wrapped in parafilm to avoid evaporation. Then, devices 
were washed with IF buffer three times each at 20 min intervals at room temperature. 
Species-matching Alexa-conjugated secondary antibodies were used at 1:500 dilution 
(Invitrogen). After adding the mixture to each sample, the devices were incubated at 
room temperature for 1 h. The devices were then washed once with IF buffer for 20 min 
followed by two times washing with PBS-Tween-20 for 10 min. 4',6-diamidino-2-
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phenylindole (DAPI, Invitrogen) (1:1000) was added to the devices to counterstain 
nucleus. Following staining, the devices were finally washed with PBS–Tween-20 three 
times each at 10 min intervals. The following primary antibodies were used: mouse anti–
Ki-67 (1:100, Dako), rabbit anti-Sox2 (Cell Signaling, 1:100), mouse CD-31 (10 µg 
mL−1, P2B1, Developmental Studies Hybridoma Bank, DHSB), mouse anti-Nestin 
(1:200, Abcam), rabbit anti-CD44 (Cell signaling, 1:400), rabbit anti-GFAP (Millipore, 
1:500), rabbit anti-pCXCR4 (Cell Signaling, 1:100). 
4.3.7 Immunohistochemistry of in vivo tissue sections 
 Immunohistochemistry was performed on free-floating sections. When antigen 
retrieval was necessary, tissues were treated for 45 minutes in citrate buffer (pH 6) at 
80°C. To block unspecific staining when mouse-raised primary antibodies were used, we 
initially incubated sections with goat anti-mouse and goat anti-rabbit IgG (Jackson 
ImmunoResearch) 1:50 in 0.1 M PB 0.4% Triton-X (PBTx). After a permeabilization and 
blocking incubation for 2 hours at RT in PBTx supplemented with 10% heat-inactivated 
GS, the sections were incubated with the primary antibodies for 12 hours at 4°C in PBTx, 
2% GS. Incubation with secondary antibodies was performed for 2 hours at 4°C in PBTx, 
2% GS. Nuclear counterstaining was achieved with DAPI (0.5 µg/mL). The following 
primary antibodies and dilutions were used: mouse anti–Ki67 (1:100, Dako), rabbit anti-
RFP (1:100, Abcam), rabbit anti-Sox2 (Cell Signaling, 1:100). For blood vessel staining, 
sections were incubated with DyLight-488 Tomato Lectin (Vector Lab) for 1hr RT at 
1:1000. Coverslips were mounted using Pro-long Gold (Vector Lab). 
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4.3.8 Imaging 
Microfluidic devices were imaged using fluorescence microscopy (Zeiss Axio 
Observer Z1 with the Zen Pro software suite) equipped with Apotome.2 (Zeiss) at 20x 
and 40x magnification. Fluorescent brain tissue sections were imaged using a Leica SPE 
Confocal microscope at 20x magnification (1.2 micrometer stacks). Analysis and 3D 
reconstructions were performed with Imaris (Bitplane). 
4.3.9 Statistical Analysis 
For all analyses, values were obtained from at least three independent experiments 
(n > 3) with 2–3 technical replicates each. Data are expressed as average ± standard 
deviation or average ± standard error of mean.  When only two conditions, we utilized an 
unpaired two-tailed Student’s t-test. Two-way ANOVA with Sidak multiple comparison 
tests were used when comparing more than two conditions and statistical significance 
defined as p < 0.05. Statistical analyses were performed within the GraphPad Prism 
software (GraphPad Prism 6). 
4.4 Results 
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Figure 4.21 Schematic of GSC-EC interaction.  
(A) Schematic of the vascular niche within the GBM tumor microenvironment 
demonstrating GSC (red) migration in response to ECs (green). (B) The 3D schematic 
and photograph of the microfluidic platform is showing the different regions for cell 
culture and migration. Blue represents the tumor region housing the GB3 and red 
represents the vasculature region containing the HUVECs. The green region in the 
middle enables GB3 migration toward the microvascular network.  
4.4.1 Formation of vasculature within the microfluidic model 
 We first established and tested the formation of a 3D microvascular network 
within our microfluidic model prior to incorporating GSCs within the tumor region 
(Figure 4.1B). To establish the microvascular network, we utilized fibrin as the candidate 
ECM for encapsulating the HUVECs. Fibrin has been widely used to model the tumor 
vasculature as it promotes physiologic vasculogenesis (Jeon et al., 2015; H. Lee, Park, et 
al., 2014). Importantly, fibrin has been well-documented to be deposited near tumor-
associated vasculature for different cancers including those of the brain functioning as a 
source of growth factors for angiogenesis and cell recruitment (Bardos, Molnar, Csecsei, 
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& Adany, 1996; Harold F Dvorak, 1986). Additionally, in our previous extensive 
characterization, we demonstrated the suitability of fibrin for physiologic vasculogenesis 
(Nagaraju et al., 2018). So, we embedded HUVECs in a fibrin gel and injected them 
within the outer layer of the microfluidic to enclose the tumor and stroma layers. The 
process of microvascular network formation occurred over the course of 3 days in 
culture. As seen in Figure 4.2A, the phase-contrast images demonstrated the formation of 
branched microvascular network within the microfluidic platform. The HUVECs began 
to elongate and connect within the first day of culture. By the third day, vessel-like 
structures could be seen similar to our prior publication (Nagaraju et al., 2018). Notably, 
fluorescent 70-kDa dextran flowed into the vasculature, demonstrating open lumens of 
the microvascular network (Figure 4.2B). CD31 staining confirmed the microvascular 
phenotype and the cross-sectional view clearly showed the formation of lumen (Figure 
4.2C). 
  122 
 
Figure 4.22 Successful formation of 3D microvascular network within the microfluidic 
platform.  
(A) Phase-contrast images of HUVECs forming microvascular network over 3 days of 
culture; Scale bar: 100 µm top image and 50 µm for bottom row. (B) Fluorescent dextran 
perfused into the media channels demonstrating open lumens within microvascular 
network. (C) CD-31 stain confirming the morphology of vessels within microfluidic 
device. Cross-sectional view (red lines) demonstrating hollow lumen of the vessels; Scale 
bar: 50 µm. 
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4.4.2 Phenotype of GSCs in the microfluidic model 
 We utilized GB3 GSCs, a patient-derived cell line established from resected 
primary GBM tumor at the Barrow Neurological Institute (BNI). GB3 GSCs have 
previously been shown to be highly invasive within 2D in vitro transwell assays as well 
as in vivo mice models (Singh et al., 2016). When cultured within 3D hydrogels, these 
cells demonstrated expression of Nestin, SOX2, and CD44, and the ability to maintain 
self-renewal which are classical GSC markers (Heffernan et al., 2017). However, the 
phenotype of patient-derived GB3 cells within the 3D microenvironment in presence of 
vasculature has not been assessed. Therefore, prior to invasion analysis, we confirmed the 
expression of specific proteins related to stemness and different neural lineages of the 
GSCs within our microfluidic model through immunofluorescent staining. While GSCs 
are typically cultured in serum-free condition, the co-culture with HUVECs requires 
further optimization of medium conditions. HUVEC growth requires media containing 
2% fetal bovine serum (FBS) along with additional growth factors which may influence 
invasion and phenotype of the GSCs in the co-culture condition. Therefore, we designed 
experiments with different media composition to conduct our biological studies.  The 
culture media were comprised of: NSC medium, NSC medium supplemented with 5% 
FBS (NSC +), and EGM-2. 
To establish working microfluidic model, we first formed the microvascular 
network within the model for 3 days. Next, we utilized Matrigel® as it is compatible with 
3D culture and rich in laminin, which is important ECM component of the GSC 
microenvironment (Rape, Ananthanarayanan, & Kumar, 2014; Xiao, Sohrabi, & Seidlits, 
  124 
2017). Patient-derived primary GSCs were encapsulated within Matrigel® and 
introduced into the primary tumor region of the platform. Subsequently, Matrigel® was 
added into the second layer (i.e. stroma) of the device to surround and enclose the tumor 
region. Within different medium compositions, we examined the expression of Nestin, 
SOX2, GFAP, and CD44 markers in the GSCs embedded in Matrigel® within the second 
layer of the microfluidic platform in the presence of microvascular network. Nestin, 
which is an intermediate filament and a neural progenitor marker, was expressed in the 
GSCs (Figure 4.3A). We did not detect expression of astrocytic marker, GFAP (Figure 
4.3B), while the transcription factor SOX2, a marker for pluripotency and self-renewal 
(Figure 4.3C) (Guo et al., 2011), was widely expressed in GSCs. Moreover, CD44, a 
receptor for hyaluronic acid which is highly expressed in malignant GBM (Breyer et al., 
2000), was clearly shown on the membrane of the GSCs (Figure 4.3D). These results 
from our 3D microfluidic model are consistent to prior publications which suggests that 
the GSCs maintain stemness and GBM phenotype markers in presence of the vasculature 
(Heffernan et al., 2017; Singh et al., 2016).  
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Figure 4.23 GB3 GSCs demonstrated stem phenotype within the 3D microfluidic device.  
(A) GSCs demonstrated positive staining for Nestin and (B) negative for GFAP while (C 
and D) SOX2 and CD44 were positively expressed in GSCs within different medium 
compositions.  
4.4.3 Invasion of GSC in presence of the 3D microvascular network 
 We intended to find out if the formed vasculature influenced the invasion 
distances of GSCs within a 3D microenvironment. As previously described, we 
introduced different medium conditions in our microfluidic model. Within the first day of 
culture, we observed that GSCs did not form spheroids but demonstrated elongated and 
branching morphology under all the conditions. Additionally, GSCs exhibited propensity 
to migrate into the stroma as chains of cells (Figure 4.4). We compared invasion of GSC 
between mono-culture (- HUVECs) and co-culture with HUVECs (+ HUVECs) for the 
three different media conditions (Figure 4.4A). Co-culture with HUVECs led to 
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significant invasion of GSC in the NSC medium (Figure 4.4B; - HUVECs 52.8 ± 11.3 
µm and + HUVECs 262.4 ± 39.2 µm) and NSC + medium (Figure 4.4B; - HUVECs 
170.5 ± 21.0 µm and + HUVECs 319.4 ± 60.6 µm).  On the other hand, we found no 
difference between mono- and co-culture conditions in EGM-2 (Figure 4.4B; - HUVECs 
310.7 ± 22.4 µm and + HUVECs 318.3 ± 29.24 µm). This suggests that EGM-2 may 
contain cytokines that elicit a strong invasion response in GSCs thereby shielding the 
influence of HUVECs on invasion. Conversely, since there was a significant increase in 
GSC migration upon co-culture in both NSC and NSC + medium conditions, this 
suggests that HUVECs do play a role in enhancing invasion of GSCs within the 3D 
tumor-vascular microenvironment. 
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Figure 4.24 GSC invasion in under different medium conditions within the 3D 
microfluidic model.  
(A) Phase-contrast image of GSC (red) invading in the presence of HUVECs in different 
medium conditions. Red dashed line delineates average migration boundary; Scale bar: 
200µm. (B) Quantification of invasion distance for each condition (* denotes p < 0.05; 
Student’s T-test; n > 3 for each data set).   
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 Based on the phase-contrast images of the invasion assay on day 3, we also 
noticed morphological differences in how GB3 GSCs invaded when co-cultured with 
HUVECs. Cell membrane protrusions or extensions from the cell body were observed 
within the GSCs (Figure 4.5A), which have been attributed to invasive phenotype in 
GBM (Jensen et al., 2016; Osswald et al., 2015). We measured the extensions of the 
leading GSCs and compared within different medium conditions. As seen in Figure 4.5A, 
the migrating GSC exhibited more elongated extensions from the cell body when co-
cultured with HUVECs, which was correlated with their invasive response (Figure 4.4). 
This is indeed also consistent with previous in vivo studies on invasive morphology of the 
GSCs (Osswald et al., 2015). Quantifications of the extensions demonstrated that GSCs 
had a significant increase in extension length upon co-culture with HUVECs within each 
medium condition (Figure 4.5B; NSC: - HUVECs 70.8 ± 16.5 µm and + HUVECs 106.5 
± 20.6 µm, NSC +: - HUVECs 60.0 ± 5.4 µm and + HUVECs 104.5 ± 19.0 µm, and 
EGM-2: - HUVECs 84.2 ± 14.9 µm and + HUVECs 129.8 ± 26.8 µm) corroborating the 
observations from phase-contrast images (Figure 4.5A). We also speculated that, apart 
from the migration distance (Figure 4.4), the presence of vascular network may influence 
the density of migrating cells within the stromal region. Therefore, we utilized two 
metrics, number of cells in a migrating chain as well as number of cells in a field of view 
(FOV) within the stroma, to quantitatively discern the density of migrating cells. For co-
culture with HUVECs in the NSC medium condition, there were significantly increased 
numbers of nuclei per chain of migrating cells (Figure 4.5C; - HUVECs 2.8 ± 0.9 and + 
HUVECs 5.6 ± 1.5) and within a FOV in the stroma (Figure 4.5D; - HUVECs 9.6 ± 6.1 
and + HUVECs 32.2 ± 9.2) as compared to mono-culture. On the other hand, no 
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significant difference between mono- and co-culture conditions was found in either NSC 
+ or EGM-2 media (Figure 4.5C and D). As such, the microfluidic model was capable of 
monitoring GSC invasive behaviors in terms of migration distance and morphology under 
different medium conditions in the absence and presence of a functional 3D vasculature.  
 
Figure 4.25 GSCs demonstrated elongated morphology during invasion.  
(A) Phase-contrast and fluorescent images of GSC invading into the stroma exhibiting 
extensions from cell bodies. (B) Quantification of the extensions in each medium 
condition. (C) Quantification of the nuclei per chain in each medium condition. (D) 
Quantification of the nuclei per FOV in each medium condition. (* denotes p < 0.05; 2-
way ANOVA with Sidak post-hoc test; n > 3 for each data set).   
 In addition to assessing GSC invasion distance and morphology, we investigated 
the behavior of the formed vessels under different media compositions. Consistent to our 
prior publication (Nagaraju et al., 2018), we measured the diameter of the vessels 
(Appendix Figure C.1A; NSC: 55 ± 5 µm, NSC +: 63 ± 14 µm, EGM-2: 48 ± 9 µm) and 
the length between junctions (Appendix Figure C.1B; NSC: 267 ± 71 µm, NSC +: 276 ± 
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103 µm, EGM-2: 247 ± 42 µm) (Nagaraju et al., 2018). We found slight differences 
between the different media compositions but none were statistically significant. 
Furthermore, we did not observe extensive angiogenesis over the three-day time-period 
of our assay. 
4.4.4 Effect of vasculature on GSC proliferation 
 As the vascular microenvironment had been demonstrated to maintain 
proliferation of GSCs (Calabrese et al., 2007), we asked if the microvascular network 
within our model played a similar role on GB3 proliferation.  In mono- and co-culture 
conditions, we utilized Ki-67, in addition to pulsing with EdU for 24 h, to assess the 
proliferation of GSCs. As shown in Figure 4.6, we observed expression of Ki-67 and 
EdU suggesting that the GSCs divided within the microfluidic platform. However, 
regardless of the medium conditions, we did not observe a significant difference in 
proliferative markers between mono- and co-culture conditions. This suggests that 
HUVECs within this model did not influence GSC proliferation. Moreover, this also 
suggests that the invasion responses of the GB3 cells were more likely due to migration 
speed and elongation of cells rather than proliferation (Figure 4.4).   
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Figure 4.26 GSC proliferated within the 3D microfluidic model.  
(A) Immunofluorescence staining of Ki-67 proliferative marker; Scale bar: 50 µm. (B) 
Quantification of Ki-67/Nuclei ratio of each medium condition. (C) Immunofluorescence 
staining of EdU incorporation into nuclei; Scale bar: 50 µm. (D) Quantification of 
EdU/Nuclei ratio of each medium condition.  
 
Figure 4.27 GSC invasion in microfluidic and PDX models.  
(A) i: GSCs (red) shown migrating toward vasculature (blue, Lectin) within the in vivo 
model; Scale bar: 50 µm. ii: 3D view of tissue-slices of the in vivo model demonstrating 
GB3 migrating along vessel. Iii: surface rendering of migrating GSCs showing the cells 
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establishing contact with the vasculature.  (B) i: Immunofluorescence staining of 
invading GSCs (GB3, red) near vasculature (CD-31, green) in microfluidic model. The 
white dashed line demarcates the border between the stroma and the vascular regions. ii: 
Surface rendering with multiple views of migrating GSCs (red) within the microfluidic 
model; Scale bar: 40 µm. (C) Comparison of chain-like migration between the two 
models; Scale bar: 25 µm. (D) Comparison of proliferating GSC (green, Ki-67) near 
vessel in both models; Scale bar: 25 µm.  
4.4.5 Comparison of the microfluidic platform of GSC invasion to in vivo PDX model 
 In parallel to our in vitro studies, we utilized a PDX model to investigate GSC 
invasive behavior in vivo to confirm the physiological relevance of our microfluidic 
platform. Notably, side-by-side validation of microfluidic models of GSC-EC 
interactions and in vivo PDX model had not been performed in prior microfluidic 
systems. (Chonan et al., 2017; H. Lee, Park, et al., 2014). Fluorescently-tagged GB3 cells 
orthotopically transplanted in mice, demonstrated migration near and along blood vessels 
(Lectin, blue) within the mouse brain (Figure 4.7Ai), appeared comparable to the 
behavior of GSCs in our microfluidic model (Figure 4.7Bi). Based on 3D and surface 
renderings of the tissue slices, we could clearly observe cells migrating along the vessels, 
consistent to other studies (Figure 4.7Aii and iii) (Watkins et al., 2014). Similarly, within 
the microfluidic model, GSCs could be observed migrating in 3D space while also 
establishing contact with the vasculature (CD-31, green) through the 3D surface 
renderings of the cells (Figure 4.7Bii and Appendix Movie D.14). Additionally, we 
observed similar chain-like migration within the in vivo PDX model that resembled the 
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migratory behavior of cells within the co-culture microfluidic model (Figure 4.7C). We 
noticed long protrusion-like extensions in both systems consistent to other studies, which 
have been associated with invasive phenotype as well as resistance to radiotherapy of the 
GSCs (Gritsenko, Leenders, & Friedl, 2017; Osswald et al., 2015). The expression of 
proliferation marker, Ki-67, was observed near vessels in both the microfluidic and in 
vivo model (Figure 4.7D). The microfluidic model could also enable in-depth 
visualization of the 3D vasculature as shown in Appendix Figure C.2A. The surface 
renderings clearly depicted the inner membrane of the vasculature providing potential for 
high-resolution observation of cell-cell interaction at a single-cell level (Appendix Figure 
C.2B, C and Appendix Movie D.15).  Taken together, these evidences showed that our 
microfluidic model reliably represented GSC invasion in vivo in the context of a vascular 
niche. Importantly, our in vitro microfluidic assay only took 6 days to conduct our 
studies, which could provide faster and higher throughput for multiple analyses as well as 
high-resolution observation of cell-cell interactions prior to in vivo studies. 
4.4.6 Effect of AMD3100 on GSC invasion within microfluidic model 
High expression of chemokine receptor CXCR4 is a hallmark of malignant GBM 
(Bian et al., 2007). As such, CXCL12-CXCR4 interaction has been previously implicated 
in malignant GBM invasion (Ehtesham et al., 2009). However, previous studies have not 
assessed the expression of this signaling axis in a 3D tumor-vascular niche model. We 
demonstrated in our model that the presence of the 3D microvascular networking 
consisting of HUVECs promoted migration of GSCs. Additionally, since HUVECs have 
previously been shown to be a source of CXCL12 (Faber et al., 2014; Grasman & 
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Kaplan, 2017). We hypothesized that CXCR4-CXCL12 signaling axis may be involved 
in the migration of GSCs when in presence of HUVECs. AMD3100 has been used to 
inhibit CXCR4 and disrupt neural stem cell and GBM cell migration (C. Liu et al., 2013; 
J. M. Liu et al., 2017; Wurth et al., 2014). Therefore, we utilized this drug to study the 
influence of CXCL12-CXCR4 on GSC invasion in the context of 3D in vitro vascular 
microenvironment.  
We chose the NSC medium condition due to the strong invasion response of 
GSCs in presence of HUVECs (Figure 4.3 and 4.4). HUVECs have previously been 
demonstrated to be a source of CXCL12 in vitro using ELISAs (Faber et al., 2014; 
Grasman & Kaplan, 2017). Therefore, we primarily validated signaling of CXCL12-
CXCR4 axis by staining for the phosphorylated active form of CXCR4 (pCXCR4) in 
GSCs (Warrington et al., 2007). In absence of the microvascular network, pCXCR4 
showed a diffuse pattern and was not localized to the nucleus (white arrows in Figure 
4.8A). In presence of the microvascular network, pCXCR4 showed a punctate pattern and 
was localized to nucleus (white arrows in Figure 4.8A), providing additional evidence for 
CXCR4 activation by CXCL12 in our model (L. Wang et al., 2009). 
We introduced AMD3100 at a concentration range between 0 and 100 µM after 
24 h of establishing the model (C. Liu et al., 2013). The cells were maintained in 
AMD3100 for 48 h while we assessed their invasion response (Figure 4.8B). In mono-
culture condition (- HUVECs) by day 3, the cells invaded in all drug treated 
concentrations but there were no significant differences in the invasion distances (Figure 
4.8C, blue line; 0 µM: 98.1 ± 20.1 µm, 1 µM: 69.4 ± 27.58 µm, 10 µM: 52.9 ± 13.1 µm, 
and 100 µM: 59.0 ± 0.5 µm). However, in the presence of HUVECs on day 3 (+ 
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HUVECs), we observed that invasion distance for 0 µM AMD3100 was significantly 
higher than all other concentrations with 1 µM being significantly higher than 100 µM 
(Figure 4.8C, red line; 0 µM: 285.1 ± 65.4 µm, 1 µM: 162.1 ± 42.4 µm, 10 µM: 137.5 ± 
65.3 µm, and 100 µM: 69.9.0 ± 15.9 µm). We observed a decreasing trend in invasion 
response with increasing AMD3100 concentration (Figure 4.8C). The enhanced invasion 
response due to presence of the 3D microvascular network could be abrogated to mono-
culture (- HUVECs) migration levels through treatment with AMD3100 by disrupting 
CXCL12-CXCR4 signaling (i.e. 100 µm). Interestingly, we did not observe a significant 
difference between mono- and co-culture even in presence of AMD3100 within the 
EGM-2 condition (Appendix Figure C.3). This suggests that there may be other cytokines 
other within EGM-2 apart from CXCL12 that may influence GSC invasion.  In that 
regard, when utilizing NSC medium condition, our findings demonstrated that CXCL12-
CXCR4 is involved in EC-mediated invasion of GSC within the 3D tumor model. 
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Figure 4.28 CXCL12-CXCR4 signaling in GSC-EC interaction.  
(A) Immunofluorescence imaging of pCXCR4 in presence of microvascular network. 
White arrow denotes absence and presence of nuclear localization in mono- and co-
culture respectively; Scale bar: 20 µm. (B) Phase-contrast image of GSC (red) invading 
in presence of HUVECs in different concentrations of AMD3100. Red dashed line 
delineates average migration boundary; Scale bar: 100 µm. (C) Quantification of invasion 
distance for each condition (* denotes a significantly different group for p < 0.05; # 
denotes a significant difference between 1 µM and 100 µM for p < 0.05; 2-way ANOVA 
with Sidak post-test; n > 3 for each data set).  
4.5 Discussion 
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In GBM, a sub-population of cells with stem-like properties, GSCs, have been 
shown to be one of the major drivers for tumor recurrence, invasion of normal brain 
parenchyma and resistance to therapies (Lathia et al., 2011; Sundar et al., 2014). Recent 
investigation on the tumorigenic influence of the microenvironment has added further 
layers of complexity to understanding GSC biology and behavior (Hambardzumyan & 
Bergers, 2015). These specialized niche microenvironments provide safe harbor to GSCs 
making these cells difficult to therapeutically target. Importantly, the niches provide 
extrinsic cues that promote GSC growth and invasion and preserve the stem cell 
phenotype. In an elegant study by Calabrese et al., GSC-EC interactions in vivo within 
the vascular niche was implicated as a key driver of tumor growth (Calabrese et al., 2007; 
Sharma & Shiras, 2016). Several signaling pathways with important roles in normal 
neural stem cell maintenance and growth, such as Notch, TGFβ, hypoxia-inducible 
factors (HIFs), and SHH have also been shown in GSC-EC interactions (Bruna et al., 
2007; Sharma & Shiras, 2016; Yan et al., 2014; Zhu et al., 2011). These studies highlight 
the complex intercellular interactions that occur within the components of the vascular 
niche and GSCs that regulate whether GSCs remain quiescent, proliferate, 
transdifferentiate into pericytes or endothelial cells, or invade along existing blood 
vasculature (Lathia et al., 2015). Hence, further investigations are required into the GSC-
niche interactions to unveil novel targets that could be used to disrupt the regulatory 
pathways that promote tumorigenesis.  
Despite the significance of GSC-EC interactions within the niches, there are few 
in vitro models that could provide a 3D suitable biomimetic microenvironment for 
studying the influence of vascular niche components on GSC invasion. In vivo models are 
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often too complex presenting challenges in determining the cause and effect relationships 
between the microenvironmental cues and tumor cell behavior (Britta Weigelt et al., 
2014). In addition, reduced spatial-temporal resolution of real-time events such as 
invasion speed within in vivo models pose additional difficulties, resulting in end-point 
analyses (Britta Weigelt et al., 2014). More complex in vitro systems consisting of higher 
dimensionality (i.e. 3D), microfluidics, and cell-laden hydrogels, have been developed to 
bridge this gap to better recapitulate the GBM microenvironment while providing better 
control over the microenvironmental cues (Britta Weigelt et al., 2014).  For instance, 
Infanger et al. developed a 3D in vitro model of the perivascular niche by utilizing 3D 
scaffolds and EC-conditioned medium. EC-conditioned medium was collected from a 3D 
scaffold and then was subsequently added to GSC cultures. They found that the EC-
conditioned medium maintained SOX2 and Nestin expression in GSCs. However, 
simultaneous co-culture of GSCs and ECs required random mixing of the two cell-types 
within the 3D scaffold which limited an organotypic architecture and quantitative 
assessment of migration. Therefore, they utilized a transwell assay instead to study 
migration in response to EC-conditioned medium (Infanger et al., 2013).  On the other 
hand, to overcome the limitations of transwell assay, Chonan et al. created a 3D 
microfluidic device to study glioma invasion influenced by ECs. The two cell types were 
seeded as monolayers in two adjacent channels separated by a 3D collagen layer in 
between. They observed that glioma cells demonstrated increased invasion capacity near 
the monolayer of ECs. In this model, ECs were seeded as a monolayer, which did not 
represent a native-like 3D vasculature of the brain microenvironment (Chonan et al., 
2017). In that regard, the relevance of our work lies in providing a 3D physiological 
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relevant in vitro model of GSC-EC interaction by spatially organizing GSCs near a 3D 
microvascular network with the possibility of adding additional cell types, such as 
astrocytes or pericytes. This enables us to engineer an organotypic architecture and to 
investigate the dynamic influence of the microvascular network on GSC invasion and 
phenotype. Importantly, we paired our in vitro study on GSC invasion with an in vivo 
PDX model to benchmark the physiological relevance of our microfluidic system. 
Therefore, aside from fundamental biological studies, the results of this study will also 
have implications for drug screening of therapeutics targeting GSC-EC interactions 
within niche microenvironments. 
The microfluidic model, presented herein is based on a well-established 3D 
microvascular network that further enables detailed study of GSC invasion into a stroma-
like region. This model also overcomes the limitation of prior work by introducing 
patient-derived GSCs after formation of the microvascular network instead of introducing 
both cell-types at the same time (Nagaraju et al., 2018). HUVECs require serum to 
develop into a 3D microvascular network which has been well-established by many 
groups (Jeon et al., 2015; S. Kim et al., 2013). GSCs are cultured in serum-free 
conditions as addition of serum induces differentiation. To avoid prolonged exposure to 
serum, we leveraged the design of our microfluidic platform to first establish a 
microvascular network using EGM-2 as the culture medium. Then we introduced GSCs 
into the microfluidic platform while exchanging EGM-2 for another medium, such as 
NSC, for the co-culture experiments. 
We studied the influence of different medium compositions (i.e. NSC, NSC+, and 
EGM-2) on GSC phenotype within the co-culture assay. Expression levels of SOX2, 
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Nestin, and CD44 were positive in GSCs across all medium conditions. In addition to 
these markers, we investigated expression of GFAP, which is an astrocytic maturation 
marker used to identify differentiated GSCs. As others have shown, GFAP expression is 
inversely correlated to SOX2 (Y. Kim et al., 2012). Consequentially, since the GSCs 
within our microfluidic device were positive for SOX2, we found negative staining for 
GFAP. Heffernan et al. utilized the same cell line, GB3, grown in serum-supplemented 
medium for 14 days which eventually resulted in expression of GFAP (Heffernan et al., 
2017). As the microfluidic assay was run for 3 days, it is possible that a longer time-
period in either the EGM-2 or NSC + media (both containing serum) may result in 
positive expression of GFAP. Overall, the expression of these markers, (i.e. SOX2, 
Nestin, and CD44), suggested that the microfluidic model could recapitulate the classical 
hallmarks of GBM (Wakimoto et al., 2012). 
Utilizing our 3D organotypic microfluidic model, we tested the influence of the 
microvascular network on patient-derived GSC invasive behavior under different 
medium conditions. We observed that microvascular network promoted protrusive 
morphology in all medium conditions suggesting transition to an invasive phenotype. 
Osswald et al. described these long protrusions as infiltrating into normal brain tissue 
during invasion (Osswald et al., 2015). Interestingly, we also observed chain migration of 
GSCs into the stroma, which is often associated with neural stem cells migrating from the 
subventricular zone (Lois, Garcia-Verdugo, & Alvarez-Buylla, 1996). This type of 
migration pattern has been described previously for glioma but only in certain settings 
(Deisboeck et al., 2001; Sander & Deisboeck, 2002). For instance, U87 and U251N 
glioma cells were observed in a 2D in vitro ring migration assay, but instead of migrating 
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as chains, the cells moved individually (Chen & Nalbantoglu, 2014). However, in 
separate study by Gritsenko et al., when the same cells were cultured as multicellular 
spheroids on a basement membrane-like ECM, the cells exhibited the same chain-like 
migration, as we observed, suggesting the influence of ECM proteins on their migratory 
behavior (Gritsenko et al., 2017). Similarly, Grundy et al. cultured patient-derived GBM 
lines on 2D substrates demonstrating individual cell migration when the cells were 
cultured in 3D Matrigel® (Grundy et al., 2016).  They observed chain migration 
consistent to our study. These evidences suggested that the chain-like migratory 
phenotype is dependent on the ECM as well as the 3D microenvironment, which we 
created in our microfluidic model. Importantly, we observed similar chain-like migration 
within the in vivo PDX model in brain tissue sections, which was also comparable to 
other studies in literature (Gritsenko et al., 2017). Taken together, this provides further 
evidence that our microfluidic platform is a suitable model to study the migratory 
behavior of GSCs in a 3D microenvironment.  
As we observed in our PDX model, the GSCs migrated near or along vasculature 
of the mouse brain. To investigate whether 3D vasculature influenced GSC invasion 
distance, we performed co-culture invasion experiments within our in vitro microfluidic 
model. Interestingly, NSC medium did not promote invasion in mono-culture. However, 
in the presence of the microvascular network, we observed significant invasion of GSCs 
using the NSC medium as opposed to EGM-2 that showed no difference between mono- 
and co-culture. Firstly, this suggests that EGM-2, which contains both serum and 
additional growth factors, influenced GSC invasion regardless of the presence of the 
microvascular network. This essentially masks the influence of the microvascular 
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network and confounds the experimental interpretation. On the other hand, using the NSC 
medium, we could identify that the microvascular network promoted invasion of GSC 
thereby allowing us to further investigate the signaling between ECs and GSCs. As such, 
our findings report the influence of medium composition on GSC-EC interaction.   
In our experiments, we did not find a significant change in proliferation rate of 
GSCs in presence of vasculature. A similar study was performed by co-culture of 
neurospheres with human brain microvascular ECs (hBMECs), showing that there was no 
difference in proliferation measured through both PCNA and Ki-67 between the mono- 
and co-culture conditions. Expression of CD133, a marker for self-renewal, was 
increased in the presence of hBMECs, which suggested that there was only an increase in 
self-renewal capacity of the cells but not proliferation (Zhu et al., 2011). Similarly, 
Galan-Moya et al. compared the amount of proliferative and quiescent cells in control 
medium and EC-conditioned medium on GSCs and found no difference in the ratio of 
proliferative to quiescent cells (Galan-Moya et al., 2011). However, like the study by Zhu 
et al., they also found that the EC-conditioned medium maintained self-renewal of the 
GSCs confirmed by expression of Nestin and SOX2. Consistently, we also observed 
expression of Nestin and SOX2 when GSCs were in presence of the 3D microvascular 
network. Additionally, we demonstrated increased density of migrating GSCs. However, 
since we did not observe a statistical increase in proliferation, we propose that this 
increase is due to enhanced migration speed of GSC. 
The CXCL12-CXCR4 signaling axis has also been shown to be important in 
GBM invasion and tumorigenesis (Bian et al., 2007; Ehtesham et al., 2009; Jiang, Zhou, 
Guan, Wang, & Liang, 2013). Since CXCL12 has been also positively detected in ECs 
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within GBM tumor tissue, it is suggested that GSC-EC interaction through CXCL12-
CXCR4 may play a role in GBM invasion (Rao et al., 2012; Salmaggi et al., 2004). To 
that end, we probed for pCXCR4, the phosphorylated form of CXCR4, as a measure of 
CXCR4 activation. We observed punctate staining for pCXCR4 in GSCs co-cultured 
with HUVECs but a diffuse staining in GSCs cultured alone, indicating more activated 
CXCR4 activation in co-culture. Moreover, we noted nuclear localization of pCXCR4 as 
additional evidence for activated CXCL12-CXCR4 signaling in the co-culture condition 
(Patsialou et al., 2009). Treatment with AMD3100, a CXCR4 antagonist, we observed a 
decreasing trend in GSC invasion in co-culture as a function of drug concentration. In 
fact, this was not observed in mono-culture of GSCs. This distinction highlights the 
importance of multi-culture 3D microenvironment in drug responsiveness of the GSCs. 
However, the cells did not respond to AMD3100 treatment in EGM-2 condition. As such, 
we hypothesized that EGM-2 promoted GSC invasion in a CXCL12-CXCR4 independent 
manner due to the growth factors and cytokines, including insulin-like growth factor, in 
EGM2 which has been previously shown to be a strong mediator of GBM invasion in 
vitro (Brockmann et al., 2003; Schlenska-Lange, Knupfer, Lange, Kiess, & Knupfer, 
2008). This behavior further highlights the critical role of medium composition in 
establishing a reliable model for molecular and cellular level analysis of GSC invasion.  
As we experimentally confirmed, CXCL12-CXCR4 signaling was crucial to GSC 
invasion in a vascular microenvironment. GSC survival and growth have been also 
shown to be dependent on the specialized niche microenvironments, such as hypoxic and 
perivascular (Hambardzumyan & Bergers, 2015). These niche microenvironments can 
further protect GSCs from chemo- and radiotherapy. Therefore, GSC-EC interactions 
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may also regulate resistance to radiotherapy. For instance, Brown et al. demonstrated that 
co-culture of HUVECs and U87 glioblastoma increased expression of ataxia 
telangiectasia mutated (ATM), a DNA damage response protein, which led to resistance 
to radiation-mediated apoptosis (Brown et al., 2004). Therefore, based on our study and 
the findings of others, combination of AMD3100 ad chemo- or radiotherapy could be a 
potential basis for GBM treatment as it has been tested in U251 GBM immortalized cell 
line in nude mice (Kioi et al., 2010). However, further investigation is required to assess 
how patient-derived GSC growth and invasion is affected as compared to high passage, 
immortalized cell lines that are used in most of the previous studies (S. Bao et al., 2006; 
Evers et al., 2010; Omuro & DeAngelis, 2013). Recently, Heffernan et al. studied the 
effects of radiotherapy on patient-derived GSCs, GB3 and GB7. The GSCs exhibited a 
dose response when grown as neurospheres, but demonstrated radioresistance when 
encapsulated in a 3D hydrogel (Heffernan et al., 2017). Therefore, the proposed 3D co-
culture model presented herein could be used to study the effect of the vascular niche on 
radioresistance as part of future work. 
Investigating tumor-associated angiogenesis due to GSCs was one of the future 
goals of our study using the microfluidic assay. Based on the current experimental 
settings, we did not observe statistically significant differences in vascular morphology 
based on different media compositions. Furthermore, we did not observe extensive 
angiogenesis over the three-day time-period of our assay. We contend that it may take 
longer to observe extensive angiogenesis (i.e. > 7 days) as demonstrated by other works 
(H. Lee, Park, et al., 2014) or that addition of brain ECs (instead of HUVECs) or other 
stromal cells, such as pericytes may influence vascular sprouting (J. Kim et al., 2015). In 
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this regard, addition of these new elements is the subject of our future work based on the 
developed assays.  
Targeting the tumor angiogenesis in GBM is another option that is being explored 
clinically (Gerstner & Batchelor, 2012; K. Lee et al., 2009). However, many studies have 
reported that tumors treated with only Bevacizumab (Avastin®), a VEGF inhibitor, all 
eventually relapse (Wick et al., 2017). One caveat of disrupting angiogenesis is driving 
the tumors toward a hypoxic niche which could in turn promote invasiveness by co-
opting native brain blood vessels (Hambardzumyan & Bergers, 2015; Rubenstein et al., 
2000). In that regard, our microfluidic model of GSC-EC interaction could provide a 
quick and economical method as a drug screening assay to study the consequences of 
disrupting the vasculature on GSC invasive behavior.  
Furthermore, future work will focus on improving our 3D organotypic in vitro 
microfluidic model by incorporating additional elements of the vascular niche. In this 
study, we utilized Matrigel® as the ECM component of model due to it containing 60% 
laminin, 30% collagen IV, and 8% enactin in addition to growth factors found in tumor 
vascular microenvironment (Rape et al., 2014; Xiao et al., 2017). However, in our future 
studies, we aim to utilize and characterize other types of hydrogels, such as hyaluronic 
acid (HA), which is a main ECM component of the brain. Our current work was also the 
first step to establish and validate a successful model of GSC-vascular interactions for 
biological studies. However, we acknowledge that stromal cells play critical roles in the 
microenvironment (Shwetal Mehta, 2018). For instance, pericytes are known to interact 
and mature the vasculature while astrocytes maintain hemostasis of the 
microenvironment, however, the roles of both cells along with neurons and 
  147 
oligodendrocytes in GSC invasion behavior are still active areas of research (Audia, 
Conroy, Glass, & Bhat, 2017). Therefore, our future work, will involve fine-tuning and 
adding higher levels of complexities to our tumor microenvironment model by addition 
of stromal cells, including pericytes, smooth muscle cells, and additional glial cells. 
4.6 Conclusions 
 We developed a 3D organotypic in vitro microfluidic model incorporated with a 
microvascular network to study the influence on patient-derived GSC and EC interaction 
on invasion and tumor behavior. Additionally, we have improved upon current in vitro 
platforms by first establishing a microvascular network prior to introducing the patient-
derived GSCs. This avoids the confounding influence of vasculogenesis on the invading 
cancer cells allowing us to focus more on cell-cell interaction and role of the established 
vasculature on the migrating GSCs.  Notably, we compared our microfluidic system to a 
PDX model using the same cells, finding similar invasive behaviors between the two 
models. In our experiments, we found evidence that the established microvascular 
network enhanced GSC invasion and promoted invasive morphology as well as 
maintained cell proliferation rates and classical GSC phenotype. Furthermore, we 
confirmed that CXCL12-CXCR4 signaling is involved in promoting GSC invasion within 
a vascular microenvironment while also demonstrating the effectiveness of this 
microfluidic model as a drug screening platform. Importantly, most of our experiments 
focused on utilizing NSC medium which did not contain serum and thereby allowed us 
study GSC-EC interactions in an unbiased experimental condition. As such, future 
studies using our model could incorporate collection of conditioned media from these 
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experiments to probe for additional possible paracrine signaling cues mediating GSC 
invasion. Indeed, this would have proven difficult if serum were included in the medium, 
such as in EGM-2, and within in vivo models which could contain confounding factors 
from other cells and microenvironmental cues. Further work will also involve fine-tuning 
the microenvironment, such as by incorporation of brain-mimetic hydrogels, patient-
derived brain microvascular ECs, pericytes, smooth muscle cells, and additional glial 
cells. Taken together, this model presents a potential platform for studying the interplay 
of GSCs with its surrounding microenvironment as well as development of future 
therapeutic strategies tailored toward disrupting key molecular pathways involved in 
GSC regulatory mechanisms.  
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 This final chapter discusses the achievements that we have made with each of the 
specific aims while providing insights and opportunities for future directions.  
5 Chapter 
5.1 Significance and Contributions 
5.1.1 Specific Aim 1 
In this chapter, we described the development of a microfluidic system that was 
used as a model for 3D chemotactic tumor-stroma invasion. We designed the 
microfluidic platform to enable side-by-side positioning of 3D hydrogel-based matrices to create a dual matrix 
architecture extending in a continuous manner. Firstly, this enabled us to establish distinct regions of tumor and stroma 
cell/ECM compositions similar to the in vivo tumor microenvironment. Next, it allowed cellular invasion from one 
3D matrix to another with a clear demarcated tumor invasion front, that enables quantitative analysis of the 
progression of cancer cells migrating into the biomimetic stroma at a tissue or single-cell level. In this chapter, 
we asked how a transient gradient of EGF through the stroma region of our device 
affected the cancers cells within the tumor region. We demonstrated through 3D tracking 
of cells at the single-cell level showed increased cellular migration speed and persistence. 
Subsequently, we observed an increase in EGF receptors, cell aspect ratio, and protrusive 
activity under EGF treatment. Overall, these findings demonstrated the unique ability of 
our model to quantitatively analyze 3D chemotactic invasion, both globally by tracking 
the progression of the invasion front, and at the single-cell level by examining changes in 
cellular behavior and morphology using high-resolution imaging.  
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In this chapter, for the first time, the influence of EGF was studied in a model 
containing two separated matrices on cancer migration speed and proliferation. Further, 
we utilized SUM-159 cells, a triple-negative breast cancer cell line, as our model which 
has not been tested for their invasive response to EGF. Our work demonstrated they 
indeed responded to EGF by increasing cell motility speed in a 3D ECM. In addition, we 
demonstrated that our microfluidic model was compatible with both phase-contrast and 
fluorescent time-lapse imaging which is crucial for feasible analysis for cell motility. 
Taken together, this chapter showed that we developed a novel platform capable of 
recapitulating 3D tumor-stroma interactions for studies of real-time cell invasion and 
morphological changes within a single platform.  
5.1.2 Specific Aim 2 
This chapter described the use of the microfluidic platform developed in Specific 
Aim 1 as a 3D in vitro organotypic model of tumor-stroma interaction with patient-
derived fibroblasts incorporated within the stroma region. As tumor-stroma interactions 
significantly influence cancer cell metastasis and disease progression, we hypothesized 
that adding CAFs to our model would enhance the invasion of cancer cells. From there, 
we intended to interrogate the molecular influence of tumor-stroma interactions on cancer 
invasion. Using this approach, we combined functional assessment of cancer invasion, 
like migration and proliferation, with transcriptome profiling. Our model demonstrated 
that CAFs were able to promote cancer invasion corroborating results from clinical 
findings and other works. Once we established our invasion model, we utilized 
transcriptome profiling to interrogate possible molecular pathways derived from CAF 
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signaling that could influence cancer invasion. Through this work, we uncovered a novel 
gene of interest, GPNMB, and utilized function knockdown through short hairpin RNA to 
unveil that CAFs enhanced breast cancer invasion. We asked if the enhanced invasion 
due to increased proliferation or cell motility and through a series of experiments, we 
determined that GPNMB modulated migration speed and not proliferation.  
In this chapter, for the first time, a microfluidic model was utilized as a 
biomimetic model tumor-stroma interactions using patient-derived fibroblasts as opposed 
to cell lines. In addition, transcriptome profiling was utilized to uncover a possible 
mediator of cancer invasion, GPNMB, which was corroborated with clinical findings and 
other literature. For the first time, CAFs were linked to expression of GPNMB in breast 
cancer cells. Additionally, GPNMB was studied in a 3D microfluidic model and we 
determined that GPNMB influenced cell migration speed and not proliferation. Overall, 
these results demonstrated the ability of our microfluidic model to recapitulate patient 
specific tumor microenvironment to investigate cellular and molecular consequences of 
tumor-stroma interactions. 
5.1.3 Specific Aim 3 
In chapter 4, we developed a new organotypic model based on our microfluidic 
technology to study glioblastoma (GBM). GBM is one of the deadliest forms of cancer. 
While there are many treatment options, prognosis of GBM still remains dismal as the 5-
year survival rate is approximately 4.7%. Furthermore, tumors can recur after treatment. 
Tumor recurrence is hypothesized to be driven by glioma stem cells (GSC), a sub-
population within GBM, which are highly tumorigenic, invasive, and resistant to several 
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forms of therapy. GSCs are concentrated around the tumor vasculature, referred to as the 
vascular niche, which provides microenvironmental cues mediating GSC stemness, 
invasive behavior, and resistance to therapies. As such, the fabricated 3D organotypic 
microfluidic platform was used in this chapter to mimic the GSC vascular niche and 
study the influence of endothelial cells (ECs) on patient-derived GSC behavior while 
identifying signaling cues that may mediate GSC invasion and phenotype. We established 
a 3D microvascular network within this model which led to enhanced GSC migration, 
promoting invasive morphology as well as maintaining GSC proliferation rates and stem 
phenotype. Notably in this chapter, we compared the migration behavior of GSCs in our 
microfluidic model to in vivo mice model and found evidence suggesting that our 
microfluidic system could represent a physiologically relevant in vivo microenvironment. 
In this chapter, we also confirmed that CXCL12-CXCR4 signaling was involved in 
promoting GSC invasion within a 3D vascular microenvironment.  
In this chapter, for the first time a model of patient-derived GSCs within a 
vascular niche was developed using microfluidics. We took advantage of the different 
culture regions within this model to spatially arrange GSCs near a microvascular 
environment to resemble the in vivo situation. Further, we provided validation of this 
model by comparison with a PDX model of the same patient-derived GSCs, which has 
seldom been performed in previous works. We also corroborated literature data 
suggesting that CXCL12 signaling was mediating GSC invasion within a vascular niche, 
demonstrating that our model could represent relevant GSC behavior. Overall, our model 
presents a potential ex vivo platform for studying the interplay of GSCs with its 
surrounding microenvironment as well as development of future therapeutic strategies 
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tailored toward disrupting key molecular pathways involved in GSC regulatory 
mechanisms. 
5.1.4 Contributions 
Below we list the outcomes and contributions of our works in peer-reviewed 
journal articles and conference posters and presentations as well as patents. 
Journal Articles: 
1. Truong, D., Kratz, A., Park, J.G., Nguyen, T., Barrientos, E.S., Saini, H., 
Pockaj, B.A., Mouneimne, G., LaBaer, J., Nikkhah, M., (2018). “Human 
Organotypic Microfluidic Model to Investigate the Interplay Between 
Patient-derived Fibroblasts and Breast Cancer Cells”, Minor Revisions.  
2. Truong, D., Fiorelli, R., Barrientos, E. S., Luna Melendez, E., Sanai, N., 
Mehta, S., & Nikkhah, M. (2018) A Three-Dimensional (3D) Organotypic 
Microfluidic Model for Glioma Stem Cell – Vascular Interactions. 
Biomaterials. In press. 
3. Nagaraju, S.*, Truong, D.*, Mouneimne, G., & Nikkhah, M. (2018). 
Microfluidic Tumor–Vascular Model to Study Breast Cancer Cell 
Invasion and Intravasation. Advanced healthcare materials. * indicates 
equal contribution. 
4. Peela, N., Barrientos, E. S., Truong, D., Mouneimne, G., & Nikkhah, M. 
(2017). Effect of suberoylanilide hydroxamic acid (SAHA) on breast 
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cancer cells within a tumor-stroma microfluidic model.  Integrative 
Biology, 9(12), 988-999. 
5. Peela, N.*, Truong, D.*, Saini, H.*, Chu, H, Mashaghi, S., Ham, SL., 
Singh, S., Tavana, H., Mosadegh, B & Nikkhah, M. (2017). Innovations in 
Advanced Biomaterials and Microengineering Technologies Towards 
Recapitulating the Stepwise Process of the Metastatic Cascade. 
Biomaterials, 133, 176-207. 17% acceptance rate. * indicates equal 
contribution. 
6. Truong, D., Puleo, J., Llave, A., Mouneimne, G., Kamm, R. D., & 
Nikkhah, M. (2016). Breast Cancer Cell Invasion into a Three 
Dimensional Tumor-Stroma Microenvironment. Scientific Reports, 6. 
Conference Presentations: 
1. Truong, D., Kratz, A., Park, JG., Barrientos, E., Nguyen, T., Saini, H., 
Pockaj, B., Mouneimne, G., & Nikkhah, M., “Gene-expression Profiling 
of Patient-Derived Fibroblast and Breast Cancer Interactions in a Three-
Dimensional (3D) Organotypic Microfluidic Platform” Annual 
Biomedical Engineering Society (BMES) Meeting, Atlanta, GA October 
15-20, 2018 
 
2. Truong, D., Saini, H., Kratz, A., Barrientos, E., Nguyen, T., Pockaj, B., & 
Nikkhah, M., “The Influence Of Patient-Derived Fibroblasts On Breast 
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Cancer Invasion Profile Within A Microfluidic Platform” Annual 
Biomedical Engineering Society (BMES) Meeting, Phoenix, AZ October 
11-14, 2017 
3. Nagaraju, S., Truong, D., & Nikkhah, M., “Tri-layer Microfluidic 
Platform for Studying Tumor Angiogenesis and Cancer Cell 
Intravasation” Annual Biomedical Engineering Society (BMES) Meeting, 
Phoenix, AZ October 11-14, 2017 
4. Truong, D., Nagaraju, S., & Nikkhah, M., “Microfluidic device to study 
Tumor-Stromal Interactions”, Invited Presentation at University of 
Arizona Cancer Center, Tucson, AZ May 11, 2017 
5. Truong, D., Barrientos, ES., Puleo, J., Mouneimne, G., & Nikkhah, M., 
“Microengineered Tumor-Stroma Platform Investigating the Biochemical 
Influence of Stromal Fibroblasts on Breast Cancer Invasion” Annual 
Biomedical Engineering Society (BMES) Meeting, Minneapolis, MN 
October 5-8, 2016 
6. Truong, D., Puleo, J., Llave, A., Mouneimne, G., Kamm, R. D., & 
Nikkhah, M., “Three-dimensional (3D) Invasion of Breast Cancer Cells in 
a Well-Defined Tumor-Stroma Platform,” NanoEngineering for Medicine 
and Biology Conference (ASME NEMB), Houston, TX, February 20-24, 
2015 
Conference Posters: 
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1. Truong, D., Fiorelli, R., Barrientos, E. S., Luna Melendez, E., Sanai, N., 
Mehta, S., & Nikkhah, M. “Interrogating Glioma Stem Cell – Vascular 
Interactions Using a Three-Dimensional (3D) Organotypic Microfluidic 
Model” Annual Biomedical Engineering Society (BMES) Meeting, 
Atlanta, GA October 15-20, 2018 
2. Truong, D., Saini, H., Kratz, A., Barrientos, ES., Nguyen, T., Pockaj, 
BA., & Nikkhah, M., "Microengineered Tumor-Stroma Platform 
Investigating the Effect of Patient-Derived Stromal Fibroblasts on Breast 
Cancer Cells”, 2017 ARCS Foundation Phoenix Scholar Awards Dinner, 
Phoenix, AZ, April 21, 2017 
3. Truong, D., Saini, H., Kratz, A., Barrientos, ES., Nguyen, T., Pockaj, 
BA., & Nikkhah, M., "Microengineered Tumor-Stroma Platform 
Investigating the Effect of Patient-Derived Stromal Fibroblasts on Breast 
Cancer Cells”, ASU Molecular, Cellular and Tissue Bioengineering 
(MCTB) Symposium, Tempe, AZ, April 1, 2017 
4. Nagaraju, S., Truong, D., & Nikkhah, M., “Three-Dimensional 
Microfluidic Platform to Study the Role of Stromal Cells in Tumor 
Angiogenesis,” Annual Biomedical Engineering Society (BMES) 
Meeting, Minneapolis, MN, October 5-8, 2016 
5. Peela, N., Truong, D., Barrientos, ES., Mouneimne, G., & Nikkhah, M., 
“Evaluation of Anti-Cancer Drug Suberoylanilide Hydroxamic Acid 
(SAHA) on Cancer Cell Phenotype In A Three-Dimensional (3D) Breast 
  157 
Tumor-Stroma Platform,” MicroTAS 2016, Dublin, Ireland, October 9-13, 
2016. 
6. Truong, D., Puleo, J., Llave, A., Mouneimne, G., Kamm, R. D., & 
Nikkhah, M., “Microengineered Breast Cancer Invasion Platform,” 
Annual Biomedical Engineering Society Meeting, Tampa, FL, October 7-
10, 2015 
7. Truong, D., Puleo, J., Llave, A., Mouneimne, G., Kamm, R. D., & 
Nikkhah, M., “Microengineered Breast Cancer Invasion Platform,” 
AZBIO Awards 2015, Phoenix, AZ, October 1, 2015 
Patents: 
1. Nikkhah, M. & Truong, D. (2018). U.S. Patent App. 2018/052151. 
Washington, DC: U.S. Patent and Trademark Office. 
2. Nikkhah, M., Kamm, R. D., & Truong, D. (2016). U.S. Patent No. 
10,017,724. Washington, DC: U.S. Patent and Trademark Office. 
	
5.2 Project Challenges 
During this dissertation, there were several challenges that we overcame or 
addressed to the best of our ability. For instance, quantification of protein or gene 
expression is an integral part of studying cancer biology. Although the microscale nature 
of microfluidics enables low input of cells, this creates a disadvantage for using 
conventional techniques such as western and Northern blots. This led us to explore 
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different options of exploring molecular changes within cells. For example, in Chapter 2, 
we quantified activated EGFRs as a ratio between the phosphorylated form vs the non-
phosphorylated form. Receptors were identified using immunofluorecent staining and 
quantifications were based on their count. In chapter 3, to measure relative protein 
expression, we followed an established technique to quantify fluorescent intensity. As the 
differences in the intensity was large between the positive and negative expressing cells, 
we felt comfortable that this method was justifiable (Acerbi et al., 2015). If the 
differences in expression were much smaller, we would explore options for more precise 
measurements such as utilizing a fluorescent standard. Another possible technique that is 
currently being explored in our lab is In-Cell Western™ assay (ICW). ICW utilizes a 
laser scanner equipped with filters to measure protein expression using the near and far-
infrared secondary antibodies (Paguirigan, Puccinelli, Su, & Beebe, 2010). ICW offers 
significant benefits over conventional immunofluorescent microscopy. For instance, 
immunofluorescent microscopy requires separate images for each sample which could 
influence the number of settings that must be held identical between conditions. In 
comparison, several microfluidic devices could be imaged in one scan, which maintains 
the same exposure setting for all samples for better consistency during the analysis.  
 Another challenge we faced in this work are patient variation and molecular 
subtyping of the patient-derived fibroblasts. Although we observed cancer cell migration 
differences due to the different patient-derived fibroblasts, not all the differences between 
cancer cell migration could be explained using α-SMA and vimentin. For instance, 
Chapter 3 of this dissertation showed that CAF1 and CAF3 promoted more migration 
than CAF2 but the expression of α-SMA was similar between these three CAF 
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populations. Fibroblast activation protein (FAP) is another useful protein that is used to 
identify CAFs within the tumor microenvironment (Kalluri, 2016). In addition, 
fibroblast-specific protein-1 (FSP-1) is another widely used marker of CAFs (Kalluri, 
2016). Prior studies have shown that α-SMA expression correlated well with advanced 
tumors and both α-SMA and FSP-1 correlated with shorter overall survival rates (Ha, 
Yeo, Xuan, & Kim, 2014). On the other hand, FAP did not correlate clinicopathologic 
parameters. Therefore, in addition to characterization of the patient-derived fibroblasts 
used in this study, other markers such as FAP and FSP-1 could be used to explain the 
differences between the CAF populations. Furthermore, if available, RNA-sequencing 
could be used to provide transcriptome profiling which would provide a broad 
characterization of the CAFs.  
5.3 Future Directions 
5.3.1 Microengineering the tumor microenvironment 
Microengineered models have provided significant advantages over conventional 
3D and in vivo models as they enable better control over the biochemical and biophysical 
properties that influence cancer invasion. The microfluidic model developed in Chapter 2 
demonstrated a biomimetic tumor microenvironment with ability to control cell/ECM 
composition and observe dynamic cancer cell migration in 3D. However, there is still room 
for development to better interrogate the influences of the tumor microenvironment on 
cancer invasion. For instance, there are very few models that are being used to study the 
combinatory effect of several stromal components (e.g. immune cells and CAFs) on cancer 
cell invasion (I. K. Zervantonakis et al., 2012). There is much information on how 
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individual stromal cells, such as CAFs, endothelial cells, macrophages, influence cancer 
invasion but the integrated influence of several stromal cells is still unknown. However, 
microengineered technologies offer the ability to better recapitulate the in vivo tumor 
microenvironment by embedding one or more cell type within 3D ECM with spatial 
arrangement similar to the in vivo situation. As such, there is a need for more complex 
models of cancer that can approach a feasible representation of the in vivo tumor 
microenvironment for better prediction of cancer behavior (Britta Weigelt et al., 2014). 
In addition to understanding the influences of stromal cells, cell-ECM interactions 
are another aspect of cancer progression that has not been well studied within 
microengineered models (Y. L. Huang, Segall, & Wu, 2017). ECM remodeling is 
important during development while also being indispensable for cancer progression (Lu, 
Weaver, & Werb, 2012). In normal physiology, the ECM is integral in modulating cell 
behavior by biophysical and biochemical methods. Mechanically, the ECM acts as a 
scaffold for supporting tissue architecture, a barrier for compartmentalizing cells and 
soluble factors, and anchorage sites/migration tracks for cell movement (Egeblad, Rasch, 
& Weaver, 2010). Chemically, the ECM can sequester a myriad of growth factors and 
cytokines that direct cell behavior through ligand-receptor interactions. Furthermore, 
changes to the ECM properties are intertwined and affect multiple characteristics of the 
ECM, such as stiffness, fiber density/architecture, and cell adhesive moieties (Kraning-
Rush et al., 2013). Alterations of the ECM are dynamic and are also influenced by cell 
behavior. In that regard, alterations of the ECM due to cell-ECM interactions are 
reciprocal, thus linking the behavior of cells and ECM dynamics (Lu et al., 2012).  
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It has been well-documented in clinical studies that abnormal ECM dynamics is a 
classical hallmark of cancer. For instance, stiffening of the ECM in breast cancer is now a 
prognostic and risk factor for patients (Casey et al., 2009; Paszek et al., 2005). ECM 
remodeling enzymes, like MMPs, are other factors that are deregulated during cancer 
progression leading to changes in ECM architecture, topography, and composition (Acerbi 
et al., 2015). These alterations change the expression of ECM components to cells 
facilitating tumor growth and progression. However, the complex nature of the tumor 
microenvironment hinders the ability to decouple the components that contribute to cancer 
progression. As such, microfluidics have emerged as a tool with significant advantages in 
building a biomimetic tumor microenvironment using a bottom-up approach (Sung & 
Beebe, 2014). Tissue engineering approaches could design biomaterials based on ECM 
components while microfluidics enable well-defined spatial and temporal modeling of 
cells, ECM, and biochemical cues to build better predictive models of cancer drug 
screening (N. Peela, Truong, et al., 2017).  
5.3.2 Characterization of the secretome in microfluidic models of the tumor 
microenvironment 
Cell signaling is a crucial aspect of biology providing a method for cells to share 
information and coordinate cell activities. Secretion of soluble factors is a key part of 
cellular communication and that disruption or deregulation of this could lead to diseases 
like cancer. Traditional biological experiments have utilized conditioned media as a way 
to simulate cell-cell signaling in vivo but with the advent of microengineered models, like 
microfluidics, a biomimetic tumor microenvrionemnt could be created to study cell-cell 
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signaling. However, much of the focus on microfluidic-based tumor models has been on 
imaging-based assays for cell migration, proliferation, apoptosis, or morphology studies. 
On the other hand, studies involving soluble factors often only involve a single growth 
factor or indirect methods using gene expression or perturbing with inhibitors and 
observing the resulting phenotypic changes. While these methods have provided 
interesting and significant results, direct characterization or study of multiple signaling 
factors and biochemical pathways are not as sufficient. As such, characterization of the 
secreted factors during cell-cell signaling of microfluidic-based tumor models still need 
further research.  
In recent years, progress has been made with coupling microfluidics with mass 
spectrometry (MS) (Feng, Liu, Li, & Liu, 2015). MS is a method which ionizes sample 
molecules to identify proteins based on mass to charge ratios. This technique has had 
widespread use in drug discovery and diagnostics. While a majority of microfluidic chips 
that have been coupled with MS (Chip-MS) had a focus on diagnostics and biomarkers 
using liquid samples, some have been developed with cell culture in mind to probe a 
biomimetic tumor microenvironment (Feng et al., 2015). For instance, Chin et al. study 
cell metabolism by culturing within a microfluidic that had been integrated with 
chambers for solid phase extraction (SPE) for sample desalting and purification 
(Abonnenc, Dayon, Perruche, Lion, & Girault, 2008). Similarly, Wei et al. developed a 
chip to co-culture different neuronal tissues and probe for growth factor signaling (Wei, 
Li, Mao, & Lin, 2011). Still a majority of these Chip-MS culturing cells on 2D and there 
have yet to be a Chip-MS utilizing 3D culture (van Duinen, Trietsch, Joore, Vulto, & 
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Hankemeier, 2015). We envision that future work will trend towards more biomimetic 
systems utilizing 3D culture. 
5.3.3 Approaching Personalized Medicine 
Much of cancer research is still devoted to utilizing cancer cell lines due to their 
ease and feasibility for drug screening (Garnett et al., 2012). However, cell lines do not 
represent the heterogeneic nature of tumors found in patients that affect drug response. 
Personalize medicine is a new and evolving field that attempts to tailor drugs based on 
the patient’s genomic and phenotypic profile (Cheng et al., 2012). Although personalized 
genomic profiling can provide biomarkers, such as mutations or overexpressed proteins, 
that could be used to predict drug response, this method is still not reliable (Costello et 
al., 2014).  
To overcome some of these issues, testing of the patient’s own cells using 
technologies such as microfluidics could prove to be a powerful method for predicting 
drug response. Work done in Chapter 3 and 4 of this dissertation demonstrated to 
feasibility of using patient-derived cells in microfluidics. A limitation for many studies 
using convention in vitro techniques is that patient-derived cells may be difficult to grow 
in large-scale. However, one advantage that is specifically leveraged when using 
microfluidics is the small-scale nature of this technology enabling low sample input. 
Coupling this fact with the ability for microfluidics to assemble the tumor 
microenvironment through precise control of cell culture conditions demonstrates the 
capability of microfluidics technologies for personalized medicine. 
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Several works have already begun to utilize microfluidics to study personalized 
medicine using patient sample. Ruppen et al. developed a platform containing eight 
replicates of patient-derived cancer spheroids consisting of primary lung cancer cells and 
pericytes (Ruppen et al., 2015). Their work demonstrated that inclusion of patient-derived 
pericytes reduced drug efficacy of cisplatin. Furthermore, as we described in the previous 
section, the studies on the influence of ECM on cancer behavior within microfluidics has 
not been as well developed. In that regard, some works have utilized patient-derived 
ECM that could potentially be combined with microfluidics to build a more biomimetic 
model of cancer (Choi et al., 2014). Cukeirman et al. developed a method for producing 
3D in-vivo-like matrices with patient-derived fibroblasts, called cell-derived ECM 
(CDM), to better mimic native ECM for mechanistic studies of different diseases 
(Franco-Barraza, Beacham, Amatangelo, & Cukierman, 2016). This method was adopted 
to characterize a series of patient-derived fibroblasts demonstrating that fibroblasts grown 
in their own CDM mimicked their in vivo characteristics in terms of expression of α-
SMA and activated FAK (Quiros et al., 2008). As such, adopting these methods for 
patient-derived ECM with microfluidic technology could provide a potential avenue 
towards personalized medicine and building a better and more predictive model of tumor 
behavior.  
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Figure A.1. Detailed schematic of tumor-stroma loading. Cancer cells (red) are injected 
into the tumor region. The stroma (green), with or without stromal cells, are injected into 
the stromal region. Media is added into the media channels. 
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Figure A.2. Depth coding of cells encapsulated within the matrix. The color represents 
where the cells are located within the 3D space.  
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Figure A.3. Whole-device images taken of actin-stained (green) cells in both conditions 
on day 4. It was apparent that by day 4, more cells within the (+) EGF group reached the 
area past the stroma (scale bar: 100 µm).  
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Figure A.4. MCF-7 3D invasion assay. (A) Devices were split into two groups where one 
group (+ EGF) was introduced to EGF (50 ng/mL) and the other was not exposed to EGF 
(- EGF). (+) EGF MCF-7 cells migrated out from the tumor region by day 2 with minor 
invasion by day 4. (-) EGF group showed little migration (scale bar: 100 µm). (B) 
Invasion distance of the tumor front was calculated from the radial distances of the 
furthest cells from the tumor region. (+) EGF exhibited significantly higher invasion by 
day 2 (P < 0.05 calculated from student’s T test with more than three devices for each 
condition). (D) Comparing (+) EGF groups between SUM-159 and MCF-7 cells showed 
that SUM-159 had almost 10-fold higher invasion (P < 0.05 calculated from student’s T 
test with more than three devices for each condition). 
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Figure A.5. (A) Cell count was quantified as the increase in fluorescently labeled cells 
over time (scale bar: 100 µm). (B) Ki-67 index was imaged and quantified by comparing 
expression of Ki-67 (red) and nuclei (blue) (scale bar: 20 µm). (+) EGF group showed 
significantly higher expression of Ki-67 compared to (-) EGF (P < 0.05 calculated from 
student’s T test with more than three devices for each condition). 
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Figure A.6. Investigation of EGFRs over time. (A) Cells were stained for EGFR (red) and 
nuclei (blue) (scale bar: 20 µm) within the first 24 h of culture on 2D glass and in the 
microfluidic device. Z-projection of cells showed EGFR near the membrane. (B) Cells 
were treated with EGF for 24 h (Day 2) and 72 h (Day 4). By day 2, (+) EGF 
demonstrated punctate EGFRs in the cytoplasm while (-) EGF showed localization to the 
cell membrane still. Day 4 showed that both conditions had punctate EGFRs but (+) EGF 
displayed clustering toward the nuclei.  
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Figure A.7. (A) AR was correlated to protrusions under the two conditions and R-squared 
for both conditions were determined to be 0.11 (p < 0.001) and 0.00 (p = 0.61) for (-) 
EGF and (+) EGF respectively. These results suggested that AR and cell protrusions 
slightly correlated prior to EGF stimulation, but upon introduction of EGF the correlation 
was reduced to none or could not be determined. (B) When correlated to circularity, it 
could be seen under (-) EGF condition that the circularity sharply decreased when cell 
protrusions increased (R-squared = 0.45, p < 0.0001). For (+) EGF, circularity 
moderately declined with increasing cell extensions where the correlation was weaker 
than without EGF (R-squared = 0.16, p < 0.001).  
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Figure A.8. (A) Z-projection of actin-stained images of cells on 2D substrate (left) and 
within the 3D matrix (right, scale bar: 25 µm). (B) Z-projection of F-actin staining of 
cells leaving the collagen matrix (yellow arrow) and protruding toward the glass (white 
arrow, scale bar: 50 µm).  
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Figure A.9. Analysis of persistence between the whole-population of cells to the filtered 
cells using a two-way ANOVA and multiple comparison’s test. * indicates a significantly 
different group when P < 0.05. 
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Figure B.1. Characterization of fibroblast markers. (A) Fibroblasts expressed vimentin 
and αSMA but did not express cytokeratin. MCF-7 expressed cytokeratin but did not 
express vimentin or αSMA. SUM-159 expressed cytokeratin and vimentin but not 
αSMA. Scale bar: 50 µm. (B) Percent of αSMA positive fibroblasts were significantly 
lower in NFs. * denotes a significantly different group for p <0.05. (C) Western blot of 
αSMA corroborated the imaging data. Vinculin was used as the loading control. (D) 
Quantification of western blot showed significantly lower αSMA expression in NFs. * 
denotes a significantly different group for p <0.05. 
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Figure B.2. Characterization of fibroblast behavior. (A) F-actin staining was used to 
delineate cell shape and area. (B) CAF2 and CAF3 had significantly enhanced cell area. 
(C) NFs had significantly increased aspect ratio compared to CAF2. * denotes a 
significantly difference for p <0.05.  (D, E) Wound healing assay depicts 2D migration of 
fibroblasts with no significant difference between them.  
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Figure B.3. Patient-derived fibroblast behavior in the stroma region of the microfluidic 
device. (A) Representative images of fibroblast location over 3 days. (B) Representative 
actin cytoskeleton image of fibroblasts in 3D. (C) Migration per day of fibroblasts.  (D) 
Spreading cell area within 3D stroma region. * denotes a significantly different group for 
p <0.05. (E) Aspect ratio of fibroblasts. 
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Figure B.4. SUM-159 migration in microfluidic over time. SUM-159 cells migrated in 
presence or absence of fibroblasts. Dashed lines represent average invading tumor front. 
  
  207 
 
Figure B.5. Breast cancer cell line behavior in response to CAF co-culture. (A) MCF7 
cells migrated into stroma in presence or absence of CAFs. * denotes a significant 
difference for p <0.05; paired t-test. (B) MDA-MB-231 cells migrated into stroma in 
presence or absence of CAFs. * denotes a significant difference for p <0.05.  
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Figure B.6. Additional clinical data determining the relevance of GPNMB in breast 
cancer. (A) GPNMB expression in different breast cancer subtype extracted from data 
sets queried in CBioPortal. (B) Kaplan–Meier analysis of distant metastasis free survival 
based on high or low GPNMB expression from Geneanalytics tool 
(http://geneanalytics.duhs.duke.edu). Patients were divided into two groups with different 
survival curves using GPNMB gene expression (quartile cutoff was set at 25% high and 
75% low GPNMB expressions). HR, 1.75; P = 4e-4. (C) Kaplan–Meier analysis of 
overall survival based on high or low GPNMB expression from GeneAnalytics tool. HR, 
2.46; P = 7e-4 
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Figure B.7. GPNMB expression in breast cancer cell line. (A) Western blot showed high 
expression in SUM-159 and MDA-MB-231 cells and low in MCF7 and MCF10A cells. 
Expression was relative to SUM-159. (B) Maximum intensity z-projection demonstrated 
that expression of GPNMB was increased in SUM-159 breast cancer cells in co-culture. * 
denotes significant difference for p < 0.05; unpaired t-test. 
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Figure B.8. Characterization of GPNMB knockdown lines. (A) Western blot showed 
knockdown of GPNMB in SUM-159 breast cancer cells. Expression was normalized to 
total protein. shG #1 and shG #4 were chosen for subsequent experiments. shG #2 had 
little growth in culture. (B) Maximum intensity z-projection demonstrated that GPNMB 
expression in knockdown lines on 2D glass substrate. (C) 2D Proliferation assay using 
AlamarBlue® for knockdown lines. shCtrl showed higher cell count after 3 days. * 
denotes a significant difference for p <0.05.  (D, E) 2D Morphometric analysis showed 
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lower cell area and higher circularity for GPNMB knockdown lines suggesting lesser 
invasive capacity.  * denotes a significant difference for p <0.05. (F) 2D collagen 
adhesion assay showed no statistical difference in adhesion for shCtrl and shG lines. 
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Figure C.1. Vessel morphology during GSC invasion. (A) Comparison of length of 
vessels between junctions and (B) diameter of vessels under different media conditions. 
(1-way ANOVA with Tukey’s post-hoc test; n = 3 for each data set).   
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Figure C.2. Microvascular network morphology in co-culture with GSCs. (A) 
Immunofluorescence staining of established vasculature (CD-31, green) in microfluidic 
model in co-culture with GSCs. Cross-sectional view (red lines) depicting the hollow 
lumen of microvascular network; Scale bar: 50 µm. (B) Surface rendering with (C) front 
view (Scale bar: 50 µm) and inner membrane of the network. The white dashed circles 
show the different vascular branches; Scale bar: 10 µm. 
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Figure C.3. CXCL12/CXCR4 signaling in EGM-2 condition. (A) Phase-contrast image of 
GSC (red) invading in presence of HUVECs in different concentrations of AMD3100 in 
EGM-2 condition. Red dashed line delineates average migration boundary; Scale bar: 100 
µm. (B and C) Quantification of migration distance in mono- and co-culture conditions. 
(* denotes p < 0.05; Student’s T-test; n > 3 for each data set).  
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Supplementary videos are readable using media players in Windows operating system.  
Chapter 2: 
Movie D.1. Time-lapse movie of cells migrating throughout the stroma. Movie duration: 
18h, time interval: 45 min, scale bar: 200 µm. 
Movie D.2. Z-projection movie of migrating cells within the stroma matrix. 
Movie D.3. 3D movie of migrating cells within the stroma matrix (scale bar: 100 µm). 
The cells were analyzed using the NIS Elements AR Microscope Imaging Software by 
Nikon. The fluorescent movies were converted to binary and thresholded. The software 
automatically calculated 3D cell bodies based on the Z-stack images. Next, the cells were 
tracked using the tracking module, which revealed the differences in cell speed and 
persistence.  
Movie D.4. Z-projection of actin (green) and tubulin (red) stained cells in (-) EGF 
condition.   
Movie D.5. Z-projection of actin (green) and tubulin (red) stained cells in (+) EGF 
condition.   
Movie D.6. Z-projection of actin (green) and tubulin (red) stained cells comparing the 
cells on 2D substrate and within the 3D stroma.  
Movie D.7. Z-projection movie of migrating cells on 2D plane. 
Chapter 3: 
Movie D.8. Time-lapse imaging of SUM-159 breast cancer cells migrating through the 
3D stroma in absence of CAFs. 
Movie D.9. Time-lapse imaging of SUM-159 breast cancer cells migrating through the 
3D stroma in presence of CAFs. 
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Movie D.10. Time-lapse imaging of CAFs migrating through the 3D stroma in absence of 
SUM-159 breast cancer cells. 
Movie D.11. Time-lapse imaging of CAFs migrating through the 3D stroma in presence 
of SUM-159 breast cancer cells. 
Movie D.12. Time-lapse imaging of shCtrl line migrating through the 3D stroma. 
Movie D.13. Time-lapse imaging of shG #4 line migrating through the 3D stroma. 
Chapter 4: 
Movie D.14. GSC invasion in microfluidic. Surface rendering with fly through of 
migrating GSCs (red) near vasculature (green) within the microfluidic model. 
Movie D.15. Microvascular network morphology in co-culture with GSCs. Fly through of 
surface rendering showing the open lumens and inner membrane of the network. 
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Table E.1 Patient data for the patient-derived cancer-associated fibroblasts 
    
    
    
  Patient #1 Patient #2 Patient #3 
Age 71 50 82 
Type  Infiltrating Lobular Invasive ductal 
carcinoma with focal 
squamous 
differentiation 
Invasive 
Tumor Size 2.1 cm 2.3 cm 2.6 cm 
Stage 1 2 3 
Receptor Status ER+, PR+, Her2- ER+, PR+, Her2- ER-, PR-, Her2- 
Lymph Node 3/6 1/2 1/11 
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Table E.2. List of differentially expressed genes between CAF and NF co-cultures 
      
      
      
Gene 
ID 
Gene 
Symbol 
Description Log2(fold 
change) 
CAF/NF 
p-
valu
e 
FD
R 
1032
4 
KLHL41 kelch like family member 41 1.15 4.8E
-05 
3.6E
-02 
6843 VAMP1 vesicle associated membrane protein 
1 
1.11 2.5E
-05 
3.1E
-02 
6931
97 
MIR612 microRNA 612 1.00 3.4E
-05 
3.5E
-02 
6412
9 
TINAGL
1 
tubulointerstitial nephritis antigen 
like 1 
0.94 2.3E
-05 
3.1E
-02 
1045
7 
GPNMB glycoprotein nmb 0.91 1.3E
-06 
6.3E
-03 
633 BGN biglycan 0.86 4.3E
-05 
3.6E
-02 
4027
78 
IFITM10 interferon induced transmembrane 
protein 10 
0.82 2.1E
-05 
3.1E
-02 
1499
54 
BPIFB4 BPI fold containing family B 
member 4 
0.78 7.4E
-05 
4.8E
-02 
1148
23 
LENG8 leukocyte receptor cluster member 8 0.73 5.1E
-05 
3.6E
-02 
5128
6 
CEND1 cell cycle exit and neuronal 
differentiation 1 
0.72 4.6E
-05 
3.6E
-02 
3576 CXCL8 C-X-C motif chemokine ligand 8 -0.55 5.6E
-05 
3.8E
-02 
4604 MYBPC
1 
myosin binding protein C, slow type -0.62 2.6E
-05 
3.1E
-02 
5493
5 
DUSP23 dual specificity phosphatase 23 -0.71 3.0E
-05 
3.2E
-02 
9021 SOCS3 suppressor of cytokine signaling 3 -0.77 1.8E
-05 
3.1E
-02 
8487
9 
MFSD2A major facilitator superfamily domain 
containing 2A 
-0.81 4.0E
-05 
3.6E
-02 
5142 PDE4B phosphodiesterase 4B -0.88 4.1E
-05 
3.6E
-02 
3569 IL6 interleukin 6 -0.98 9.4E
-06 
2.2E
-02 
6288 SAA1 serum amyloid A1 -1.44 2.4E
-07 
3.4E
-03 
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7850 IL1R2 interleukin 1 receptor type 2 -1.49 3.6E
-06 
1.3E
-02 
6004 RGS16 regulator of G-protein signaling 16 -1.49 6.1E
-07 
4.3E
-03 
6289 SAA2 serum amyloid A2 -1.73 1.2E
-05 
2.4E
-02 
6279 S100A8 S100 calcium binding protein A8 -2.40 8.3E
-06 
2.2E
-02 
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